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ABSTRACT 
 
 
 
ABSTRACT 
Group B Streptococcus (GBS) is a leading cause of neonatal meningitis and 
septicaemia. During the progression of invasive disease, GBS must be able to detect 
and adapt to a diverse range of environments. One of the challenging environments 
the organisms will encounter is the antimicrobial phagosome of cells of the innate 
immune system.   
Combining microscopy with pharmaceutical approaches, I have been able to show 
that GBS is residing within a vacuole that acquires phagolysosomal markers and, 
that acidification of the phagosome is required for GBS to survive.  In addition this 
work has demonstrated that GBS induces only a weak reactive oxygen burst in 
macrophages and consequently reactive oxygen species are of limited importance.  
Interestingly, however, the GBS acid response regulator CovS/R is crucial for the 
organism’s ability to survive within murine macrophages. This is most likely due to 
the regulation of genes required for adaption to the intracellular environment. 
Lastly, to facilitate investigations into the interaction of GBS with the phagosome it 
would be desirable to be able to visualise live organisms within cells. In the final part 
of this thesis, I describe an evaluation of different approaches to generate a suitable, 
fluorescently labelled, strain of GBS.
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THESIS OVERVIEW 
Group B Streptococcus is the leading cause of neonatal septicaemia and meningitis 
in the UK. During the natural course of invasive disease the organism must be able 
to overcome the efforts of the host immune system.  Chapter One reviews potential 
methods that the organism can use to overcome barriers to infection, both physical 
and immunological, with a particular focus on the organism’s ability to persist within 
phagocytic cells. 
An intracellular survival assay was developed to quantitatively analyse GBS survival 
within phagocytic cells, specifically macrophages. Chapter Three describes work 
performed using this assay to investigate intracellular survival from the organism’s 
perspective. The contribution of known virulence factors to intracellular survival was 
measured by looking at strains deleted in these genes. 
Chapter Four focuses on the host response to GBS, by first asking whether this is 
actively modified by the organism and then looking specifically at the role of reactive 
oxygen species and phagosome acidification on control of intracellular organisms. 
Chapter Three and Four should be considered together to gain a better 
understanding of the host pathogen interactions of GBS and consequently chapter 
five draws together and discusses the data from the two previous chapters. This 
chapter combines the results obtained from this study with published evidence to 
suggest possible explanations for my findings and also proposes future lines of 
enquiry.   
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Chapter Six is a “stand alone” chapter describing an on-going project throughout this 
study; the development and evaluation of a strain of GBS expressing GFP. The 
availability of such a tool would be greatly beneficial to the study of the fate of GBS 
within host cells.
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1.1 GROUP B STREPTOCOCCUS 
Lancefield group B streptococcus (GBS) or Streptococcus agalactiae is a Gram 
positive encapsulated bacterium exhibiting  haemolysis on blood agar.  The 
organism is found as a commensal in the gastrointestinal and the genitourinary tract 
of up to 30% of healthy adults.  However, GBS is a significant cause of neonatal 
meningitis and septicaemia; in 2010 the rate of bacteraemia (England, Wales and 
Northern Ireland) in neonates up to 90 days was 0.64 per 1000 live births (HPA, 
2011). Infection is seen increasingly in adults, especially those with underlying 
diseases, particularly diabetes mellitus, and in 2005 two thirds of all invasive GBS 
infections in the US were in older adults (Edwards and Baker, 2005). GBS is also a 
significant agricultural and veterinary problem, since it can colonise the mammary 
glands of ruminants  and is the major course of subclinical mastitis (Sorensen et al., 
2010). Rarely, it has  been isolated from dogs, horses, guinea pigs and fish (Elliott et 
al., 1990)
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1.1.1 The Genus Streptococcus 
Bacteria, Firmicutes, Bacilli, Lactobacillales, Streptococcaceae, Streptococcus, 
Streptococcus agalactiae. 
Functionally, Group B Streptococcus are classified as homofermentative lactic acid 
bacteria, since they produce lactic acid as the sole or major fermentation product.  As 
catalase-negative, non-sporulating, Gram positive cocci with a low GC content they, 
along with most of the other lactic acid bacteria, fall in the phylum Firmicutes, order 
Lactobacillales (Figure 1). Lactobacillales is a diverse order containing industrially 
important genera including Lactococcus, Enterococcus, Streptococcus, Oenococcus, 
Pediococcus, Leuconostoc and Lactobacillus (Makarova et al., 2006). 
The family Streptococcaceae (Figure 2) includes the species Enterococcus, generally 
associated with faeces, Lactococcus, associated with plants and dairy products, and 
Streptococcus (Makarova and Koonin, 2006). 
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Makarova K et al. PNAS 2006;103:15611
Figure 1:  Phylogeny of the Lactobacillales
Phylogenetic trees of the order Lactobacillales constructed on the basis of concatenated alignments of 
ribosomal proteins.  Species are coloured according to  family:  Lactobacillaceae, blue; Leuconosto-
caceae, magenta; Streptococcaceae, red.  The Genus Streptococcus  represented by the species Strepto-
coccus thermophilus   and  the genus  Lactococcus  with the species Lactococcus lactis  subspecies 
cremoris  can be seen on different branches of the family Streptococcaceae. Modified from (Makarova, 
Slesarev et al. 2006)
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Figure 2: The position of Streptococcus agalactiae (GBS) within the Lactobacillales
A phylogenetic tree of the order Lactobacillales constructed on the basis of concatenated alignments of 
four subunits of the DNA-dependent RNA polymerase.  The family Streptococcaceae is highlighted in red, 
the two organisms that have been used in this study S.agalactiae  and L.lactis  are boxed. Modified from 
Makarova et al (Makarova and Koonin 2007)
Makarova K S , Koonin E V J. Bacteriol. 2007;189:1199
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Streptococcal species of clinical importance are split into six groups based on 
pathogenic and clinical features. Streptococcus agalactiae falls into the pyogenic 
group.  The pyogenic streptococci are identified on blood agar plates by the classical 
zone of β haemolysis surrounding colonies.  Further classification of the -haemolytic 
streptococci is by serological typing of the polysaccharide capsule, a method 
developed by Rebecca Lancefield in the 1940s.  Streptococcus agalactiae is 
serologically classified as Lancefield Group B, hence it being commonly called Group 
B Streptococcus or GBS (Madigan et al., 2006, Greenwood et al., 2002).  
Despite bring described as homofermentative, the organism is predicted to be able to 
ferment a variety of carbon sources to produce a number of different by-products, 
including lactate, acetate, ethanol, formate and acetoin.  Bovine strains are able to 
ferment lactose, present at high levels in the mammary glands;  this is less often 
seen in strains isolated from humans, with only 13% of 128 clinical isolates having 
this ability, including the strain used in this work NEM316  (Sorensen et al., 2010). 
The organism is aero-tolerant and can undergo respiration if the environment can 
supply quinone or haem which will activate an electron transport chain (Yamamoto et 
al., 2006, Rezaïki et al., 2008).  GBS is auxotrophic for several essential amino acids.  
Based on genome sequencing it appears that the organism has a genetically similar 
bioenergetic metabolism to Lactococcus (Glaser et al., 2002).
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1.1.2 Group B streptococci show considerable intraspecies diversity 
Group B streptococci are sub classified into ten serotypes according to the 
immunological reactivity of the polysaccharide capsule.  Of these, serotypes Ia, Ib, II, 
III and V are responsible for the majority of human invasive disease.  Serotype III is 
the serotype most often isolated from neonatal disease and is associated with 80% of 
cases of neonatal meningitis. Serotype V is the most common serotype isolated from 
GBS infection in non pregnant adults (Glaser et al., 2002, Johri et al., 2006).  Multi-
locus sequence typing has identified six main clonal complexes; CC1, CC10, CC23, 
CC19, CC17 and CC67 (Tazi et al., Sorensen et al., 2010, Jones et al., 2003c, 
Brochet et al., 2006, Tettelin et al., 2005).  Sequence type 17 (ST17) is the 
predominant sequence type isolated from neonatal meningitis, this lineage appears 
to represent a highly successful invasive clone and is described as hypervirulent 
(Manning et al., 2009, Brochet et al., 2006, Jones et al., 2003c, Poyart et al., 2008). 
The emergence of ST17 is thought to have occurred via stepwise genome 
recombination from other clonal types, this group appear to be host adapted and 
show less diversity than other sequence types (Sorensen et al., 2010). The genomes 
of Streptococcus agalactiae NEM316 (serotype III), A909 (serotype Ia) and 2603v/r 
(serotype V) have been fully sequenced.   
The GBS genome is approximately 2100Kb in size with 2000 predicted protein 
coding genes. From the sequenced strains it is estimated that approximately 80% of 
genes form a core genome, with a large and still increasing pan genome (Tettelin et 
al., 2005). The genome contains a large number (14) of putative chromosomal 
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pathogenicity islands, which are not seen in other streptococcal genomes sequenced 
to date (Glaser et al., 2002).  However, despite carrying putative virulence 
determinants none of the identified pathogenicity islands have been specifically 
linked to disease phenotype (Herbert et al., 2005). 
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2. GROUP B STREPTOCOCCAL DISEASE 
Group B Streptococcus emerged as a cause of neonatal meningitis, sepsis and 
pneumonia in the 1970’s (Anthony and Okada, 1977). GBS had been previously 
been identified as having the potential to cause human infection,  but it is possible 
that during this period the clonal expansion of a successful host adapted lineage  
increased the prevalence of the disease. This has been seen recently with ST-17 
clones (Sorensen et al., 2010). In England, Wales and Northern Ireland the rate of 
GBS bacteraemia including neonatal disease is 2.8 per 100 000 population (HPA, 
2011).
 
1.2.1 Colonisation 
Group B Streptococcus is part of the normal human microbiota and approximately 
30% of the population are colonised at any one time. Colonisation is important as it 
appears to precede invasive disease.  GBS has been isolated from the rectum, 
perianal area, vagina, cervix and urethra (Melin, 2011). Many of the prevalence 
studies looking at colonisation have been carried out on pregnant women and from 
these it is known that colonisation rates are higher in sexually active individuals, 
especially those with multiple sexual partners, and increases with maternal age 
(Sendi et al., 2008, Rocchetti et al., 2010) .  It is known that the vaginal flora can be 
an important factor in pregnancy outcome and GBS colonisation is associated with 
previous spontaneous abortion (Rocchetti et al., 2010).    
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1.2.2 Neonatal disease 
Neonatal disease is subdivided into early onset disease (EOD), in which presentation 
occurs within the first week of life, and late onset disease (LOD) for cases presenting 
between one week and three months of life (90 days).  60-70% of neonatal GBS 
disease is early onset. 
 Neonatal disease is preceded by the asymptomatic colonisation of the female genital 
tract during pregnancy and 30-70% of babies born to colonised mothers will be 
colonised themselves. 1-3% of babies born to colonised mothers will develop disease 
(Schuchat, 1999, Melin, 2011, Daniels et al., 2011, Heath and Schuchat, 2007). 
Density of vaginal colonisation is thought to be the most significant risk factor for 
early onset neonatal disease (Hansen et al., 2004, Van Der Mee-Marquet et al., 
2009), although additional maternal and obstetric risk factors for the development of 
EOD  include (Poyart et al., 2008, Melin, 2011) : 
 Premature birth or low birth weight 
 Prolonged rupture of amniotic membranes 
 Maternal fever during labour or chorioamnionitis,  
 GBS isolated from urine samples during pregnancy  
 A previous baby being born with GBS disease. 
The route of infection in early onset neonatal disease is thought to be fetal aspiration 
of the vaginal contents during passage through the birth canal, or by ascending 
infection. The organism may travel through intact or ruptured amniotic membranes 
into the amniotic fluid, where it is able to replicate and be aspirated.  Following 
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aspiration by the fetus the organism can remain localised in the lungs, causing 
pneumonia, or progress to sepsis (72%) and meningitis (2.5%) (Poyart et al., 2008, 
Doran and Nizet, 2004). Mortality rates for early onset disease have decreased in 
recent years from 50% to 4-10%, due to the implementation of prevention measures.  
Despite improvements in treatment, however, 50% of infants that survive neonatal 
disease will have long term neurological sequelae (Daniels et al. 2011, CDC, 2010). 
Late onset disease commonly presents as meningitis or bacteraemia. The route of 
infection is yet to be proven but exposure is likely to be via horizontal transmission 
from the mother or a contaminated environment (Melin, 2011). The organism may 
then gain accesses to the blood stream by adhering to and translocation of the gut 
epithelium (Tazi et al., 2010).   LOD carries a lower mortality rate than early onset 
disease at 2-6% (Schuchat, 1999, Johri et al., 2006), however deaths attributable to 
meningitis are higher at 14.5% of all LOD fatalities, compared to 2.5% in EOD 
(Poyart et al., 2008, Tazi et al., 2012).
 
1.2.3 Adult disease 
Group B Streptococcus can cause maternal infection during pregnancy or labour, 
being associated with approximately 12-25% of puerperal fever (infection during 
childbirth). In pregnant women, GBS cause endometritis, chorioamnionitis and 
bacteremia (Rodriguez-Granger et al., 2012). Women colonised with GBS during 
pregnancy are at increased risk of stillbirths and premature delivery (Melin, 2011).  
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In non-pregnant adults GBS can cause skin and soft tissue infections, urinary tract 
infections, infection of the joints and a wide range of other presentations. The 
incidence in the US of invasive GBS disease in adults has been reported as 2.4-4.4 
cases per 100,000; this rate is rising, which could be a reflection of the increasing 
population at risk. In the non-pregnant adult population risk factors for GBS disease 
include co-morbidities such as diabetes mellitus, cardiovascular disease, liver 
disease and cancer (Edwards and Baker, 2005).   
Recently cases of GBS causing necrotising fasciitis and toxic shock syndrome have 
been reported in both adults and neonates (Sendi et al., 2009b). Relapsing infection 
has been seen in adults, especially presenting as cellulitis, this could be due to a 
reservoir in the GI tract, repeated exposure through a close contact or insufficient 
tissue clearance due to poor lymphatic drainage. However there is the possibility that 
the organism inhabits a privileged niche such as within host cells, preventing 
clearance (Sendi et al., 2008).
 
1.2.4 Epidemiology of disease and serotype distribution 
Five serotypes (Ia, Ib, II, III and V) are responsible for 85% of neonatal GBS disease 
worldwide and the distribution of these serotypes is the same across all WHO regions 
(Edmond et al., 2012). Type III is the most prevalent serotype, being isolated from 
37% of EOD and 67% of LOD (Weisner et al., 2004). A similar serotype distribution is 
also seen within isolates causing adult disease and is representative of the 
colonisation frequency of the different serotypes (Sendi et al., 2008). 
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1.2.5 Prevention of Group B Streptococcal disease 
Current prevention of GBS disease in the UK is based on the administration of 
antibacterial prophylaxis, immediately before and during labour (Intrapartum 
prophylaxis or IAP) to women who have been identified to have risk factors.  If the 
antibiotics are able to be administered four hours before birth it has been shown to 
significantly reduce the chance of babies born to colonised mothers becoming 
themselves colonised (from 40% to 25%) (Daniels et al., 2011). The implementation 
of IAP in the UK to at risk groups in 2000-2003 reduced the rate of culture-proven 
early onset disease by 83% (Brocklehurst and Kenyon, 2008, CDC 2010, Heath and 
Schuchat, 2007). 
Guidelines introduced in 2002 in the USA advised screening all pregnant women at 
35-37 weeks gestation, followed by IAP if a positive result was obtained. Screening 
has reduced the rate of EOD by a further 20-40% (CDC, 2010). Screening of all 
pregnant women at 35-37 weeks gestation has also been implemented in other 
European countries. Current United Kingdom National Institute of Clinical excellence 
(NICE) guidelines state ‘Pregnant women should not be offered routine antenatal 
screening for Group B Streptococcus because evidence of its clinical and cost 
effectiveness remains uncertain.’ (NICE, 2010). This has been further supported by a 
modelling study which suggested that the safest and most cost effective way to 
further reduce GBS disease in the UK is to give all women IAP without screening, a 
practice which would not be practical or well received (Kaambwa et al., 2010, 
Brocklehurst and Kenyon, 2008).  One of the problems with the screening protocol is 
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the sensitivity of detection and the fact that the absence or presence of the organism 
at the time of screening is not necessarily predictive of the presence or absence of 
the organism at the time of birth.  Trials have been carried out looking at rapid 
screening methods at the time of labour using nucleic acid amplification based 
techniques,  but the conclusions from these have not supported changing current 
guidelines (Daniels et al., 2011, Brocklehurst and Kenyon, 2008, CDC, 2010) . In the 
USA, approximately 30% of all women now receive antibiotics during labour (Stoll et 
al., 2011).   
One study has suggested that the increased use of antibiotics has increased the 
incidence of neonatal sepsis with E.coli (Johri et al., 2006). However, generally the 
concern that IAP would increase the rate of sepsis with Gram negative resistant 
organisms has not been proven and GBS remains the leading causative organism of 
neonatal sepsis despite preventative measures (Stoll et al., 2011).  
IAP has reduced the incidence of EOD but has not changed the incidence of LOD 
which has remained steady over a 20 year period at about 0.4 cases per 1000 live 
birth (CDC, 2010, Melin, 2011).
 
1.2.6 Treatment and antibiotic resistance 
Treatment of GBS disease is with Penicillin or other -lactam antibiotics with 
resistance being very rare. In cases where penicillin is counter indicated 
Erythromycin or Clindamycin would be the second choice. Resistance to macrolides 
and clindamycin is reported at 14% and 10% respectively. Resistance is thought to 
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be brought about by methylation of ribosomal RNA, thus altering the target site of the 
drug, or due to the presence of an efflux pump (HPA, 2011).  An intriguing treatment 
possibility is to increase the ability of the host immune system to remove the 
organism by giving passive immunity (Senn et al., 2011).
 
1.2.7 Vaccine development 
Currently there is not a vaccine available for Group B Streptococcus, although 
vaccination is an attractive preventative strategy. It is known that high levels of 
capsular type specific antibodies are protective against invasive neonatal disease 
(Lin et al., 2004). It could be predicted that vaccination, unlike IAP, could also reduce 
the incidence of LOD and adult disease.  Capsular polysaccharide vaccines with 
tetanus toxoid or CRM conjugates are in human clinical trials, and protective levels of 
antibodies have been seen for up to two years following vaccination (Heath, 2011).  
Antibodies raised against the capsule have been shown to be protective but only 
against homologous serotypes, thus a successful vaccine would need to be 
multivalent.  Vaccination against serotypes III, Ia and V could theoretically provide 
protection against 88% of GBS disease in the UK (Weisner et al., 2004). The 
disadvantages of capsular polysaccharide vaccines, notably the poor immunogenicity 
of polysaccharide and the serotype specificity, have led to research looking at GBS 
surface expressed proteins as potential vaccine candidates. Out of the proteins being 
investigated only two, the C5a peptidase and Sip are conserved at the gene level in 
most isolates, highlighting the challenges encountered with this approach (Johri et 
al., 2006).  
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1.3 OVERCOMING BARRIERS TO INFECTION 
1.3.1 Physical barriers 
GBS is able to colonise the mucus membranes lining the gastrointestinal and 
genitourinary tract of humans. If the organism is able to breach these barriers and 
gain access to the soft tissue and bloodstream it can lead to serious disease.  
Multiplication of the organism in the bloodstream can lead to bacteraemia and sepsis, 
whilst adherence to endothelial cells can lead to penetration of the blood brain barrier 
and the development of meningitis (Figure 3).
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Figure 3: Barriers to infection
Group B Streptococcus is able to adhere to the mucus membranes of the gastrointestinal and genitourinary 
tract (1).  In pregnant women the organism can ascend, invade the chorioamniotic membranes and replicate in 
the amniotic fluid (2). In EOD the organism enters the body through the lungs (3) in LOD the route of entry may 
be the gut epithelial cells (4). Within the mucosal tissue and the lung tissue resident macrophages will be the 
first cells of the immune system to encounter invading GBS. The organism is able to cross lung endothelial and 
epithelial cells and gut epithelial layers to gain access to the blood stream (5). The host prevents invading 
organisms from surviving in the blood by the presence of soluble factors such as antibodies or complement  
and the antimicrobial cells of the innate immune system namely the professional phagocytes, monocytes and 
polymorphonucleocytes (PMN’s).  From the blood stream the organism can adhere to and invade brain 
microvessel endothelial cells (BMEC) then cross the blood brain barrier (6).  In adults the organism has been 
associated with skin and soft tissue infections, urinary tract infections and joint and bone infections (7) 
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1.3.1.1 Adhesion and invasion into cells 
GBS has been shown to adhere to and invade vaginal epithelial cells (Sheen et al., 
2011), lung epithelial and endothelial cells, human brain microvessel endothelial cells 
and gut epithelial cells (Rubens et al., 1991, Rubens et al., 1992, Tazi et al., 2010). 
Adherence and invasion has been shown both in tissue culture and in whole 
organism infection. Adherence to the extracellular matrix is an important factor in the 
establishment of disease and it is noteworthy that the highly virulent ST-17 clones 
show enhanced adherence properties, due to a combination of a unique surface 
protein HgvA (Tazi et al., 2010), regulation of fibrinogen binding through the two 
component system (TCS) RgfA/C (Safadi et al., 2011) and a novel keratin binding 
Srr-2 protein (Seifert et al., 2006).  Cell adherence may confer host specificity; bovine 
strains do not contain the genetically linked fibronectin binding ScpB protein and the 
laminin binding Lmb protein (Lindahl et al., 2005). 
Successful colonisation by GBS of mucus membranes may be initially dependent 
upon an organism’s ability to interact with the extracellular matrix (ECM). The ECM is 
a structural component of epithelial and endothelial cell layers consisting of 
glycoproteins such as collagen, laminin, fibronectin and fibrinogen. Initial low avidity 
interactions between lipotechioic acid in the organisms cell wall and ECM allows for 
surface expressed proteins to form stronger bonds with ECM components. GBS has 
numerous cell surface proteins implicated in binding epithelial cells, endothelial cells 
and ECM components; two of these currently attracting interest in the field are the 
pilus protein and HvgA. These are highlighted later in this section.  Binding to the 
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ECM is multifactorial, since proteins that show isolated binding properties are 
dispensable for binding in the whole organism (Dramsi et al., 2012). In addition many 
of the proteins appear to have multiple ligands, allowing the organism to attach to a 
diverse range of cell types. 
Regulation of adherence 
GBS has a number of regulatory systems allowing the organism to respond and 
adapt to different environments encountered in the host. Proteins implicated in 
adherence appear to be under considerable, often negative, regulation. The 
transcriptional regulator RovS and the two component system CovS/R are both 
repressors of multiple genes whose products confer adherence to different ECM and 
cell types.   
Strains deleted in components of the CovS/CovR two component system show 
hyper-adherence (Lamy et al., 2004, Jiang et al., 2005). CovS/R is a repressor of the 
Rga transcription factor which is a positive regulator of the pilus and the Srr-1 
proteins (Dramsi et al., 2012).  However overexpression of the pilus protein PI-1 in 
CovS/R deleted strains does not appear to contribute to the hyper-adherence of the 
mutant  (Jiang et al., 2012).  CovS/R mutant strains also show overexpression of cell 
wall proteins, such as BibA and ScpB which have been indicated to have roles in 
adherence (Lamy et al., 2004, Jiang et al., 2005).   
Strains deleted in RovS show increased expression of fsbB a fibrinogen binding 
protein and demonstrate enhanced binding to fibrinogen and epithelial cells (Samen 
et al., 2006). As mentioned previously regulation of fibrinogen binding through the 
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TCS RgfA/C has been implicated as a factor leading to hyperadherence in the highly 
virulent ST-17 strain (Safadi et al., 2011). 
The Role of the Pilus protein in adhesion and invasion 
GBS displays a pilus protein which has been shown to be important for the 
organism’s ability to adhere to and invade multiple cell types (Maisey et al., 2008b, 
Lauer et al., 2005, Dramsi et al., 2006). In Gram positive organisms the pilus is 
predicted to have a role in cell adherence and biofilm formation.  All clinical isolates 
of GBS encode a pilus from at least one of the two loci, PI-1 and PI-2 (which has two 
allelic variants PI2a and PI2b).  Group B streptococcal pili are trimeric; a minor 
subunit of pilin PilC forms the base, covalently bound subunits of the major pilin PilB 
form the backbone and PilA (the adhesin) is located along the backbone and forms 
the tip. PilB was identified as a protein required for invasion but not for adhesion 
before the pilus structure was identified (Adderson et al., 2003) and is thought to be 
important in paracellular translocation of the organism (Pezzicoli et al., 2008). PilA is 
able to bind collagen by a Von Willebrand type A factor domain (Gilmore et al., 
2009). The pilus is not always essential for cell binding (Jiang et al., 2012), mostly 
likely due to the numerous other adherence factors on the surface of the organism. 
However, there is more support for the role of the pilus in cell invasion, maybe 
through the binding of collagen in focal adhesion kinases as shown on hBMEC 
(Banerjee et al., 2011, Tazi et al., 2012). 
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BibA, HvgA and hypervirulent  ST-17 
BibA is a surface expressed GBS adhesin which aids binding to epithelial cells (Santi 
et al., 2007). A variant in the BibA locus is seen specifically in the hypervirulent MLST 
type 17, this has been described as the Hypervirulent GBS adhesin (HvgA).  HvgA 
increases the adherence and invasion of ST-17 clones to intestinal epithelial cells 
and cells of the blood brain barrier, which could explain the increased association of 
this sequence type with late onset neonatal disease (Tazi et al., 2012, Tazi et al., 
2010).  
1.3.1.2 Invasion and tissue destruction 
During systemic infection GBS traverses lung epithelial and endothelial cell barriers, 
the blood brain barrier (BBB) and the intestinal epithelium, giving the organism 
access to body compartments such as the amniotic compartment, the blood stream 
and the central nervous system.  Bacterial translocation of cellular barriers can be 
through transcytosis, paracellular translocation or cell and tissue damage.  GBS has 
been reported to use all three of these mechanisms.  Epithelial cell layers may be 
broken down by internalised organisms causing apoptosis or necrosis of infected 
epithelial cells (Da Costa et al., 2011) or crossed by paracellular translocation 
(Soriano et al., 2006). The blood brain barrier is breached by cellular injury or 
transcytosis (Doran et al., 2003).  The organism has shown to be able to trancytose 
through intact chorion cell monolayers (Winram et al., 1998).  
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Tissue damage and destruction; pore forming toxins and enzymes 
One of the most important known virulence factors in Group B Streptococcus is the -
haemolysin/cytolysin (-h/c), a surface associated pore forming toxin which is 
responsible for the characteristic zone of haemolysis on blood agar plates (Nizet, 
2002, Nizet et al., 1996). The -h/c toxin is expressed by cylE, a single open reading 
frame on the cyl operon (Forquin et al., 2007). cylE deletion mutants have been 
shown to be less virulent than wild type GBS in animal models (Liu et al., 2004). Four 
main roles in pathogenicity have been ascribed to the cyl operon, (i) apoptosis in 
macrophages (Fettucciari et al., 2000, Ulett and Adderson, 2005) (ii) induction of a  
pro-inflammatory host response (Lembo et al., 2010), (iii) increased resistance to 
phagocytic killing (Liu et al., 2004) and (iv) induction of cytolysis.  The first three are 
discussed elsewhere in this chapter.  The cytolytic action of the -h/c toxin, can lead 
to cell necrosis, promoting bacterial invasion of epithelial and endothelial barriers and 
the production of pro inflammatory cytokines (Nizet et al., 1996).  β-h/c has been 
implicated in cytolytic injury to lung endothelial cells, brain endothelial cells and at 
sub-cytolytic concentrations can promote the organism’s invasion into cells (Nizet et 
al., 1996, Nizet, 2002, Doran et al., 2002).  
In addition to β-H/C, GBS also produces CAMP factor, a second pore forming toxin 
whose activity is seen mainly on red blood cells pre-treated with sphingomyelinase 
(Sterzik and Fehrenbach, 1985). Purified CAMP factor encoded by the cfb gene has 
been shown to be toxic when injected into rats (Lang and Palmer, 2003), although its 
role in virulence in the whole organism is uncertain (Hensler et al., 2008). 
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Group B Streptococcus also produces a hyaluronate lyase (Lin et al., 1994), which 
may aid tissue dissemination of the organism by breaking down hyaluron, a major 
component of the ECM found in high concentrations in the placenta, amniotic fluid 
and lung (Rajagopal, 2009).  
1.3.1.3 Crossing the blood brain barrier 
The blood brain barrier (BBB) comprises of choroid plexus epithelial cells and 
specialized brain microvessel endothelial cells (BMEC). The ability of GBS to cross 
the blood brain barrier has been suggested to be through a combination of 
mechanisms; direct invasion of the BMEC’s, toxin mediated damage and through the 
induction of a host inflammatory response which can compromise BBB integrity.  
Initial interaction of GBS with the BBB endothelium is likely to be through the 
attractive properties of LTA (Doran et al., 2005). Stronger attraction may then be 
mediated by the Srr-1 protein (Van Sorge et al., 2009), the organism’s ability to bind 
glycosaminoglycan (Gilmore et al., 2011) and the pilus protein (Maisey et al., 2007).  
Subsequent breakdown of the BBB seen in GBS meningitis is due to the production 
of inflammatory mediators and cytokines (Barichello et al., 2011). The production of 
pro-inflammatory cytokines and chemokines in the brain microvessel cells has been 
attributed to collagen binding by the pilus protein and the presence of β-haemolysin 
(Doran et al., 2003, Banerjee et al., 2011, Lembo et al., 2010). Both the pilus and the 
β-h/c are repressed by CovR, the response element of the CovS/R TCS. A strain 
deleted in CovR (and therefore overexpressing β-h/c) shows an increased ability to 
incite a pro-inflammatory response and penetrate the blood brain barrier (Lembo et 
al., 2010).
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1.3.2  Adaptation to the host environment 
During the course of GBS infection, the organism is able to detect and rapidly 
respond to different environments and challenges encountered within the host.  The 
organism can grow to a high density in the vagina, amniotic fluid, lung and 
bloodstream.  In such sites, conditions will be varied, ranging from the low pH and 
micro-aerophillic environment of the vagina to the neutral pH and aerobic conditions 
of the blood stream. Growth rate and resistance to immune clearance will determine 
the ability of the organism to establish infection (Johri et al., 2003). In addition to the 
benefit to the organism of having increased biomass within the host, increased 
growth rate also promotes invasion into cells and enhances resistance to immune 
clearance, this is thought to be due to growth phase gene regulation (Malin and 
Paoletti, 2001, Johri et al., 2003, Shelver et al., 2003). 
Adaptation  
The GBS transcriptome shows considerable plasticity and remodelling in response to 
growth phase, exposure to human blood or growth in amniotic fluid (Ahmed et al., 
2008, Mereghetti et al., 2008, Sitkiewicz et al., 2009). Regulation changes are 
complex, with global transcriptional regulators being both  up and down regulated.  
The CovS/R TCS, for example, shows down regulation after 30 minutes incubation in 
blood but is up-regulated at 90 minutes (Mereghetti et al., 2008).  Similarly, CovR is 
downregulated at late logarithmic phase in amniotic fluid (Sitkiewicz et al., 2009).  In 
both blood and amniotic fluid, the strongest differential gene expression is seen in 
genes mediating metabolism (Ahmed et al., 2008, Mereghetti et al., 2008, Sitkiewicz 
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et al., 2009). In amniotic fluid, in which the organism can grow, GBS is not seen to up 
regulate a stress response but there is an increase in transport of amino acids 
(Sitkiewicz et al., 2009). In contrast, after 90 minutes incubation in blood (Mereghetti 
et al., 2008), in which GBS cannot grow, stress response genes and cell surface 
factors that bind or activate fibrinogen are strongly activated (Mereghetti et al., 2008, 
Yang et al.). The cylE operon is up regulated in amniotic fluid and also at fever 
temperature, this may have implications for pathogenesis due to the destructive and 
immunomodulatory properties of the toxin it produces (Mereghetti et al., 2008, 
Sitkiewicz et al., 2009).  
Regulation of gene expression through two component systems 
Signalling in bacteria is frequently achieved through two component systems (TCS), 
which sense environmental signals such as changes in chemical gradients, Mg 2+ 
concentration, osmolarity and the presence of auto-inducing or anti-microbial 
peptides (Beier and Gross, 2006). A two component system generally comprises of a 
sensor histidine kinase on the bacterial membrane which becomes auto 
phosphorylated and will phosphorylate a cognate DNA binding protein. Group B 
Streptococcus has 17-20 identified two component systems (Tettelin et al., 2002, 
Tettelin et al., 2005, Glaser et al., 2002) and six standalone transcriptional regulators 
(Glaser et al., 2002). Compared to closely related streptococcal species, GBS has a 
high number of TCS: S.pneumoniae has 14, S.pyogenes  13 and L.lactis 8. This may 
reflect the lifestyle of GBS, which requires the organism being able to adapt to and 
thrive in different host environments (Glaser et al., 2002).  A eukaryotic-like 
serine/threonine kinase regulator (Stk1) has been described in GBS, which can 
alternatively phosphorylate the DNA binding protein CovR, lifting repression. Finally, 
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a tyrosine kinase and phosphatase system has been implicated in regulation of 
capsule expression by GBS.  A summary of these regulatory systems can be seen in 
Table 2 and they are discussed in the relevant sections of this chapter.  
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Table 1: Gene regulation systems of Streptococcus agalactiae 
Name  
(response 
element/histidine kinase) 
Regulates Role in host adaptation Details Reference 
CovS/CovR (CsrS/CsrR) Global regulatory system; secretory 
pathway, cell wall modification, metabolic 
genes, virulence factors. 
CovR binds to and represses CylE.  
Negative regulator of fbsA independent of 
RovS and RogB 
Activates CAMP factor 
Cps 
Adherence and virulence 
factor expression. Many 
genes regulated in 
response to pH change 
Phosphorylation of CovR by 
CovS enhances CovR 
promoter binding. 
Phosphorylation by Stk1 
decreases CovR promoter 
binding. 
 
(Lamy et al., 
2004, Jiang 
et al., 2005, 
Santi et al., 
2009a) 
DltR/DltS DtlR binds to promoter DNA of the dlt 
operon 
Activates expression of the 
dltRSA-BCD operon 
increasing the D-alanine 
content of lipotechoic acid 
Increasing the D-alanine 
content of LTA increases the 
resistance of the organism to 
AMP’s 
(Poyart et 
al., 2001a) 
RgfA/RgfC Down regulation of ScpB (C5a peptidase) 
fsbB gene activation, fsbA gene inhibition. 
Regulation of fsbA independent of RovS 
 
Regulation of cell surface 
proteins implicated in 
adhesion. 
Differential regulation 
through this TCS is 
suggested to be important in 
the increased adherence 
seen in the ST-17 strains. 
(Spellerberg 
et al., 2002, 
Safadi et al., 
2011) 
CiaR/CiaH Regulation of purQ. Positive regulation of 
CiaR. 
Positive regulation of peptidases and 
proteins of unknown function. 
Resistance to antimicrobial 
peptides. Plays a role in the 
organism’s ability to survive 
within multiple cell type. 
Promotes resistance to 
Antimicrobial peptides, 
oxidants and lysosome 
Actions postulated to be due 
to cell wall stability or 
restructuring. 
(Quach et 
al., 2008) 
C
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A
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Stand alone regulators Regulates Role in host adaptation Details Reference 
RovS Binds to and activates cylE,and sodA, 
expression. 
Negative regulator of fsbA 
 
Adherence to epithelial cell 
surfaces, expression of 
virulence factors which may 
facilitate intracellular 
survival. 
 (Samen et al., 
2006) 
RogB Repressor or negative regulator of cpsA, the 
capsule operon. 
Positive regulation of pilus (PI-2b) and fbsA 
expression 
Adherence and capsule 
production. 
Not present in all strains (Gutekunst et al., 
2003, Dramsi et 
al., 2006) 
RgfB ScpB (C5a peptidase) Adherence  (Spellerberg et 
al., 2002) 
Rga Global regulation, 60 genes downregulated 
36 upregulated in a deletion mutant. 
Includes proteins of unrelated functions 
including the Pilus and Srr-1. 
Adherence. Possible 
antimicrobial peptide 
resistance due to pilus 
regulation. 
 (Rajagopal, 2009, 
Samen et al., 
2006, Dramsi et 
al., 2012) 
MtaR Methionine uptake and transport, genes 
involved in arginine biosynthesis and cspA. 
 Mutant strains show 
attenuation in a mouse 
model.  Does not regulate 
capsule genes. 
(Rajagopal, 2009) 
CpsA Transcriptional regulator of the capsule 
locus, and possibly cell wall. 
Cell wall integrity Aids whole blood survival 
and virulence in zebrafish 
model 
(Hanson et al., 
2012) 
Serine/threonine 
signalling 
    
Stk1/Stp1 Phosphorylates CovR, decreasing promoter 
binding and repression, consequently acts 
as a positive regulator of the β-h/c. Negative 
regulation of the CAMP factor. 
Resistance to reactive 
oxygen species and 
intracellular killing 
Stk1 is membrane 
associated 
(Rajagopal et al., 
2006) 
Tyrosine phosphorylation     
CpsD/CpsB 
 
 
 
Polysaccharide length Capsule synthesis  (Whitmore and 
Lamont, 2012, 
Rubens et al., 
1993) 
C
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Energy and metabolism 
The majority of bacteria are heterotrophic, that is they require a carbon source for 
energy and substrates available for catabolism of macromolecules.  Analysis of the 
GBS genome has predicted that the organism is auxotrophic for multiple amino 
acids, identified by the absence of biosynthetic pathways (Glaser et al., 2002). It is 
thought therefore that the organism must obtain most nutrients from the host. This 
hypothesis is supported by the presence in the genome of a large number of 
transporters suggesting a broad catabolic capacity (Glaser et al., 2002). Additionally, 
regulation of methionine utilisation through the MtaR transcription factor facilitates the 
organism’s growth in human plasma (Shelver et al., 2003). Small molecule 
transporters are proven to be important for the virulence of the organism - in their 
absence the organism is unable to take in peptides and scavenge residues for amino 
acid synthesis (Jones et al., 2000).   
GBS is generally regarded as a strict fermentative organism.  It is however not only 
aerotolerent, but can undergo oxidative respiration if supplied with exogenous haem 
or quinone.  In the presence of these co-factors and oxygen, the organism shows 
improved survival in human plasma and increased biomass (Yamamoto et al., 2006, 
Lechardeur et al., 2010).  Growth of the organism in aerobic conditions has been 
shown to increase growth rate, invasiveness of the organism to epithelial cells and 
virulence (Johri et al., 2003). Accordingly, inactivating aspects of the oxidative 
respiration pathway reduces virulence in an animal model (Yamamoto et al., 2006). 
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 1.3.3  Systemic response to Group B Streptococcus 
Having breached the physical barriers of the host and adapted to the new 
environment, the next challenge an invading organism faces is the host immune 
system. 
1.3.3.1 Immunity to Group B Streptococcal infection 
The presence of type specific antibodies against capsular polysaccharide has been 
shown play a role in protecting individuals against invasive GBS disease (Edwards et 
al., 1979, Lin et al., 2004). Capsule specific antibodies improve opsonophagocytic 
killing of the organism in both neonates and adults (Santi et al., 2009b, Sendi et al., 
2008, Cheng et al., 2001), and can offer protection through neutralising properties 
(Wessels et al., 2011). Individuals who do not have high levels of antibodies, for 
example the elderly and the very young, are at a greater risk of GBS disease (Amaya 
et al., 2004). The cells of the adaptive immune system are developed and able to 
start responding to challenges at birth.  However levels of immunoglobulin are low in 
neonates, with the exception of IgG transferred placentally from the mother during 
the third trimester. Due to the poor immunogenicity of the GBS capsule only 10-20% 
of mothers have protective antibody levels (Melin, 2011), leaving neonates at risk of 
infection.  During birth the fetus travels from the sterile intrauterine environment 
through the vagina where it will encounter commensal bacteria such as GBS.  The 
innate immune response will be the main defence mechanism against these 
potentially pathogenic bacteria (Delves et al., 2011, Kenzel and Henneke, 2006).  
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1.3.3.2 The innate immune system 
The innate immune system has an important role in being able to distinguish self 
from non self. In comparison to the adaptive immune system which recognises 
specific epitopes the innate immune system has no epitope specificity and is often 
described as a non-specific system.  It has a special role in protecting neonates 
against infection as it does not require pre-exposure to a pathogen. 
The innate immune system has two arms; soluble molecules in blood such as 
complement and antimicrobial enzymes, and cells of the myeloid lineage. Cells of the 
innate immune system function to ingest and kill micro-organisms, present antigen 
and signal to other immune cells. They include the ‘professional’ phagocytes, 
macrophages and monocytes, neutrophils, and dendritic cells.  Macrophages are 
tissue resident phagocytes which mature from circulating monocytes.  They act as 
the first line of defence against invading microbes and orchestrate the subsequent 
inflammatory response. Macrophages are a major source of pro-inflammatory 
cytokines and immunomodulatory factors such as tumour necrosis factor α (TNFα), 
interleukin (IL) -1 and IL-12; they also function to resolve inflammation through the 
production of anti-inflammatory cytokines such as IL-10. If, when a tissue resident 
macrophage encounters microbial attack, they are not able to kill the organism, they 
produce cytokines and inflammatory mediators which lead to the recruitment of 
neutrophils and monocytes.  Indeed this may be the primary role for this cell type. 
Neutrophils are granulocytes, they circulate in the blood and are recruited to sites of 
inflammation. Granulocytes, also called polymorphonuclear leukocytes (PMN’s) 
contain pre-formed granules containing antimicrobial enzymes and toxic molecules. 
They are highly antimicrobial but short lived.  The main role for dendritic cells is 
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phagocytosis and then antigen presentation (Kenzel and Henneke, 2006, Murphy et 
al., 2008).  
The neonatal innate immune system 
Neonatal serum is generally poor at killing microorganisms, since levels of 
complement and other soluble enzymes are lower than in adult serum.  However, 
neutrophils and monocytes are present in the developing foetus from the end of the 
first trimester and by birth are present at adult levels.  
Despite adult levels of neutrophils, the most important immune deficiency in 
neonates is the reduced neutrophil response to infection, which is especially 
apparent in pre-term babies.  The inability of neutrophils to respond to infection is 
thought to be due to a limited pool of neutrophils, poor tissue penetration and poor 
acceleration of production from bone marrow. Neonatal polymorphonuclear 
leukocytes (PMN’s) that are not activated have been suggested to have defects in 
production of reactive oxygen species and decreased levels of lactoferrin, lysozyme 
and other degradative enzymes (Henneke and Berner, 2006).  
The distribution of tissue resident macrophages in neonates is the same as in the 
adult, with the exception of alveolar macrophages which are low until just before 
term, although this rises in the first 24-48hours after birth (Remington et al., 2010).  
Phagocytosis and antimicrobial functions of neonatal macrophages are similar to that 
seen in adults, with the exception that they are insensitive to IFN activation. The 
ability of macrophages to recruit monocytes and neutrophils to a site of infection is 
delayed in neonates (Remington et al., 2010).   
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Innate immune system response to GBS.  
The humoral arm of the innate immune system is probably ineffective at removing 
Group B Streptococcus.  Along with host deficiencies in complement levels, GBS 
surface components BibA and the β protein GBS prevent activation of complement 
and hinder the formation of the membrane attack complex (Santi et al., 2007, Maisey 
et al., 2008a).  
Both neonates (especially preterm newborns) and another high risk group, diabetics, 
have been shown to have defects in neutrophil function (Bjorkqvist et al., 2004). In 
addition, GBS produces two serine proteases, C5a peptidase (ScpB), which 
proteolytically cleaves the complement derived chemoattractant C5a, and CspA, 
which is able to cleave chemokines leading to reduced neutrophil chemotaxis (Bryan 
and Shelver, 2009, Cheng et al., 2002).  
The reduced neutrophil function and recruitment to the site of invasion will leave 
resident macrophages as the key phagocytic and signalling cells of the neonatal 
innate immune response.   
Recognition of GBS by the innate immune system can induce a pro-inflammatory 
response 
An infectious agent may cause pathogenesis through its own virulence factors or it 
can be the host immune response to infection that causes the physiopathology of 
disease. The immune response to an invading organism must be carefully controlled 
to ensure that host damage is minimised whilst the organism is removed; 
macrophages and monocytes are important effector cells in this context. In neonatal 
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GBS disease a major pathogenic feature is the dysregulation of the immune 
response leading to sepsis and multi organ failure. 
Macrophage and monocytes in neonatal blood and in the urinary tract respond to 
GBS with a pro-inflammatory cytokine release, involving Interleukin (IL) IL-1α, tumour 
necrosis factor (TNF) and IL6 (Currie et al., 2011, Kline et al., 2011). Elevated levels 
of TNF-α are characteristic of GBS sepsis. Monocytes can produce TNFα in 
response to GBS following deposition of complement factors on the organism’s 
surface (Levy et al., 2003).  Similarly, macrophages activated in the liver and spleen 
secrete TNF- into the blood stream, which acts on blood vessels to cause systemic 
oedema and can progress to disseminated intravascular coagulation leading to 
multiple organ failure (Kenzel and Henneke, 2006). The high level of monocyte 
derived TNFα in neonatal GBS sepsis could be due to monocytes being the most 
abundant cell type of the innate immune system in newborns, or due to the altered 
cytokine profile seen in neonatal cells (Remington et al., 2010, Levy et al., 2003).  
TNF-α does also have a positive effect, since it is important in activating 
macrophages to produce a protective response to GBS (Mancuso et al., 2009). 
However it is known that neonatal macrophages cannot be activated by TNF-α 
(Remington et al., 2010), so in this situation the high levels of TNFα are unlikely to be 
protective.  
Cells of the immune system recognise invading pathogens through pattern 
recognition receptors such as the Toll-like and cytosolic NOD receptors, which then 
activate signalling pathways leading to cytokine production. GBS has been shown to 
activate a pro-inflammatory cytokine response through the interaction of the cell wall 
lipoteichoic acid (LTA)  and lipoproteins with Toll like receptor 2 and 6 (TLR2/6), 
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involving the MyD88 and c-Jun kinase pathways (Draper et al., 2006, Henneke and 
Berner, 2006, Henneke et al., 2002). However production of TNF-α, a critical 
inflammatory mediator, occurs not through interactions with the organism’s 
polysaccharide capsule, peptidoglycan, lipoteichoic acid or lipoproteins but through 
the recognition of ssRNA by endosomal TLR-7 (Mancuso et al., 2009, Deshmukh et 
al., 2011a) and DNA through TLR-9 (Talati et al., 2008). 
Recognition of GBS single stranded RNA activates host cells to increase production 
of Nitric oxide. Nitric oxide (NO) is an important inflammatory mediator which 
activates macrophages, aids phagosome acidification and subsequent processing of 
phagosome contents. Activation of macrophages in this way gives positive feedback, 
releasing more GBS nucleic acids which can then be detected to further activate the 
macrophage and generate more NO (Deshmukh et al., 2011b).   
The β-h/c has immunomodulatory properties, it stimulates the detrimental production 
of pro-inflammatory cytokine production  (IL-1 and IL-6) and can activate 
macrophages through the nitric oxide pathway (Maisey et al., 2008a), both 
contributing to sepsis. However, recognition of β-h/c in a dose dependent manner is 
required for inflammasome formation and subsequent beneficial pro-inflammatory 
cytokine release providing the host with a protective immune response (Costa et al., 
2012).   
Toxic shock syndrome has been seen infrequently in conjunction with invasive GBS 
infection. Toxic shock syndrome is an overproduction of polyclonal T cells in 
response to inappropriate antigen presentation, leading to massive cytokine release 
and multisystem disease.  Isolates recovered from a patient with toxic shock 
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syndrome appeared phenotypically hyperhaemolytic, which was attributed to 
derepression of cylE due to mutations in CovR, a β-h/c repressor (Sendi et al., 
2009a).  
Together, the recognition of GBS by phagocytic pattern recognition receptors induces 
a pro-inflammatory response which, when correctly regulated, will aid the host 
removal of the organism. If incorrectly regulated or in the absence of responding 
cells, however, such responses can lead to immune dysregulation and sepsis. Thus, 
the interaction between GBS and macrophages warrants further investigation.
 
1.3.4 Phagocytosis and killing of GBS by cells of the innate immune 
system. 
Phagocytosis is the receptor mediated endocytosis of particles into a new 
cytoplasmic compartment - the phagosome. This is a feature of professional 
phagocytic cells namely the neutrophils, dendritic cells and macrophages.  The study 
of the interaction of cells of the innate immune system and bacterial pathogens has 
mainly focused on macrophages, and macrophages are also the main focus of the 
work in this thesis. Recognition and phagocytosis of an organism can be due to the 
direct interaction (‘non-opsonic’) of bacterial substrates with host cell receptors such 
as scavenger receptors, complement receptor 3 (CR3), lectins for example Dectin-1 
and DC SIGN. Phagocytosis can be enhanced by host opsonins, which bind to 
surface components of the microorganism leading to opsonophagocytosis. Opsonins 
are primarily antibodies and complement but also other proteins such as surfactant 
protein A (Gil et al., 2009) or mannan binding lectin. Opsonisation of the organism 
  CHAPTER 1: Introduction   
 
37 
 
targets the bacteria to receptors such as the Fc receptor and complement receptors. 
Uptake by this method is efficient and generally leads to killing of invading pathogens 
by the host cell (Plüddemann et al., 2011). 
1.3.4.1 GBS resists phagocytosis 
GBS has mechanisms to prevent the deposition of opsonin on the surface of the 
organism. Many of the GBS components that prevent opsonophagocytosis 
(discussed in more detail below) are required for virulence, supporting the 
importance of opsonophagocytosis in allowing the host to raise a protective immune 
response. Host cells are unable to respond to GBS through signalling via cell surface 
expressed Toll like receptors, so phagocytosis and subsequent lysosomal processing 
is an important step in mounting a protective immune response to this organism 
(Deshmukh et al., 2011b). 
Sialylated polysaccharide capsule 
Group B Streptococcus possess a polysaccharide capsule, which is considered to be 
one of the major virulence factors of the organism since unencapsulated strains show 
reduced virulence in animal models (Rubens et al., 1987).  
Group B Streptococcus is unusual among bacteria in that all serotypes display a 
terminal sialic acid (N-acetylneuramininc acid) on the capsular polysaccharide. 
Streptococcus suis is the only other Gram positive organism where this has been 
observed (Maisey et al., 2008a, Segura, 2012).  Sialic acid is also present on the 
glycan of vertebrate cells, and GBS is therefore decorated with sugars that mimic the 
host cell, a form of molecular mimicry that has been suggested to be a major 
contributor to GBS virulence (Wessels et al., 1989).   
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The most important role of the capsule is probably in inhibiting opsonophagocytosis 
by preventing complement factor C3b deposition on the surface of the organism.  
Preventing activation of C3b has the added effect of reducing the production of the 
chemokine C5a (Marques et al., 1992, Maisey et al., 2008a). Additionally, and 
unrelated to phagocytosis, the sialyated residues on the capsule increase the affinity 
of the organism for factor H, an inhibitor of complement activation, thus preventing 
direct complement mediated killing (Maruvada et al., 2008).  An unencapsulated 
serotype III GBS mutant was shown to be internalised almost twice as much during 
initial infection than its corresponding wild type strain, reinforcing the importance of 
capsule for evading opsonin-dependent uptake. Similarly, a serotype Ia strain with 
higher capsule content was phagocytosed less well than a serotype III strain 
(Cornacchione et al., 1998).  However, we and others have shown that un-
encapsulated strains are phagocytosed to the same extent as those with capsule 
under non-opsonic conditions (Segura et al., 1998). Thus, the capsule may be 
important in protecting the organism against opsonophagocytic complement killing 
but does not affect internalisation or intracellular survival in the absence of opsonin. 
 (Areschoug et al., 2008) have suggested an additional role for the capsule to hide 
surface components, such as the lipoprotein Blr which can function as a ligand for 
the nonopsonic macrophage scavenger receptor (SR-A). However, this was drawn 
from experiments showing reduced uptake of the organism in the absence of both 
the scavenger receptor from the host cell and the capsule, and it is not clear if in the 
presence of the scavenger receptor they see increased uptake of the un-
encapsulated mutant (Areschoug et al., 2008). 
GBS surface components implicated in resisting phagocytosis 
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In addition to the sialic acid capsule the organism resists opsonophagocytosis 
through surface components. The organism can be coated in an adherent fibrin like 
substance, a breakdown product of host fibrinogen through the action of the CspA 
protein (Harris et al., 2003). This layer helps resist complement deposition as it 
resembles host protein.  
1.3.4.2 Phagocytosis of GBS in the presence of opsonising serum 
Despite the efforts of the capsule, in the presence of opsonising serotype specific 
antibodies GBS can be phagocytosed and rapidly killed by the phagocytic cells of the 
innate immune system. Uptake is mediated by Fc receptors FcRII and III and the 
engagement of these receptors leads to efficient intracellular killing of the organism 
(Henneke and Berner, 2006, Valenti-Weigand et al., 1996, Cheng et al., 2001). GBS 
has been visualised by electron microscopy residing in membrane bound 
compartments  irrespective of uptake being in the presence or absence of opsonic 
factors (Marodi et al., 2000).  More efficient killing of antibody opsonised organisms 
in phagosomes could be due to the observed increase in lysosomal vesicles (Valenti-
Weigand et al., 1996) and a more frequent and intense oxidative burst (Cheng et al., 
2001). In the absence of type specific antibodies, but in the presence of other 
opsonins such as lectins and L-ficolin, the competent receptor CR3 is very important 
in internalising and killing GBS (Fujieda et al., 2012). In the presence of complement 
the Fc receptor is not required for internalisation and killing (Albanyan and Edwards, 
2000) and thus it is thought that opsonophagocytosis through the complement 
receptor may explain the low incidence of neonatal disease despite the high number 
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of mothers with insufficient IgG (Henneke et al., 2002, Henneke and Berner, 2006, 
Fujieda et al., 2012).  
1.3.4.3 Opsonin independent phagocytosis of GBS 
Opsonin independent phagocytosis is likely to be the major uptake mechanism of 
GBS due to host and pathogen factors.  As previously discussed the organism 
produces a poor antibody response and levels of antibody are likely to be insufficient 
for opsonisation in the at-risk groups. Neonates have low levels of complement and, 
especially in preterm babies, lung surfactant may be low.  Opsonin independent 
uptake of GBS is thought to involve direct recognition of the organism by the integrin, 
complement receptor 3 (CR3) (Antal et al., 1992), a receptor that shows decreased 
expression on preterm neonate cells (Remington et al., 2010). Internalisation is 
independent of TLR activation (Henneke and Berner, 2006) and engagement of the 
scavenger receptor A (Areschoug et al., 2008).  Uptake requires actin (but not 
microtubules) suggesting it is a phagocytic event (Valenti-Weigand et al., 1996).  
CR3 is an integrin which in addition to a complement binding domain contains a 
lectin domain that is thought to interact directly with the GBS capsule (Albanyan and 
Edwards, 2000). Generally CR3 is thought to require additional signals to trigger 
phagocytosis such as complement deposition, TNFα, microbial products or 
fibronectin (Underhill and Ozinsky, 2002). Given that antibody blocking the CR3 
receptor only reduced internalisation by 50% (Antal et al., 1992), and in neutrophils 
lectin-mediated GBS interaction with CR3 is insufficient for internalisation (Albanyan 
and Edwards, 2000) the mechanism for non opsonised GBS uptake is still unclear. 
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1.4  WHAT HAPPENS AFTER PHAGOCYTOSIS: LIFE ON THE INSIDE 
1.4.1 The intracellular fate of phagocytosed microorganisms. 
After phagocytosis the organism is internalised into a membrane bound vacuole, the 
phagosome. The phagosome undergoes a series of fission and fusion events with 
the endocytic pathway cumulating in the formation of a mature phagolysosome  (see 
Figure 3 for a schematic of the phagosome maturation pathway). The 
phagolysosome is a hostile environment for  micro-organisms, not only is it nutrient 
limiting, it is highly acidic and contains reactive oxygen species (ROS), reactive 
nitrogen species (RNS) and antimicrobial proteins and peptides (Flannagan et al., 
2009, Basset et al., 2003, Soldati and Neyrolles, 2012, Haas, 2007, Plüddemann et 
al., 2011, Kinchen and Ravichandran, 2008). 
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Figure 4: Phagosome maturation
After phagocytosis the organism is internalised into a membrane bound vacuole, the phagosome (1).  Phagosomes mature through fusion with membrane 
bound endosomes (2) and lysosomes (3) to form the phagolysosome (4).  Very quickly (within 15 minutes) after engulfment the environment in the lumen of 
the phagosome becomes acidified through the fusion of early endosomes (acidified endocytic vesicles) and the recruitment and activity of V-type ATPases.  
The plasma membrane derived NAPDPH oxidase gives rise to reactive oxygen speces and reactive nitrogen species are generated by inducible nitric oxide 
synthase (iNOS). The phagosome is a nutrient limiting environment with host transferrin sequestering available iron and the NRAMP (natural resistance-
associated macrophage protein) transporter protein pumps divalent cations out of the vacuole.  Maturation to the late phagosome is characterised by an 
increasingly acidic lumenal pH due to the increased recruitment of the vATPase pump, and the acquisition of late endocytic markers such as lysosomal associ-
ated membrane protein (LAMP) and cathepsin D.  The fusion of the phagosome with lysosomes, organelles containing hydrolytic enzymes, results in the 
formation of a phagolysosome and the culmination of the maturation process. 
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1.4.2 GBS can persist within macrophages 
(Valenti-Weigand et al., 1996) and (Cornacchione et al., 1998) demonstrated that 
after infection of J774 macrophage like cells or thioglycolate-elicited peritoneal 
murine macrophages, viable intracellular GBS can be recovered for up to eight hours 
at levels similar to those internalized and at reduced levels for up to 48 hours post 
infection (Valenti-Weigand et al., 1996, Cornacchione et al., 1998). Internalised 
organisms can be seen within a membrane bound vacuole presumed to be a 
phagosome (Cornacchione et al., 1998, Valenti-Weigand et al., 1996).  Survival of 
GBS in murine cells is higher than that of Streptococcus suis despite similarities in 
the capsule between the organisms (Segura et al., 1998), accordingly the presence 
of a capsule is not important for intracellular survival (Cornacchione et al., 1998). 
Importantly, persistence is also observed in primary human monocytes and monocyte 
derived macrophages (Peotta et al., 2001). Activation of macrophages with 
recombinant murine IFN, GM-CSF and LPS enhanced the ability of cells to remove 
GBS (Cornacchione et al., 1998, Marodi et al., 2000). In the context of neonatal 
disease, intracellular survival may be particularly relevant, since cord blood derived 
monocytes show a reduced ability to clear the organism compared to adult 
monocytes (Marodi et al., 2000).  This is likely due to a combination of low levels of 
complement factors (Gille et al., 2009) and the insensitivity of cord blood monocytes 
to activation by IFN (Marodi et al., 2000).   
Survival inside cells of the innate immune system is relevant in terms of disease 
pathogenesis, since many factors that are required for intracellular survival are also 
required for virulence in whole organisms (Poyart et al., 2001b, Maisey et al., 2008b). 
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The intracellular localisation of GBS in macrophages may protect the organism from 
neutrophils, which are the most antimicrobial and abundant phagocytic cells in blood.  
The potential importance of the survival of bacteria in cells of the innate immune 
system has been demonstrated in the GBS related bacteria Streptococcus pyogenes, 
since persistence of S.pyogenes in PMN cells can transfer infection to previously 
uninfected mice.  This suggests that persistence inside cells could be a mechanism 
for systemic spread in the host (Medina et al., 2003). Many antibiotics show poor 
eukaryotic cell penetration, hence residing within host cells protects organisms from 
the action of these antibiotics which may lead to recurrent infections and persistent 
colonisation (Thwaites and Gant, 2011, Kaplan et al., 2006, Sendi et al., 2008).
 
1.4.3 How does GBS avoid killing by phagocytic cells?  
In addition to avoidance of phagocytosis as discussed in the previous section several 
pathogens can evade the host immune response by being able to survive within 
phagocytic cells. Organisms can modify the host response by being poorly 
immunogenic, thus producing a weak phagocyte response, or by fighting back and 
initiating programmed cell death.  Avoidance of phagosomal killing is a commonly 
employed strategy and can be mediated through a number of mechanisms; arresting 
phagosome maturation in an early and non-antimicrobial stage, manipulating 
phagosome maturation to lead the vacuole to fuse with endosomal vesicles that are 
not highly antimicrobial, escape from the phagosome or resistance to the 
antimicrobial arsenal of the phagosome. The interaction of GBS with phagocoytic 
cells is known to be weakly activating and the organism can initiate immune cell 
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death.  There is little evidence for manipulation of phagosome maturation or escape 
from the phagosome but the organism has several factors which will enable it to cope 
with intra-phagosomal conditions. The following section will review the antimicrobial 
features of the phagocytic cells and mechanisms GBS may use to avoid killing. 
These mechanisms are summarised in Figure 5.
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Figure 5: GBS factors that aid immune avoidance
GBS has multiple mechanisms which may aid the organism overcome the host immune response.  The 
organism can prevent recognition, uptake and activation of cells and humoral components of the innate 
immune system.  Additionally, the organism encodes gene products which can protect it from the phago-
some environment, providing protection against antimicrobial peptides, reactive oxygen species and the 
limited availability of nutrients. 
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1.4.3.1 Modification of host response 
To survive within phagocytic cells, pathogenic organisms can alter or prevent 
activation of the cell.  
The sialic acid residue present on the capsule of all serotypes of GBS is similar to the 
sialylated glycans seen on host cells. Sialic acids (Sia) are recognised by Siglec 
receptors present on leukocytes. Siglec receptors are Sia-recognizing Ig superfamily 
lectins, thought to have a role in distinguishing self from non self and preventing 
inappropriate immune cell activation. GBS type III can interact with siglec receptors 
on neutrophils through the lectin domain and depress the activation of the cell 
leading to a reduced oxidative burst, NETS and increased bacterial survival (Carlin et 
al., 2006). GBS has also been shown to interact with Siglecs and depress immune 
cell function through interaction of the receptor with a surface protein (β-protein, Bac 
or β C) that is expressed in some strains of GBS (Nordström et al., 2011, Carlin et 
al., 2009). Additionally the surface expressed β protein, also known as Bac or β C is 
able to bind the Fc region of IgA. This prevents IgA from binding CD89 and therefore 
prevents downstream immunostimulatory signalling through this receptor (Pleass et 
al., 2001, Sendi et al., 2008, Nordström et al., 2011). 
Once internalised there is some data to support GBS interacting with protein kinase 
C (PKC) an important mediator in signalling pathways leading to the activation of 
immune cells. In cells infected with GBS, PKC cannot be activated by exogenous 
stimuli (Valenti-Weigand et al., 1996).  GBS is also able to interact with the host cell 
cytoskeleton; cytoskeletal modification can lead to signalling and cytoskeletal 
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dependant antimicrobial mechanisms.  A decrease in intracellular survival of GBS is 
observed when the ability of the organism to induce calpain dependent cytoskeletal 
changes is inhibited (Fettucciari et al., 2011).  
GBS does not stimulate host cells to produce a large oxidative burst. 
The method of uptake into phagocytic cells can have effects on the subsequent 
activation state of the cell and the production of an oxidative burst.  In the presence 
of antibodies and subsequent phagocytosis of GBS through the Fc receptor, levels of 
ROS induced are higher than those seen in non-opsonising conditions (Cheng et al., 
2001, Poyart et al., 2001b) and correspond with improved removal of the organism.  
In the absence of antibodies GBS is preferentially phagocytosed by the complement 
receptor (Antal et al., 1992). Unlike antibody-mediated uptake, it is not thought that 
phagocytosis through the complement receptor leads to a high level of superoxide 
production (Underhill and Ozinsky, 2002). Recognition of GBS through unspecified 
pattern recognition receptors, independent of uptake, is important in the generation of 
ROS (Henneke et al., 2002). Henneke et al. 2002 observed that deletion of the CR3 
receptor did not alter ROS production in response to GBS phagocytosis, despite a 
decrease in uptake.  
 
1.4.4 GBS induces apoptosis in macrophages 
 A strategy to circumvent the host immune response by Group B Streptococcus is to 
induce apoptosis in macrophages. The role of apoptosis of phagocytic cells in 
disease progression is unclear; on one hand loss of effector cells may reduce the 
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host’s ability to clear infection, however it has been suggested that early in sepsis 
apoptosis of phagocytic cells is advantageous (Gille et al., 2009).  Host cells may use 
apoptosis to remove intracellular organisms and many pathogens have methods to 
prevent apoptosis in the cells they infect.  Apoptosis is programmed cell death, tightly 
regulated by a signalling cascade of cytosolic cysteine proteases, the caspases or 
calpains. In contrast to necrosis or pyroptosis, apoptosis does not induce a host pro-
inflammatory response. Pathogen induced apoptosis is seen in GBS infected host 
cells, but to a lesser extent in cord blood monocytes than adult monocytes (Gille et 
al., 2009). 
Initially, GBS induced apoptosis is a β-h/c dependant process which does not require 
internalisation of the organism (Fettucciari et al., 2000). β-h/c dose dependent 
membrane permeability leads to a calcium influx and calpain initiated modification of 
the host cell cytoskeleton. Modification of host cell cytoskeleton can act to signal 
proapoptotic or survival signals to the cell (Fettucciari et al., 2011).  GBS apoptosis is 
a calpain dependent process, so could be triggered by cytoskeletal rearrangements, 
or an alternative yet to be described mechanism (Fettucciari et al., 2011).  
Post phagocytosis of GBS, apoptosis is also seen to involve the caspase pathway 
and is β-h/c independent. In murine cells caspase dependent apoptosis  is related to 
increasing levels of Nitric oxide through iNOS activity (Ulett and Adderson, 2005) and 
can also be induced by GAPDH, a protein which is detected on the surface and in the 
supernatant of lysed organisms (Oliveira et al., 2012). 
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1.4.5 Resistance to the antimicrobial conditions within the phagosome 
1.4.5.1 Low pH 
A drop in bacterial cytoplasmic pH, caused by acidic environmental conditions such 
as those within the phagosome, can lead to inactivation of acid sensitive enzymes 
important for metabolism, as well as structural damage to membranes and DNA.  
Initially phagosomal pH is lowered by the fusion of the phagosome with early 
endosomal vesicles. The pH of the phagosome is then further lowered through 
recruitment of the vacuolar type ATPase (vATPase) proton pump and the prevention 
of leakage of H+ irons out of the organelle (Huynh and Grinstein, 2007, Kinchen and 
Ravichandran, 2008).  Low pH is required for membrane fusion events which are 
integral to phagosome maturation; this is likely to be due to the recruitment of 
effectors at the cytoplasmic face of the phagosome membrane (Huss and Wieczorek, 
2009, Huynh and Grinstein, 2007).  The antimicrobial capacity of the phagosome is 
increased at low pH due to this being an optimal condition for activity of the 
degradative proteins contained within the phagolysosome.  
Group B Streptococcus can produce lactic acid as a by product of carbohydrate 
fermentation and is therefore expected to have mechanisms to cope with conditions 
of low pH.  Lactic acid bacteria regulate cytoplasmic pH primarily through the activity 
of a proton pump, pumping H+ ions out of the cytoplasm, and additionally the 
consumption of H+ ions by amino acid decarboxylases. Other protective mechanisms 
employed are general cellular protection and repair systems and changes to the 
membrane composition. The induction of an inducible acid tolerance response (ATR) 
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can lead to up regulation of general heat shock proteins, proteins involved in pH 
homeostasis and repair mechanisms (Cotter and Hill, 2003).  
Group B Streptococcus regulates approximately 18% of its genome on adaptation to 
pH5.5 from pH7.0 (Santi et al., 2009a). Genes that are upregulated include those that 
would enhance the organism’s ability to cope with low pH including proteins involved 
in osmotic stress, cell wall and membrane composition and transport proteins (Santi 
et al., 2009a). The cell wall composition also offers some pH tolerance as strains that 
are not able to correctly D-alanylate lipoteichoic acid show reduced ability to replicate 
at low pH (Poyart et al., 2003). 
Within the Group B Streptococcus genome there are genes encoding enzymes 
involved in the arginine deiminase pathway (Glaser et al., 2002), which will lead to an 
increase in cytoplasmic ammonia and thus neutralise protons (Cotter and Hill, 2003). 
Interestingly, these genes are up regulated at pH5.5 compared to pH7.0, suggesting 
that GBS may use this mechanism to regulate pH homeostasis (Santi et al., 2009a).  
Some organisms use the low pH of the cytoplasm as an environmental cue to 
regulate genes which aid intracellular survival (Arpaia et al., 2011), although this 
response needs to be tightly regulated to prevent inappropriate antigen expression.  
Accordingly, GBS is seen to down regulate ‘virulence factors’  β-h/c, BibA and C5a 
peptidase in low pH.  However the pilus island-1 and CAMP factor are up regulated 
in low pH (Santi et al., 2009a). The majority of gene regulation changes induced 
when GBS is exposed to low pH are mediated by the two component system 
CovS/CovR also called CsrS/CsrR (throughout this thesis it is referred to as CovS/R 
with the exception of strains that have been obtained from laboratories that use the 
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CsrR/S nomenclature) (Santi et al., 2009a, Lamy et al., 2004, Jiang et al., 2005).  
The mechanism of activation of the CovS/CovR TCS in GBS has not yet been 
described but given that it does mediate transcription changes in response to pH it 
will be discussed in this context. 
CovS/CovR (CsrS/CsrR) 
The CovS/CovR (Control of virulence) two component system (TCS) is of particular 
interest in the field, since this TCS regulates multiple virulence factors required for 
host adaptation and intracellular survival.  CovS is a sensor, in GAS known to be 
membrane associated with extracellular domains which phosporylates CovR the 
response regulator increasing its DNA binding affinity (Churchward, 2007). CovR 
can, however, be alternatively phosphorylated by the activity of a serine threonine 
kinase (Stk1) which is also a membrane associated sensor (Rajagopal et al., 2006), 
leading to a reduction in DNA binding affinity at certain promoter sequences.  CovS/R 
in GBS was identified by homology with the CsrR (Capsule synthesis regulator) gene 
in Group A Streptococcus (GAS) (Lamy et al., 2004, Jiang et al., 2005, Churchward, 
2007). In GAS and also in Streptoccus suis deletions in the TCS lead to increased 
intracellular survival and virulence in animal models (Tran-Winkler et al., 2011, Pan et 
al., 2009). Indeed in GAS, natural mutations in this TCS have led to the emergence 
of a highly successful virulent clone M1TI causing outbreaks in the pacific (Tran-
Winkler et al., 2011, Churchward, 2007). In GBS the importance of this regulator in 
virulence is not as clear cut; mutant strains have been shown to display reduced 
virulence in mice and rat models (Lamy et al., 2004, Jiang et al., 2005). Conversely, 
however, strains deleted in CovR have also shown increased sepsis and blood brain 
barrier penetration in animal models, potentially explained by the lack of repression 
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of β-h/c in these strains (Lembo et al., 2010). As seen in GAS, virulence of mutant 
strains of GBS is variable depending on the strain background and there is 
considerable diversity among regulons from different strains (Jiang et al., 2008). 
Despite the role of this TCS in mediating global gene expression changes in 
response to change in pH, the exact stimulus for the GBS CovS phosphorylation has 
not been identified. In GAS, Mg2+ and the antimicrobial peptide LL-37  can stimulate 
the membrane associated CovS probably by inducing general membrane stress 
(Tran-Winkler et al., 2011, Churchward, 2007).  In contrast to GAS, where CovR acts 
only as a repressor, the CovS/R system in GBS acts both as a repressor and an 
activator.  However in its role of pH adaptation CovR appears to act predominantly as 
a repressor (Santi et al., 2009a).  
GBS strains deleted in CovS/R are hyperpigmented, hyperadherent and unable to 
grow in nutrient limited media.  Accordingly, genes that are down regulated through 
this system include cylE  (encoding the β-h/c and being required for carotenoid 
pigment synthesis), through direct binding of CovR to regulatory elements, several 
surface expressed proteins including FsbA and FsbB and many genes required for 
metabolism and transport. Strains deleted in the CovS/R system show an up 
regulation of genes associated with stress response, which may be due to regulation 
of these processes through the TCS but could also be explained by the mutant being 
generally stressed due to cell wall and metabolic defects.  Table 3 details genes that 
are differentially regulated in ∆covS/R strains.  
In the low pH of the phagosome, data indicate that virulence factors such as the β-
h/c, BibA, and C5a peptidase would be down regulated due to CovS mediated CovR 
gene repression. CovS/R associated changes in metabolism and transport proteins 
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would also be expected. The pilus protein is up regulated in low pH independently of 
its observed CovR repression and is therefore likely to be abundant (Jiang et al., 
2012). 
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Table 2:  Gene expression changes seen in ∆covS/R (∆csrS/R) or ∆covR (∆csrR) 
strains 
Modification Function Reference 
 Secretory pathway 
Cell wall associated enzymes 
(Lamy et al., 2004) 
 Iron transport (Jiang et al., 2008) 
 Stress responses (Jiang et al., 2008) 
 
 
 
 
 
Metabolic pathways* 
Trehalose pathway 
FoF1  ATPase 
Amino acid synthesis 
Glycerol and glycerol phosphate uptake 
(Lamy et al., 2004, 
Santi et al., 2009a) 
 ABC Transporter proteins* Transporters of amino 
acids, peptides and amines. 
(Jiang et al., 2008, 
Santi et al., 2009a, 
Lamy et al., 2004) 
 cylE,  β- haemolysin/cytolysin * (Lamy et al., 2004, 
Jiang et al., 2008, 
Jiang et al., 2005, 
Santi et al., 2009a) 
 Surface proteins with LPXTG motif 
Aminopeptidase 
Protease 
Endopeptidase 
(Lamy et al., 2004) 
 General stress protein in Enterococcus and 
Lactococcus  
(Jiang et al., 2008) 
 Glycine/betaine osmoregulation system (Jiang et al., 2008) 
 Immunogenic surface proteins Rib (strain 2603) and 
Alpha-like protein1 (Strain 515) 
(Jiang et al., 2005) 
 BibA* (Jiang et al., 2005, 
Santi et al., 2009a) 
 Pilus* (but up regulation in low pH, independent of 
CsrR) 
(Jiang et al., 2012, 
Santi et al., 2009a) 
 fbsA and fbsB Fibrinogen binding proteins (Lamy et al., 2004) 
 C5a peptidase* (Santi et al., 2009a) 
 Capsule and sialic acid content (moderate, not seen 
in all strains) 
(Lamy et al., 2004) 
(Jiang et al., 2008, 
Jiang et al., 2005) 
 Homologue of alkyl hydroperoxide reductase, Gls24 (Jiang et al., 2008) 
 CAMP factor * (Jiang et al., 2005, 
Santi et al., 2009a) 
* indicates that CovS/R is thought to mediate expression of this gene in response to 
environmental pH (Santi et al., 2009a) 
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1.4.5.2 Oxidative killing  
Micro-organisms can evade the damaging effects of reactive oxygen and nitrogen 
species by evasion, suppression, enzyme inactivation, scavenging and up regulation 
of stress response and repair mechanisms. There is evidence to support GBS using 
all of these mechanisms with the exception of evasion. 
Reactive oxygen species 
The non-mitochondrial generation of reactive oxygen species upon engulfment of 
bacteria known as the oxidative burst, involves the membrane bound NADPH 
oxidase which converts oxygen (O2) to superoxide (O2`-) which in turn is a precursor 
for hydrogen peroxide (H2O2). Hydrogen peroxide is membrane diffusible and within 
the phagosomal lumen or the bacterial cytoplasm exerts antimicrobial effects in 
combination with iron or copper ions forming highly damaging superoxide and 
hydroxyl radicals (OH ‘).  Hydroxyl radicals can cause lipid peroxidation, protein 
oxidation and DNA damage.  The subunits of NADPH oxidase are dissociated from 
each other and inactive in resting cells; components are translocated to the 
phagosome membrane upon cell activation.  Concentrations of hydrogen peroxide in 
an activated cryptococcal phagosome have been suggested to be as high as 14mM 
(Brown et al., 2007). However, Slauch 2011. calculated the steady state 
concentration of hydrogen peroxide to be in the region of 1-4μm based on the rate of 
superoxide production, the rate of spontaneous dismutation, the diffusion of 
hydrogen peroxide and the phagosome volume (Slauch, 2011, Diacovich and Gorvel, 
2010, Fang, 2004).  As previously discussed the oxidative burst of GBS-infected cells 
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may be suppressed, either through active dampening of the immune response, 
uptake mechanisms or deficiencies in neonatal phagocytes.  Proteomic changes in 
cells infected with GBS suggest that the organism is actively reducing the amount of 
NADPH oxidase and iNOS that can be assembled. Such changes are not seen in 
macrophages infected with heat inactivated GBS (Susta et al., 2010) 
Group B Streptococcus is able to inactivate reactive oxygen species through the 
activity of the enzyme superoxide dismutase (SodA).  Despite the generally low 
levels of ROS generated in un-opsonised GBS infected cells (Cheng et al., 2001), 
SodA has been shown to be important for virulence in mouse models and to aid 
intracellular survival in murine bone marrow derived macrophages (Poyart et al., 
2001b). Bacterial SodA offers resistance to oxidative killing by converting superoxide 
ions into oxygen and hydrogen peroxide. GBS is a catalase negative organism but 
can potentially detoxify hydrogen peroxide by the enzymes NADH peroxidase, NADH 
oxidase, a thiol peroxidase and an alkylhydroperoxide reductase (Glaser et al., 2002) 
(Jiang et al., 2008). The GBS encoded NADH oxidase nox2, is able to generate H2O2 
from oxygen, which again is then detoxified by enzymes mentioned above.  In vitro 
this is protective against the superoxide generating agent paraquat (Yamamoto et al., 
2006).  Resistance to ROS through SodA is hypothesised to protect the organism 
against phagocytic killing in the blood, where the GBS will encounter 
polymorphonuclear leukocytes (PMNS) which have a higher oxidative burst than 
tissue macrophages (Poyart et al., 2001b).  SodA may also play a role in protecting 
the organism against endogenous ROS; mutant strains show higher mutation rates 
when treated with rifampicin (Poyart et al., 2001b). 
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There are two proteins that have been identified in GBS that have the ability to 
scavenge oxygen metabolites; glutathione which is reported to be present in high 
levels within the cell and a carotenoid pigment produced in concert with the β-
heamolysin/cytolysin (Hamilton et al., 2006, Glaser et al., 2002, Liu et al., 2004).  
CylE, β-h/c and the carotenoid pigment 
As previously discussed, one of the most important known virulence factors in Group 
B Streptococcus is the pore forming -haemolysin/cytolysin ( -h/c).  The -h/c toxin 
is expressed by cylE, a single open reading frame on the cyl operon (Forquin et al., 
2007). Along with the 78kD  -h/c toxin, this open reading frame is associated, 
through yet to be identified mechanisms, with  production of an orange carotenoid 
pigment (Pritzlaff et al., 2001). Strains deleted in CylE are less virulent in animal 
models and are more susceptible to phagocyte killing than the wild type organism 
(Liu et al., 2004). The role of CylE in intracellular survival and virulence at a high 
bacterial inoculum is thought to be due to the cytolytic activity of the toxin (Fettucciari 
et al., 2000, Liu et al., 2004). However, at a low bacterial inoculum cell death is not 
observed and survival is attributed to the production of the carotenoid pigment. 
Carotenoid pigments from plants and animals are known to be free radical 
scavengers and have antioxidant properties.  Strains deleted in the CylE gene show 
increased sensitivity to hydrogen peroxide, hypochlorite, superoxide and singlet 
oxygen and a wildtype phenotype can be recovered by the addition of filtered 
pigment extract (Liu et al., 2004).   
CylE is repressed by CovR - when CovR is phosphorylated by CovS or small 
molecule phosphodonors activated CovR binds directly to the CylE promoter 
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sequence CylX (Jiang et al., 2008).  CovR mediated repression of CylE can be lifted 
by the action of a serine threonine kinase (Stk1), which phosphorylates CovR at an 
alternative residue, preventing promoter binding (Lin et al., 2009).  Strains deleted in 
Stk1 show increased sensitivity to phagocyte killing and oxidative stress 
hypothesised to be due to an inability to regulate cylE expression (Rajagopal, 2009). 
In addition to cylE regulation, the CovS/R TCS may promote resistance to ROS by 
up-regulating expression of homologs of the S.pyogenes alkyl hydroperoxide 
reductase system, AphC and AphF. The alkyl hydroperoxide reductase system 
contributes to hydrogen peroxide scavenging and has been linked to virulence in a 
murine model (Jiang et al., 2008). Thus sensing the intracellular environment and 
converting this into an appropriate gene expression pattern through TCS such as 
CovS/R may be crucial for the organism’s ability to deal with ROS. 
Reactive nitrogen species 
Nitric oxide (NO.) is generated through the actions of the inducible nitric oxide 
synthase (iNOS) on the cytosolic side of the phagosome membrane.  NO. can pass 
through the membrane and into the phagosome where it can react with oxygen 
radicals generated by the NADPH oxidase and form damaging reactive nitrogen 
species (RNS) such as peroxynitrite. Nitric oxide (NO.) can reversibly inhibit bacterial 
DNA replication and prevent respiration, potentially pushing the organism into a non-
replicating state. Peroxynitrite (ONOO-) is a highly reactive species which can interact 
with metal centres, lipids, thiols, amino acids and DNA (Fang, 2004).  Expression of 
iNOS is upregulated during GBS infection in mouse cells - it is thought that peak 
RNS levels are achieved at approximately eight hours post phagocytosis (Slauch, 
2011). RNS are thought to player a larger contribution to the antimicrobial function of 
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macrophages than in neutrophils, and are more important in murine cells in 
comparison to human cells (Fang, 2004).   
As previously discussed, NO also has a role as a signalling molecule in cells infected 
with GBS in response to the recognition of ssRNA and bacterial DNA.  Accumulation 
of NO can lead to apoptosis and provides a pro-inflammatory signal to the host cell to 
aid removal of the invading organism. (Ulett and Adderson, 2005) suggest that in 
vitro and in vivo GBS survival is not affected by nitric oxide (Ulett and Adderson, 
2005), whereas Deshmukh et al 2011 show that iNOS is important for the host’s 
ability to control infection both at a cellular and whole organism level (Deshmukh et 
al., 2011b).  
In other microorganisms, resistance to RNS generally occurs through detoxification, 
suppression of iNOS and general stress response and repair. To date, however, no 
specific gene products have been associated with GBS resistance to RNS. 
Thus the role of both ROS and RNS as antimicrobial effectors is controversial and 
they may be more important in signalling pathways to effect host clearance of 
invading microorganisms than in directly acting against invading GBS (Fang, 2004). 
1.4.5.3 Nutrient limiting conditions 
The phagosome is not rich in nutrients (Flannagan et al., 2009) and as previously 
discussed GBS encodes a large number of small molecule transporters which are 
required for virulence (Jones et al., 2000). Transporters are one of the classes of 
genes seen up regulated in low pH (Santi et al., 2009a), thus within the phagosome 
the organism may adapt and increase its scavenging capacity promoting survival.  
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Low Iron 
Bacteria are estimated to require 10-8M of iron for metabolic processes, DNA 
synthesis and defence against ROS. Levels of available ferric iron can be as low as 
10-18M within the host cell, due to the high affinity iron binding proteins transferrin and 
lactoferrin, both of which are present in the phagosome. Additionally, the membrane 
protein NRAMP (Natural Resistance-Associated Macrophage Protein) pumps 
divalent cations including Fe2+ out of the acidified phagosome (Soldati and Neyrolles, 
2012).  
GBS require iron for growth, when iron rich media is depleted using NTA the 
organism is unable to grow. Growth is restored in a concentration dependant manor 
by the addition of feCitrate above 2mM (Clancy et al., 2006). The organism has a 
surface expressed siderophore-dependent iron transporter FhuD. Siderophores are 
iron chelating proteins expressed and secreted by organisms to bind Fe3+ which can 
compete with and remove iron from host iron binding proteins. Despite the presence 
of FhuD, which has demonstrated an ability to bind siderophores, GBS expressed 
siderophores are yet to be identified (Clancy et al., 2006) therefore the organism may 
utilise siderophores produced by other organisms.  
The exact mechanism by which GBS is able to grow in limited iron is still to be 
characterised, since strains with FhuD deleted can still grow in low iron conditions 
and retain adequate levels of cytoplasmic iron.  However, genome analysis of GBS 
reveals two NRAMP transporters which pump manganese or iron into the bacterial 
cell (Tettelin et al., 2002) as well as homologues of iron transport and uptake 
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systems from S. pyogenes  and S. mutans (Ahmed et al., 2008), all of which may 
contribute to iron homeostasis during intracellular persistence.  
1.4.5.4 Antimicrobial peptides and hydrolases 
Direct antimicrobial activity of the phagosome is mediated by the presence of 
antimicrobial peptides and hydrolytic enzymes. Hydrolytic enzymes include those that 
will break down carbohydrate, lipids and protein.   
Cathepsins are a diverse class of proteases, seen in high abundance in the late 
phagosome and phagolysosome.  At different points during phagosome maturation, 
different classes of cathepsins are present.  The cathelicidins and defensins are 
preformed cationic antimicrobial peptides (CAMP) that are both present in the 
macrophage late phagosome and phagolysosome and are secreted by human 
epithelial cells and cells of the innate immune system (Peschel, 2002, Maisey et al., 
2008a) and, at least in the case of cathelicidins, increase in expression following 
invasion by GBS (Quach et al., 2008).   
Cationic antimicrobial peptides are positively charged, which allows them to interact 
with negatively charged bacterial membranes. Once the peptides have gained 
accesses to their target they can compromise the integrity of the membrane 
(Peschel, 2002). There are two ways for a microbe to increase resistance to AMPs 
and antimicrobial enzymes - firstly, by changing the surface of the bacteria, thus 
preventing the interaction with the peptide, or by production of proteins that can 
inactivate or degrade AMPs.  In both cases, resistance to AMPs in vitro corresponds 
with increased intracellular survival and whole animal virulence (Peschel, 2002).  
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The cell wall composition of GBS is crucial to the organism’s ability to prevent 
damage caused by AMPs.  Lipoteichoic acid of GBS has a reduced negative charge 
due to the incorporation of a basic amino acid through D-ala esterification, by the 
DltA enzyme.  The subsequent reduced negative charge will electrostatically repel 
AMPs, preventing them from reaching their targets.  Consequently, a strain deleted in 
the dltA gene shows increased susceptibility to CAMPs and consistent with this 
reduced intracellular survival (Poyart et al., 2003).  
Resistance to CAMPs is also dependent on correct cell wall biosynthesis, 
independent of charge. The penicillin binding protein (PBP1a), encoded by the gene 
ponA, offers the organism increased resistance to CAMPs (Hamilton et al., 2006).  
Genes regulated through the TCS CiaR/H have homology to genes involved in 
regulation of proteolysis which, in other organisms, are critical for correct cell wall 
formation.  Strains deleted in CiaR show increased sensitivity to CAMPs compared to 
wild type strains (Quach et al., 2008).  Another surface expressed enzyme, 
phosphoglycerate kinase, plays a role in CAMP resistance as shown by the 
increased sensitivity of a deletion mutant, although the function of this enzyme 
outside of the cytoplasm is unknown (Boone and Tyrrell, 2012, Boone et al., 2011).   
Thus, correct cell wall stabilisation and restructuring is important for the ability of GBS 
to display resistance to CAMP’s. 
In addition, the PilB subunit of the pilus protein of GBS has been suggested to have a 
role in sequestering AMPs, therefore preventing them from reaching the membrane.  
Deletion of the PilB subunit increases the organism’s sensitivity to AMP in vitro and 
corresponds with reduced intracellular survival. When the PilB subunit was 
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expressed in L .lactis it conferred resistance to CAMP mediated killing in this 
normally sensitive organism (Maisey et al., 2008b). The pilus has been shown to be a 
multifactorial virulence factor of GBS and, in contrast to work mentioned above 
showing that the PI-1 pllus and PilB are required for intracellular survival and AMP 
resistance (Maisey et al., 2008a, Jiang et al., 2012), the PI-2a pilus did not play a role 
in resistance to AMP, nor did a deletion mutant show reduced ability to survive within 
phagocytic cells (Papasergi et al., 2011). Differing reports on the importance of the 
pilus protein in virulence between strains may reflect variations in the pilus backbone 
(Chattopadhyay et al., 2011).
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1.5 SUMMARY 
 
Despite the implementation of prophylaxis to prevent early onset neonatal infection 
GBS still remains the major cause of neonatal bacteremia in the UK.  
Pathogenesis of Group B Streptococcus infection is multifactorial and the organism is 
a successful coloniser of mucous membranes by means of a multitude of cell surface 
proteins. The organism is then able to invade these membranes through a 
combination of cell invasion and tissue damage, potentially mediated by the 
expression of a β-haemolysin- cytolysin. When in the host GBS is able to adapt to the 
host environment through diverse signalling mechanisms and resist 
opsonophagocytosis, principally through the action of the polysaccharide capsule. 
GBS is an opportunistic pathogen, infecting the very young and those with underlying 
co-morbidities.  Such individuals may be immunocompromised with low levels of 
antibody, opsonin and reduced neutrophil function.  Therefore macrophages are 
important effector cells in the context of this disease.  Tissue resident macrophages 
are the first cells to encounter invading organisms and if they are unable to kill the 
organism they will produce cytokines to activate other immune effector cells. In 
neonatal GBS disease this signalling cascade can be potentially fatal, since high 
levels of cytokine release can lead to devastating sepsis and multisystem organ 
failure.   
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Thus, the interaction between macrophages and GBS is an important aspect of the 
disease which warrants further investigation. There are several explanations for the 
ability of GBS to survive within macrophages, ranging from stimulating a weak host 
response to mechanisms promoting survival against oxidative stress and degradative 
proteins.
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1.5 SCOPE OF THIS THESIS 
 
Macrophages are important effector cells in the recognition, destruction and 
pathogenesis of GBS. It has been established that the organism is able to survive 
within these cells and mechanisms that promote this persistence have been 
proposed. This work aims to further characterise the resistance of GBS to 
macrophage killing.  Whilst most of the current research interest in GBS is in 
identifying vaccine candidates, the fundamental basis of this host-pathogen 
interaction remains un investigated.  
As introduced in section 1.4.3 there are various mechanisms by which pathogenic 
microorganisms are able to survive killing by phagocytic cells.  In this study several 
questions were asked in order to improve the understanding of the mechanism by 
which GBS is able to persist within macrophages: 
 Is the organism able to modify the phagosome maturation pathway? 
 What is the contribution of GBS genes previously described to have a role in 
pathogenesis to the organisms ability to persist within cells?   
 Can the organism tolerate the physiological stressors found in the 
phagosome? 
 How does the host response, specifically the generation of reactive oxygen 
species and the decreasing phagosome pH act to control the growth of 
intracellular Group B Streptococcus?  
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The first results chapter of this thesis (Chapter Three) focuses on the tools the 
organism has to be able to resist host cell killing. Using mutants deleted in 
characterised virulence factors the contribution of each gene product to intracellular 
survival was evaluated. The second results chapter (Chapter Four) investigates the 
intracellular environment which GBS will be exposed to when internalised within 
macrophages, looking at the role of reactive oxygen species, phagosome 
acidification and maturation of the phagosome. The results of these two chapters 
should be considered together (Chapter Five) to get an overall picture of the 
interactions between macrophages and GBS. 
To study host-pathogen interactions it is desirable to be able to visualise the 
organism within the eukaryotic cell, since this will allow the fate of the organism to be 
monitored and facilitate investigation into the subcellular localisation. Chapter Six 
therefore describes the evaluation of green fluorescent protein (GFP) expressing 
constructs for use in streptococci, specifically in relation to levels of fluorescence and 
fitness cost to the Streptococcus in which it is expressed.    
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2.1. BACTERIAL STRAINS AND CULTURE CONDITIONS 
2.1.1 Streptococcus  
For streptococcal strains and mutants used in this study see Table 3 
Streptococcus agalactiae strains were grown in Todd Hewitt broth1 with the addition 
of 5% yeast extract (MPbio,UK) subsequently referred to as THY, or on THY agar 
plates (THY broth with 1.2% agar).  When appropriate spectinomycin was used at 
150g/ml.  Bacteria were always grown at 37oC in air, when grown in broth 
streptococci were grown in standing cultures with head space.  For long term storage 
strains were frozen at -80oC in THY with 30% glycerol.  Strains recovered from frozen 
stocks were replaced every seven days and stored on THY plates at room 
temperature for this time.  
The three strains used for survival, A909, COH1 and NEM316 were chosen as they 
represent the major serotypes associated with colonisation and disease and have 
whole genome sequence data available.  To measure the contribution of 
streptococcal gene products, cylE, cspE, sodA and CovS/R  to intracellular survival,  
deleted strains were compared in viability to their isogenic parent.  
                                            
1 Unless specified all reagents are from Sigma (Poole, UK) 
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Table 3: Group B Streptococcus strains
Strain Genotype Serotype Details Source Reference
NEM316 GBS Wild 
Type 
III  Isolated from neonatal blood 
culture (early onset disease).  
ATCC 12403, 
CIP82.45 
 
A909 GBS Wild 
Type 
Ia  Mouse-passaged prototype 
strain 090. Isolated from 
neonatal blood culture. 
M. Anthony, 
University of 
Birmingham/ 
Oxford John  
Radcliffe 
Hospital 
(Martins et 
al., 2011) 
COH1 GBS Wild 
Type 
III (ST-17) Highly encapsulated, isolated 
from neonatal blood culture. A 
member of the clonal complex 
17, associated with 
hypervirulence. 
M. Anthony, 
University of 
Birmingham/ 
Oxford John  
Radcliffe 
Hospital 
(Rubens et 
al., 1993) 
2603v/r GBS Wild 
Type 
V   Clinical isolate M. Anthony, 
University of 
Birmingham/ 
Oxford John  
Radcliffe 
Hospital 
(Tettelin et 
al., 2002) 
Group B Streptococcus  mutant strains
COH-13 COH1 ∆cpsE III Unencapsulated strain. 
COH1 with Tn917deltaE 
insertion in cpsE 
C. Rubens, 
Seattle 
children’s 
hospital. 
(Rubens et 
al., 1993) 
A909 ∆cpsE A909 ∆cpsE Ia Unencapsulated strain. 
Strain A909 with deletion in 
cpsE capsule gene. 
C. Rubens, 
Seattle 
children’s 
hospital. 
Described 
in (Jones et 
al., 2003b) 
NEM2456 NEM316 
∆cylE 
III Non haemolytic strain, cylE is 
the structural gene for the 
haemolysin/cytolysin. 
S. Dramsi, 
Institut Pasteur. 
(Forquin et 
al., 2007) 
NEM1641 NEM316 
∆sodA 
III SodA deleted, sodA encodes a 
superoxide dismutase 
enzyme. 
S. Dramsi, 
Institut Pasteur. 
(Poyart et 
al., 2001b) 
NEM2089 NEM316 
∆covS/covR 
III NEM316 with aphA-3 
kanamycin cassette replacing 
covS/covR  region. CovS/R is 
a two component system. 
C. Poyart, 
Institut Pasteur 
(Lamy et 
al., 2004) 
2603 csrR∆ 2603∆csrR V 2603 with the response 
regulator of the CsrRS 
(CovRS) CsrR deleted 
M.Wessels, 
Childrens 
Hospital, Boston 
(Jiang et 
al., 2005) 
2603 
csrR∆rep 
2603 csrR∆ 
repaired 
V 2603 csrR∆ transformed with 
pJRS233csrR∆, this plasmid 
contained a genetically 
labelled copy of csrR which 
was inserted into the 
chromosome of csrR∆ strains. 
M.Wessels, 
Childrens 
Hospital, Boston 
(Jiang et 
al., 2005) 
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2.1.2 Escherichia coli 
Please see table 4 and 5 for strains used. 
E.coli was cultured in Luria Broth (LB) broth or LB plates (1.2% agar) Growth was at 
37oC in air, if grown in broth the culture was shaken at approximately 200rpm. 
spectinomycin was used at 100g/ml.  Strains were stored at -80oC in LB broth with 
the addition of 10% glycerol. DH5α strain was chosen as a control in survival assays 
as it is not associated with disease. 
2.1.3 Lactococcus 
Please see table 4 for strains used. 
Lactococcus was grown either on M17 (Oxoid, Basingstoke, UK) plates with the 
addition of 0.5% glucose (M17G) at 30oC, or at 37oC in standing cultures of  M17G 
broth.  Strains were stored at -80oC in M17G broth with the addition of  30% glycerol.  
Organisms to be used in experiments were recovered from frozen at 30oC on M17G 
plates, and stored at room temperature for no longer than seven days.  
Lactococcus lactis  sub species cremoris was used in intracellular survival assays as 
a non-pathogenic control.  This type strain was chosen as it has been classified as 
generally recognized as safe (GRAS) by the US Food and Drug Administration  and 
has been used as a control in similar assays (Gentry-Weeks et al., 1999, Maisey et 
al., 2007).  Lactococcus are Gram positive, lactic acid bacteria and part of the 
Streptococcaceae family.  The organism is therefore a good representative non-
pathogenic relative of Streptococcus. The natural source of cremoris has not been 
identified however other lactic acid bacteria can be isolated from green plants and 
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dairy products.  Lactococcus  is not part of the normal human microbiota but can 
survive for 3-4 days in the human gastrointestinal tract (Michelsen et al., 2010).
 
 
2.1.4 Sensitivity of GBS strains to physiological stress  
Sodium phosphate buffers of specified pH were made by mixing appropriate volumes 
of 0.2 M NaH2PO4 and 0.2 M Na2HPO4 and the pH adjusted with HCl when 
necessary. 
Oxidative and nitrosative stress 
To assess the organisms resistance to the conditions of physiological stress that 
would be experienced in the phagosome, an overnight culture of GBS was washed in 
PBS then diluted 1/500 into buffer containing hydrogen peroxide or sodium nitrite.  
This gave an inoculum of GBS of approximately 1x106 organisms/ml.  To investigate 
nitrosative stress, sodium nitrite (NaNO2) was added at concentrations from 1 to 
Table 4: E.coli  and Lactococcus strains 
Strain Genotype Serotype Details Source 
E.coli DH5α  K12 
derivative 
This is a strain of E.coli 
commonly used for molecular 
biology techniques.  
Chromosomal mutations in 
DNA repair genes allow for 
stable acceptance of nucleic 
acid.  It is not associated with 
pathology. 
 
Lactococcus 
lactis 
subspecies 
cremoris 
MG1363, 
type strain 
 Plant and dairy bacterium, 
generally recognized as safe. 
H. Jenkinson, University 
of Bristol 
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20mM (Voelz et al., 2010) in  0.1M sodium phosphate buffer at pH4.4.  Sensitivity to 
reactive oxygen intermediates was measured by adding hydrogen peroxide (H2O2) to 
0.1M sodium phosphate buffer at pH7.4 and at pH4.4 at concentrations from 0.125 
mM to 14 mM (Voelz et al., 2010). In each experiment a buffer only control tube was 
included. 
After one hour incubation at 37oC, cultures were serially diluted tenfold and plated 
onto THY plates to give an estimated viable count in colony forming units per ml 
(CFU/ml).  A survival ratio was estimated for each condition by dividing the number of 
viable organism recovered after exposure to each stressor with the number of viable 
organisms recovered from the control tube with buffer only 
Low pH 
To test acid tolerance, approximately 1x106 organisms/ml were added to 0.1 M 
sodium phosphate buffers of varying pH and incubated at 37oC for one hour. Viable 
counts were estimated by a serial dilution and plating at the end of this incubation 
period. To estimate a survival ratio the number of recovered organisms from each pH 
buffer was divided by the starting inoculum.
 
2.2  J774 MACROPHAGE-LIKE CELL LINE 
2.2.1 J774 murine macrophage- like cell line 
The J774.16 mouse monocyte derived macrophage-like cell line was originally 
isolated from a murine reticulum cell sarcoma arising in a female BALB/c mouse 
(Ralph et al., 1975).  A reticulum cell sarcoma is a lymphoma comprising of large 
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tumour cells resembling histocytes, these are large immobile macrophages found in 
connective tissues.  The cell line is semi adherent and expresses Fc and 
complement receptors. 
2.2.2 Culture of J774 cells 
Cells were cultured in Dulbecco`s modified Eagle’s medium (DMEM) with the addition 
of 2mM L-glutamine, 100 units/ml penicillin, 0.1mg/ml streptomycin and 10% Foetal 
Bovine serum (FBS)2.  Cells were incubated at 37oC in 5% CO2.  For maintenance 
culture, cells were grown to semi confluence in T75cm2 tissue culture flasks with 
15mls of media and split approximately every two days by scraping the cells off the 
plastic and diluting cells to between 1/3 and 1/8 in fresh complete DMEM.  Cells were 
grown for no more than 15 passages and used in experiments between passages 5-
15. 
2.2.3  Storage of J774 cells 
For long term storage, J774 cells were frozen in liquid nitrogen as follows. Four 
T75cm2  flasks with confluent growth of J774 macrophages at passage two were 
harvested and pooled into 10ml of complete DMEM in a centrifuge tube. The cells 
were pelleted by centrifugation for 10mins at 1000 x g at room temperature.  The 
medium was discarded and the pellet re-suspended in 10ml of filter sterilised freezing 
medium consisting of 50% FBS, 40% complete DMEM and 10% dimethyl sulfoxide 
(DMSO).  Re-suspended cells were then quickly dispensed into 1ml cryovials and 
slowly frozen at -800C.  The freezing process is carried out slowly in the presence of 
                                            
2 This media will now be referred to as complete DMEM 
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DMSO to reduce the formation of ice crystals.  After 24 hours cryovials containing 
cells were transferred to liquid nitrogen. 
To recover cells from frozen stocks, cryovials were removed from liquid nitrogen and 
quickly defrosted at 37oC.  DMSO is cytotoxic to defrosted cells so the time that cells 
are exposed to this solvent must be minimised.  The defrosted cell suspension was 
immediately added to 10ml of complete DMEM and spun at 1000 x g, room 
temperature for four minutes.  The media was discarded and the cells re-suspended 
in 15ml of complete DMEM and transferred into a T75cm2 tissue culture flask.
 
2.3 ISOLATION OF HUMAN MONOCYTE DERIVED MACROPHAGES (HMDMS) FROM 
BUFFY COAT 
Intracellular survival of GBS was measured in human macrophages, this cell type 
may represent a more clinical relevant model system than the murine cell line J774. 
Monocytes were isolated from buffy coat. Buffy coat is the layer of lymphocytes that 
can be segregated when whole blood is separated by centrifugation into plasma and 
red blood cells.  To isolate monocytes, buffy coat was separated by density 
centrifugation using Ficoll-plaque PLUS (Ficoll, GE healthcare, Bucks, UK). Ficoll is a 
synthetic high molecular weight polymer of sucrose and the cross linker 
epichlorohydrin which allows for differential migration of cells during centrifugation.   
Monocytes were selected for by their adherent properties and differentiated into 
macrophages using human recombinant granulocyte macrophage stimulating factor 
(GM-CSF, Immunotools, Germany).   
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25ml of buffy coat was gently transferred into 50ml tubes and diluted in an equal 
volume of sterile PBS (Oxoid, Basingstoke, UK. Tablets dissolved in dH2O and 
sterilised by autoclaving at 121oC for 15minutes).  Approximately 30mls of diluted 
buffy coat was layered on top of 20ml of Ficoll in a fresh centrifuge tube without 
mixing.  The layered solution was centrifuged for 40 minutes at 2000 x g, room 
temperature with the brake off.  Erythrocytes will aggregate and therefore sink to the 
bottom of the tube. Granulocytes will remain with Ficoll in the bottom layer. 
Mononuclear cells and other cells that are slow to sediment such as platelets are 
found in a layer on top of the Ficoll-Paque media (figure 6)
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Cell free layer
Mononuclear cells (with platelets)
Ficoll-Paque media
Granulocytes
Aggregated Erythrocytes
Figure 6: Isolation of Mononuclear cells by density centrifugation. 
Ficoll allows the differential migration of cells. Mononuclear cells are slow to sediment so form a layer on 
top of the Ficoll media (arrowed).
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The mononuclear layer (arrowed on Figure 6) was carefully removed using a Pasteur 
pipette into a new centrifuge tube and washed in PBS at 680 x g for five minutes, the 
supernatant was discarded and the pellet re-suspended in the residual liquid. The 
washing step was repeated until the supernatant appeared clear, this is required to 
remove platelets from the preparation. The cell pellet was then re-suspended in 
RPMI media with 2% FBS, counted by haemocytometer and plated into T75 or T25 
tissue culture flasks at a cell density of 1-6x106/ml.  Flasks were incubated at 37oC 
and 5% CO2 for one hour, this allowed the separation of monocytes by the adherent 
nature of the cells to plastic.  After one hour the flasks were washed twice in warm 
PBS to remove non adherent cells and the media replaced with RMPI containing 
10% FBS, 100 units/ml  penicillin, 0.1 mg/ml streptomycin (complete RPMI) and 
100units/ml of recombinant Human Granulocyte Macrophage Colony Stimulating 
Factor (GM-CSF).  GM-CSF is a cytokine that controls the production, differentiation 
and function of granulocytes and macrophages and will stimulate the differentiation of 
monocytes into macrophages (hMDMs).  After overnight incubation hMDMs were 
detached from the flasks by incubation on ice, counted and seeded in complete 
RPMI with additional 100 units/ml of rhGM-CSF at a density of 1-0.5x106/well in 24 
well plates and 1-2x105/well in 96 well plates.  After a further 24 hours of incubation 
the media was changed for complete RPMI (without GM-CSF). The media was 
changed every three days from this point. hMDMs were used in each assay at day 
five post isolation.  Each buffy coat yielded between 6x106 and 12x106 hMDMs. 
 
Infection of hMDMs was carried out following the same survival assay protocol as for 
J774 macrophages using RPMI in the place of DMEM.
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2.4 INTRACELLULAR SURVIVAL ASSAY 
An intracellular survival assay was developed in the J774 macrophage like cell line to 
measure intracellular survival of range of GBS strains and mutants. The assay was 
used in conjunction with drug treatments to investigate the role of phagosome 
acidification and IFN activation on intracellular survival of the organism (Figure 7).  
The same infection method was used to look for recruitment of the LAMP protein to 
streptococcal containing phagosomes and to monitor the level of reactive oxygen 
species.  
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IFNγ treatment 30mins 
pre infection
Concanamycin A
Lysate plated onto
THY or M17G plates.
MOI 10:1
Overnight culture of GBS, 
Lactococcus or E.coli
Plates incubated for 18hours, 
Colonies counted
Cells lysed at 30minutes
post antibiotic addition (T0), then
at 3,6,9,13,16,19 and 21 hours 
post infection (PI)
Iron Supplementation
Figure 7: Intracellular survival assay. 
The survival of GBS inside macrophages was measured by infecting macrophages with bacteria, then 
lysing cells and counting viable organisms at subsequent time points. The same method was used to 
investigate the effect of treating macrophages with concanamycin A, iron supplementation and IFNγ,
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2.4.1 Preparation of macrophages 
J774 macrophages at between 5 and 15 passages were subcultured into a 24 well 
tissue culture dish at a concentration of 1x105 macrophages/well in 1ml of complete 
DMEM.  The dish was incubated at 37oC in 5% CO2 for approximately 18-24 hours to 
allow the macrophages to settle, hMDM were plated at 1-0.5x106/well as described 
earlier. The higher inoculum of hMDM is required as these cells, in contrast to the 
J774 cells, are terminally differentiated and therefore do not undergo cell division. 
The only change to the infection protocol for hMDM was the use of RPMI in the place 
of DMEM. 
2.4.2 Preparation of bacteria 
To prepare bacteria for infection 1ml of overnight broth culture was centrifuged for 5 
minutes at 7000 x g, the bacterial cell pellet washed twice in PBS and re-suspended 
in PBS to an OD600 of 1.0.  The bacterial suspension was diluted 1/500 into warm 
serum free DMEM (DMEM containing 2mM of L-glutamine but no FBS or antibiotics).  
This dilution gave approximately 10x105 bacteria/ml which gives a multiplicity of 
infection (MOI) of 10 GBS to one macrophage (MOI of 10). The bacterial suspension 
was mixed vigorously by vortex to try to reduce clumping and to break up long 
chains.   
2.4.3 Infection procedure 
Before infection macrophages were washed 3 times in warm PBS, 1ml of the 
bacteria diluted in DMEM as described above was added to each well, dishes were 
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incubated for 30 minutes at 37oC in 5% CO2.  To end infection, after 30 minutes the 
medium was removed, macrophages washed three times in PBS and serum free 
DMEM containing 5g/ml penicillin and 100g/ml gentamicin was added. This media 
remained on the cells for the remainder of the assay. Time point 0 in the assay was 
taken 30 minutes after the replacement of the media with antibiotics, this ensured 
that only intracellular bacteria were counted at this time point. Uptake for each strain 
was estimated as the viable count/well at time point 0. 
2.4.4 Measurement of intracellular survival 
At time 0, 3, 6, 9, 13 16, 19 and 21 hours  post infection the media was removed from 
the well, the macrophages washed 3 times in PBS then 1ml of 0.02% triton-X added 
to the well.  The macrophages were lysed for 10 minutes at 37oC before being 
scraped into a 1.5ml micro-centrifuge tube.  The macrophage lysate was centrifuged 
in a micro-centrifuge at 7000 x g for 5 minutes to pellet the bacteria then re-
suspended in 100l of PBS. The lysate was serially diluted 10 fold in PBS and 10l of 
each dilution plated out on THY, LB or M17G plates. Bacterial colonies were counted 
after approximately 18 hours growth and the number of viable bacteria/well 
estimated.  
2.4.5 Analysis 
To analyse the number of bacteria surviving over time compared to the initial number 
of intracellular bacteria the relative colony forming units (rCFU) was calculated.
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The assay was repeated at least five times and the data analysed using SPSS 16.0 
software. The Mann Whitney U test or Kruskall Wallis test were used with a cut off of 
p<0.05 to establish significant differences between strains or conditions.  Due to the 
biological variability of the assay it was decided that the box and whisker plot was the 
most appropriate way to display the data (see section 2.8 for a description of these 
graphs).
 
2.5 THE GROUP B STREPTOCOCCUS-CONTAINING PHAGOSOME 
2.5.1 Concanamycin A treatment  
To look at the importance of the acidification of the phagosome in control of 
intracellular streptococci the compound concanamycin A was added to GBS or 
Lactococcus infected macrophages.  Concanamycin A is a macrolide antibiotic 
structurally related to the bafilomycins. First isolated from Streptomyces species, 
concanamycin A is biologically active against many fungi but not bacterial species 
and is an inhibitor of the membrane bound vacoular type ATPase (vATPase) (Drose 
and Altendorf, 1997).  The compound inhibits the Vo, membrane bound subunit of 
the complex, this is involved in iron translocation (Huss et al., 2002). 
To measure intracellular survival in the absence of phagosome acidification, 0.1M of 
concanamycin A  dissolved in DMSO was added to serum free DMEM  along with 
antibiotics after a 30 minute infection period (Figure 7) and remained with the cells for 
Relative cfu (rCFU) = 
Number of bacterial colonies/well at a particular time point
Number of bacterial colonies/well at time 0 (uptake)
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the duration of the assay.  Macrophages were lysed, viable intracellular organisms 
enumerated and relative CFU calculated as previously described. 
2.5.2 Iron Supplementation 
One consequence of preventing phagosome acidification is the requirement of low 
pH for intracellular transport and mobilisation of iron.  Within the host cell iron is 
bound in iron storage proteins such as ferritin and transferrin. Ferric irons are 
released from storage proteins at the low pH of the phagosome and the ferrous iron 
is available to the organism.  In neutral conditions ferric iron remains protein bound 
and survival of the intracellular organisms may be compromised (Byrd and Horwitz, 
1991).  To rule out the effects of iron limitation in conjunction with concanamycin A, 
GBS infected macrophages were supplemented with ferric nitrilotriacetate (FeNTA) 
an iron chelator that releases iron independently of pH.  
Compounds were made up as previously described (Bates and Wernicke, 1971).  
Ferric chloride (FeCl) was dissolved in distilled H2O (dH2O) with 2% HCl to a 
concentration of 6 mg/ml, nitrilotriacetate (NTA) was dissolved in dH2O and the pH 
adjusted to neutral using NaOH. Both preparations were filter sterilised. To make up 
ferric nitrilotriacetate (FeNTA) FeCl and NTA were mixed in equal volumes (3 mg/ml) 
and the pH adjusted to neutral by the addition of 0.9 M NaOH.  The volume of NaOH 
added was recorded to allow for an estimation of the concentration of FeNTA. The 
solution was then filter sterilised through a 0.22 M filter.  All solutions were made 
fresh for each experiment.  Iron solutions were then added to GBS infected J774 
cells, with or without concanamycin A treatment, at time 0 (T0) at concentrations of 
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5M, and 50M of FeNTA and 50g/ml of NTA or FeCl and remained in the media 
for the duration of the experiment. 
2.5.3 IFN activation of macrophages 
Macrophages were plated as described for the survival assay (2.4.1). Before 
infection with bacteria the cells were washed and the media replaced with serum free 
media containing 10 U/ml IFN (Immunotools).  After 30 minutes incubation at 37oC 
cells were washed and infection and survival measured as described above (from 
2.4.3). 
 
2.6  REACTIVE OXYGEN SPECIES 
2.6.1 Measurement of hydrogen peroxide production using Amplex® UltraRed 
Hydrogen peroxide generated through the activity of the NADPH oxidase complex 
can pass through cell membranes and therefore can be detected in the culture 
supernatant.   Hydrogen peroxide was measured by the horse radish peroxidase 
(HRP) catalysed oxidation of the non coloured Amplex® UltraRed reagent (amplex 
red, Invitrogen, life technologies, Paisley), to a fluorescent derivative resorufin.  Using 
this method, hydrogen peroxide production from cells infected with GBS in 96 well 
plates was measured using a plate reader to detect fluorescence, therefore allowing 
a quick and convenient method of screening multiple strains of GBS. 
J774 cells and hMDM were settled in a 96 well plate at 0.4x105 J447 cells/well and 1-
2x105 hMDM/well.  Organisms were prepared as previously described (2.4.2)  and 
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added to cells at MOI 10 in filter sterilised Krebs-Ringer phosphate solution (145mM 
NaCl, 5.7mM Sodium phosphate, 4.86mM KCL, 0.54mM CaCl2, 1.22 mM MgSO4, 
5.5mM glucose, 10mM HEPES, pH adjusted to 7.35) with 50μM of Amplex® 
UltraRed reagent and 0.1 U/ml of HRP.  A well containing cells with no stimulus was 
included with each run. To one well 150ng/ml of Phorbol-12-myristate 13-acetate 
(PMA) was added as a positive control.  PMA is a stimulator of the protein kinase C 
(PKC) signalling transduction pathway. 
Amplex red was prepared by dissolving one, 1mg vial in 100μl of DMSO to give a 
stock solution of 10mg/ml, this was frozen at -20oC in single use aliquots.  A 10mg/ml 
stock solution was prepared of HRP in 0.1M phosphate buffer (0.2 M NaH2PO4, 0.2 
M Na2HPO4) this has an activity of 2520U/ml, to make a working stock solution this 
was diluted 1/1000 in Krebs-Ringer phosphate solution.  
Post infection with organisms plates were sealed using a breathe easy membrane 
(Breathe-EasyTM sealing membrane, Fisher) and immediately placed within the BMG 
FLUOstar omega plate reader (BMG labtech, Basingstoke, UK).  Fluorescence 
measurements were taken at an excitation of 544nm and an emission of 580nm, 
immediately post-infection, then every subsequent 15 minutes for eight hours. For 
the duration of the assay the plate was incubated within the plate reader at 37oC in 
normal atmospheric conditions. 
Results were analysed using the BMG labtech analysis software, Mars. To compare 
the rate of hydrogen peroxide production in infected cells, the maximum slope was 
calculated using the kinetic calculation wizard function. 
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2.6.2 Measurement of ROS using H2DCFDA and flow cytometry 
To measure generation of reactive oxygen intermediates in infected and non infected 
J774 cells the cell-permanent fluorescent dye 2',7'-dichlorodihydrofluorescein 
diacetate (H2DCFDA, Invitrogen) was used.  H2DCFDA is a chemically reduced form 
of the fluorescent compound fluorescein.  H2DCFDA is non- fluorescent until 
cleavage by intracellular esterases and oxidation within the cell, making it a specific 
marker of intracellular ROS.  
J774 cells were infected with GBS as previously described for the survival assay 
(2.4). At individual time points cells were removed from plastic using accutase 
treatment.  
Accutase treatment 
Accutase is a mix of proteolytic and collagenolytic enzymes which will break the 
bonds between the macrophages and ECM components.  J774 cells can adhere to 
plastic, this is mediated through cellular interaction with extracellular matrix (ECM) 
proteins, present in the culture dish either from FBS or produced by macrophages 
themselves.  Cells in a 24 well plate were washed twice in PBS before being 
incubated for 10 minutes at 37oC in 200μl of accutase. Cells were removed from the 
plastic by adding 400μl of PBS and using this to ‘flush’ round the plate, cells were 
then washed in PBS at 1500 x g for two minutes in a micro centrifuge and re-
suspended in 200μl of DMEM containing 5μM H2DCFDA.  
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ROS staining and flow cytometry 
H2DCFDA powder was dissolved to 10mM in DMSO and stored at -20OC in 10μl 
aliquots under nitrogen.  Cells were incubated with the dye for 45 minutes at 37oC 
before immediate analysis. Fluorescence was measured by flow cytometry using a 
FACSCaliber instrument and analysed with CellQuestPro (BD Biosciences).  10000 
events were counted and the percentage of positive cells identified by gate analysis. 
2.6.3 Blocking ROS generation through inhibition of the NADPH oxidase 
To investigate the role of ROS generated through the NADPH oxidase for the control 
of intracellular streptococci, the activity of the enzyme was blocked using Apocynin 
(4-hydroxy-3-methoxyacetophenone).  Apocynin is a prodrug which upon activation 
by H2O2 or myloperoxidase oxidises thiols in the NADPH oxidase complex thus 
preventing subunit assembly.  Apocynin, made fresh for each experiment was 
dissolved in serum free DMEM overnight at 50oC to make a stock solution of 15mM 
this was added to cells at the time of infection at a final concentration of 0.5mM (Hu 
et al., 2011). The survival assay was performed as previously described (2.4). 
Apocynin remained in the media for the duration of the experiment. In parallel 
apocynin treated cells were detached, stained for ROS using H2DCFDA, and 
analysed using flow cytometry as described above (2.6.2). 
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2.7 MICROSCOPY AND IMMUNOSTAINING 
2.7.1 General techniques 
Preparation of macrophages for microscopy 
Macrophages at the density required for the assay were seeded into 24 well dishes 
which contained a 13mm prepared glass coverslip in each well. Coverslips were 
prepared by washing the coverslips for 10 minutes in 1M Nitric acid, followed by 
repeated washing in large volumes of water and a final wash in 100% ethanol. 
Coverslips were then left at room temperature to allow residual ethanol to evaporate.  
Macrophages were allowed to settle onto the coverslip for 18 hours and infected as 
described previously (2.4). 
Paraformaldehyde fixation of cells for microscopy. 
Before microscopy, macrophages adhered to glass coverslips were fixed to ensure 
preservation of the cell structure.  Paraformaldehyde (PFA) forms cross links 
between cellular proteins via basic amino groups. PFA powder was added (in a fume 
hood) to a concentration of 4% weight to volume in PBS. To completely dissolve the 
powder the solution was incubated overnight at 37oC. PFA was frozen at -20oC for 
long term storage and kept at 4oC when in use.  To fix cells; after washing three 
times in PBS, the coverslips were removed, and placed into a well of a 24 well plate 
containing 0.5ml of 4% PFA.  Fixation was carried out for 10 minutes at room 
temperature. Following this coverslip’s were removed from PFA, washed three times 
in PBS and stored in PBS at 4oC for a maximum of 24 hours.  Fixed cells were either 
mounted directly and used for microscopy or used for immunostaining. 
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Antibody labelling 
For long term storage, antibodies were diluted  in equal volume of 100% glycerol, 
aliquoted and stored at -80oC.  In use aliquots were kept at 4oC.  All labelling 
incubations were carried out at room temperature by placing the coverslip cell side 
down on a 100l drop of the reagent on laboratory sealing film.  
Immunostaining was carried out as follows:  Fixed coverslips were washed three 
times in PBS and incubated for 10 minutes in 50 mM ammonium chloride. 
Ammonium chloride inhibits the activity of PFA by quenching free aldehyde groups; 
this reduces the background fluorescence.  Following three washes in PBS Cells 
were permeabilised for four minutes using a weak detergent such as 0.1% Triton X 
100 or 0.1% Saponin, this allows antibodies to access intracellular targets.  
Coverslips were then immediately transferred to the primary antibody for 20 minutes 
(for specific antibody concentrations and buffers see later sections), washed three 
times and then incubated with secondary antibody for 20 minutes.  Human IgG at 
1mg/ml was added to both primary and secondary antibody reactions at five times 
the volume of the staining antibody. The presence of human IgG will block Fc 
receptors on the macrophages thus preventing non specific binding of the secondary 
antibody to these receptors which would lead to background fluorescence.  Following 
incubation with the secondary antibody coverslips were washed three times in PBS, 
three times in water and mounted in 6μl of mowiol mounting media on a glass slide 
as described below. 
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Mounting of coverslips 
Mowiol mounting media (mowiol) contains 9% Mowiol (Calbiochem), 25% glycerol 
and an antifade reagent p-phenylene diamine (Sigma) in 100mM TRIS-HCl pH8.5. 
Mowiol is a polyvinyl alcohol solution with hardening properties, it is non absorbent 
and non light scattering.  To prepare mowiol media, Mowiol powder is initially mixed 
by rotation with glycerol and water for two hours, after which time Tris-Cl is added 
and the mixture is left to dissolve overnight at 50oC. Once dissolved the solution is 
filtered through a 0.45μm filter, anti fade is added and the mowiol is aliquoted for 
storage at -80oC.  Once defrosted mowiol can not be stored.   
Mounted coverslips were left either at 37oc for one hour or at room temperature 
overnight to allow the mowiol to harden. 
2.7.2 Immunostaining and scoring for LAMP acquisition 
Synchronised infection 
J774 cells were seeded overnight on 12mm coverslips then infected with GBS, heat 
killed GBS or latex beads. Infection was synchronised by incubating GBS or beads 
with J774 cells on ice for 30 minutes.  During this time, under these conditions 
adherence will take place but internalisation will be inhibited.  The assay plates were 
moved to 37oC to stimulate uptake and the experiment was carried out as described 
above for the survival assay (2.4.3) except for the procedure at each time point. 
LAMP-1 antibody labelling 
At each time point coverslips were removed, fixed and immunostained as described 
previously (2.7.1).  For optimal LAMP staining, cells were permeabilised with 0.1% 
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Saponin, this and all antibody dilutions were made up in blocking buffer, comprising 
of PBS with the addition of 3% normal goat serum (Invitrogen).  To stain for 
lysosomal associated membrane protein-1 (LAMP-1) the supernatant of the rat 
monoclonal antibody ID4B was used at a 1/25 dilution (Developed by J. Thomas 
August, ID4B was obtained from the Developmental Studies Hybridoma Bank and 
developed under the auspices of the NICHD and maintained by the University of 
Iowa.).  To stain for GBS, the mouse anti-Streptococcus agalactiae monoclonal 
antibody 1.B.501 was used diluted 1/50 (Santa Cruz Biotechnology).  The anti-GBS 
antibody was raised in mice against UV irradiated non-typable bovine isolate, 
ATCC27956.  The target of this antibody is not identified, but when visualised by 
microscopy it localises round the edge of the organism so is presumed to be capsule 
or cell wall.   Secondary antibodies used were anti-rat TRITC conjugate for the 
detection of LAMP-1 and anti-mouse FITC conjugate for the detection of GBS, both 
at a concentration of  1/100 (Invitrogen). 
2.7.3 Microscopy 
Fluorescent microscopy; LAMP-1 scoring 
For visualisation of LAMP-1 and streptococcal staining cells were viewed using the 
100x differential interference contrast (DIC) oil immersion objective on a Nikon 
Eclipse Ti microscope with TRITC and FITC filter set.  Images were captured using 
an ORCA-R2 camera (Hamamatsu) and NIS elements software (Nikon).  Images 
were processed in Adobe Photoshop (Adobe) and each streptococcal containing 
phagosome was scored by eye for LAMP acquisition.  At least 50 streptococcal 
containing phagosomes were scored for each time point in three independent 
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repeats.  Acquisition is presented as a percentage of GBS containing phagosomes 
that could be seen having a ring of LAMP surrounding the contents. Statistical 
analysis was carried out using the raw data by 2  test (section 2.9). 
Fluorescent microscopy; GFP expression 
To visualise intracellular GFP expressing GBS, macrophages infected with GFP 
expressing organisms were fixed and visualised using phase contrast and a GFP 
filter set under 63x oil immersion objective on a Zeiss Axiovert 135TV.  Images were 
captured using a Qimaging 12-bit QICAM with a 0.63x camera lens and Qimage pro 
software (Qimaging) 
Stereo microscopy 
GFP expressing colonies were visualised for fluorescence using a 1x objective and 
zoom (range 0.75 to 7.5) on a stereo microscope (Nikon, SMZ-U).  Colonies were 
viewed using brightfield and then for GFP expression using a GFP filter set. Images 
were captured using a Qimaging 12-bit QICAM with a 0.63x camera lens and 
Qimage pro software (Qimaging)  
Live cell imaging 
To visualise the intracellular location of GBS and to follow the course of infection in 
real time J774 macrophages were infected with GFP expressing streptococci and 
imaged. 
J774 macrophages were infected with the GFP expressing plasmid NEM:pMA2 (for 
plasmid details please see Table 5) as previously described (2.3)  but with the 
addition of spectinomycin 150g/ml in the media during infection for plasmid 
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maintenance.  Following infection the medium was replaced with DMEM without 
phenol red, containing spectinomycin 150g/ml, penicillin 5g/ml and gentamycin 
100g/m.  Cells were cultured in a controlled chamber maintaining the normal culture 
conditions of 37oC and 5% CO2 and visualised on a Nikon Eclipse TE2000-U 
microscope using a 20x objective with phase contrast and a GFP filter set.  Images 
were captured every two minutes for 16 hours with a Nikon Digital Sight DS-QilMC 
camera and compiled into time lapse movies using the software NIS-Elements AR3.0 
(Nikon). 
For presentation images were processed in Image J (Rasband, W.S., ImageJ, U. S. 
National Institutes of Health, Bethesda, Maryland, USA, http://imagej.nih.gov/ij/, 
1997-2012) and Adobe Photoshop.
 
2.8  DEVELOPMENT AND EVALUATION OF STRAINS EXPRESSING GREEN 
FLUORESCENT PROTEIN (GFP) 
2.8.1  Transformation of E.coli 
To increase plasmid yield GBS plasmids pBSU98, 100 and 101 (Table 5) were 
shuttled through E.coli and plasmid prepped. Transformation was carried out in 
accordance with the protocol supplied with the competent cells.  XL-blue E.coli 
cells treated with β-mercaptoethanol were incubated on ice with 0.1-50ng of 
plasmid DNA then heat-shocked at 42oc for 45-50 seconds. Cells were returned 
briefly to ice before an hour incubation, shaking at 37oC in SOC medium (2% 
Tryptone,0.5% Yeast Extract, 10mM NaCl, 2.5mM KCL, 10mM MgCl2.6H2O, 
CHAPTER 2: Materials and Methods 
 
96 
 
10mM  MgSO4.7H2O, 20mM Glucose [anhydrous]).  Transformed cells were 
plated onto LB agar with appropriate antibiotics, cultured overnight and 
antibiotic resistant colonies isolated. Confirmation of transformation was by 
PCR.
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Table 5: GFP Streptococcal –E.coli  shuttle vectors 
plasmid Backbone Antibiotic 
resistance 
Promoter  Properties Source Reference 
pMA02  pDL277 
Streptococcus – 
E.coli shuttle vector 
Spectinomycin PhppA 
(Streptococcus 
gordonii)  
GFP cassette 
from pBJ169 
A. Nobbs, 
University of 
Bristol,UK 
(Aspiras, 
Kazmerzak et 
al. 2000) 
pBSU98 pAT28 (Trieu-Cuot et 
al., 1990) 
Spectinomycin Cfb 
(Streptococcus 
agalactiae 
CAMP factor) 
Plasmid from 
strain BSU98 
C. Gille, University 
Hospital Tbingen, 
Germany 
(Gille et al., 
2009) 
pBSU101 pAT28 Spectinomycin Cfb  GFP from 
clonetech EGFP 
B. Spellerberg, 
University of Ulm, 
Germany 
 (Aymanns et 
al., 2011) 
pBSU100 pAT28 Spectinomycin None GFP from 
clonetech EGFP 
B. Spellerberg, 
University of Ulm, 
Germany 
(Aymanns et al., 
2011) 
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Table 6: E.coli  strains used for molecular biology 
Strain Genotype Details Source Reference 
HB101:pMA2 HB101 E.coli strains with 
pMA2 E.coli-
streptococcal shuttle 
vector 
A. Nobbs, 
University of 
Bristol,UK 
(Aspiras et 
al., 2000) 
XL-blue cells  recA1 recombination 
deficient 
endA1  Endonuclease 
deficient 
hsdR17  Prevents 
cleavage by EcoK 
endonuclease system 
XL-blue chemically 
competent cells. 
Used for subcloning 
Streptococcal 
plasmids 
Agilent 
technologies 
 
 
2.8.2  Plasmid preparation from E.coli 
Plasmid pMA2 was received in E. coli strain HB101, plasmids PBSU98, 100 and 101 
were transformed into E. coli for storage and amplification purposes. To obtain a 
sufficient level of high quality plasmid DNA for streptococcal transformation plasmid 
DNA was extracted using a Qiagen midi prep kit (Qiagen, Crawley, UK).  
A single colony of HB101 or XL-Blue was inoculated into 5ml of LB broth with 
150g/ml spectinomycin and incubated shaking for six hours. This culture was then 
diluted 1/500 into a 500ml flask containing 100ml of LB broth with 150g/ml 
spectinomycin and incubated overnight.  The nucleic acid extraction for plasmid DNA 
was carried out according to manufacture’s instructions.  Bacterial cells were pelleted 
and re-suspended in a Tris-EDTA buffer containing RNaseA, cells were then lysed by 
sodium dodecyl sulfate (SDS) with the addition of sodium hydroxide (NaOH) which 
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denatures genomic DNA, plasmid DNA and proteins.  The solution was neutralised 
and protein and genomic DNA precipitated by the addition of acidic potassium 
acetate; plasmid DNA remained in solution.  The lysate was cleared by centrifugation 
and the supernatant containing plasmid DNA added to a QIAGEN-tip.  The QIAGEN 
Anion-Exchange resin can bind DNA under these salt and pH conditions, but RNA 
and protein are not able to bind.  The QIAGEN-tip was washed using a medium salt 
buffer to remove any remaining RNA and proteins before elution of DNA with a high 
salt buffer.  Plasmid DNA was precipitated from the eluate using an isopropanol and 
ethanol precipitation protocol.  DNA was dried and re-suspended in Tris-EDTA (TE, 
1mM EDTA, 10mM Tris). The concentration of plasmid DNA was measured using a 
spectrophotometer at 260nm, purity was checked using the OD280/OD260 ratio.
 
2.8.3 Plasmid preparation from GBS 
Plasmid pBSU98 was removed from strain BSU98 to allow transformation into 
NEM316 (see table 5 for plasmid details and table 7 for strain details).  Plasmid DNA 
was purified using the QIAprep spin mini prep kit (Qiagen) with an initial enzymatic 
lyis step required to break down the gram positive cell wall. 
A single colony of BSU98 was inoculated into 5ml of THY broth containing 150μg/ml 
spectinomycin and cultured overnight at 37oC.  Cells were pelleted by centrifugation 
at 3000 x g for 10mins and re-suspended in 100l of TG buffer (50mM Tris-HCL pH8 
with the addition of 25% glucose).  To lyse the streptococcal cells, 100l of TES 
buffer (50mM Tris, 5mM EDTA, 0.15M NaCl) was added containing  0.42mg/ml of 
RNase A, 8.3mg/ml lysozyme and 1KU/ml mutanolysin.  Lysosome and mutanolysin 
CHAPTER 2: Materials and Methods 
 
100 
 
are muramidase enzymes which break down the peptidoglycan cell wall structure.  
Following lysis at 37oC for one hour 250l of buffer P2 from the QIAprep spin mini 
prep kit was added, this alkaline buffer will denature proteins and genomic DNA and 
allow the subsequent purification of plasmid DNA. The manufacture’s protocol was 
then followed. For a more detailed explanation of the process of plasmid isolation 
please see section 2.6.2. Plasmids were eluted in 50μl of buffer EB (10mM Tris-Cl, 
pH8.5) and stored at -20oC.  The concentration of plasmid DNA was measured using 
a spectrophotometer at OD260, purity was checked using the OD280/OD260 ratio.
 
2.8.4 Transformation of GBS 
GBS strain NEM316 was transformed with plasmids pMA2, pBSU98, pBSU100 and 
pBSU101 by electroporation following a modified method from Framson et al 
(Framson et al., 1997). For details of streptococcal strains used please see table 7. 
Preparation of electrocompetent GBS 
GBS is made electrocompetent by culturing the organism in minimal medium with 
glycine, which will modify the cell wall.  When grown in these conditions the organism 
is sensitive to lysis by detergent, therefore single use plastic ware was used to avoid 
this occurring 
One colony of streptococcus was inoculated into 10ml of M9/YE (1% M9 salts, 0.2% 
glucose, 0.3% Yeast extract, 1% casaminoacids, 2 mM MgSO4, 1mM CaCl2).  After 
overnight culture 500μl was transferred to 50ml of M9/YE plus 0.6% glycine and 
grown overnight.  The following morning,  10ml of this culture was added to 500ml  
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M9/YE+ 0.6% glycine and incubated untill the culture reached early exponential 
phase OD600 0.13-0.2 (transformation efficiency is increased at this growth phase).  
The culture was split into two sterile, detergent free centrifuge tubes, and rapidly 
cooled on ice for 15 minutes.  Cells were kept on ice throughout the procedure. 
Bacterial cells were centrifuged at 18000 x g for 10 minutes at 4oC, the supernatant 
was immediately discarded and two pellets pooled and resuspended in 150ml of 
0.625M sucrose pH4. The cell suspension was centrifuged again at 18000 x g for 10 
minutes, the supernatant removed and the pellet resuspended in 1ml of 0.625M 
sucrose pH4 in a 1.5ml centrifuge tube.  The thick cell suspension was centrifuged at 
16000 x g for 1 minute and cells were removed to a fresh 1.5ml centrifuge tube with 
1ml of 0.625M sucrose. Cells were snap frozen, using liquid nitrogen then stored at -
80oC. 
Electroporation of competent GBS 
Up to 5g of plasmid DNA was added to 75l of competent GBS on ice then 
electroporated in a 1mm cuvette (gene flow) at 1.25kV, 600  and 25F in a Bio-Rad 
Gene pulser electroporator.  Immediately 2ml of THY with 0.5M sucrose, pH7, was 
added to the cuvette and the bacteria removed.  The bacteria were incubated in this 
medium for two hours at 37oC before pelleting by centrifugation and plating out on 
THY agar plates containing 150g/ml spectinomycin.  Plates were incubated for 24-
48 hours; resulting colonies were purified and presence of the plasmid confirmed 
using molecular techniques as described below.
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Table 7: Group B Streptococcus strains containing GFP expressing plasmids 
Strain Genotype Details Source Reference 
NEM316:pMA2 NEM316 NEM316 carrying 
plasmid pMA2 
This work (Aspiras et 
al., 2000) 
BSU98 090R Serotype 1a strain 
carrying plasmid 
pBSU98 
C. Gille, University 
Hospital Tbingen, 
Germany 
(Gille et al., 
2009) 
BSU99 090R Serotype 1a strain 
carrying control 
plasmid 
C. Gille, University 
Hospital Tbingen, 
Germany 
(Gille et al., 
2009) 
NEM316:pBSU100 NEM316 NEM316 carrying 
plasmid pBSU100 
This work (Aymanns et 
al., 2011) 
NEM316:pBSU101 NEM316 NEM316 carrying 
plasmid pBSU101 
This work (Aymanns et 
al., 2011) 
 
2.8.5  Molecular methods used to confirm GFP expressing strains. 
 To confirm positive transformants of GBS with GFP plasmid a crude DNA isolation 
method was used followed by PCR. 
Streptococcal DNA isolation  
DNA was extracted by mechanical cell lysis.  1ml of TE (10mM Tris-HCL, 
1mMEDTA.Na2) was added to a lysing matrix B tube (MPbio). Lysing matrix B 
consists of 0.1mm Silica spheres in a 2ml screw cap tube.  A suspension of GBS was 
made in the TE buffer in the tube. Tubes were agitated for two cycles of 23 seconds 
at 6500rpm using a Precellys 24 lysis and homogeniser (Precellys).  The cell lysate 
was centrifuged at 16000 x g for 3 minutes and the supernatant which contains 
nucleic acids removed to a fresh tube.  This crude lysate was used immediately for 
PCR and not stored. 
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Table 8: Primers used in this study3 
Primer Sequence (5’-3’) Details Reference 
16sfwb GCTCAGGAYGAACGCTGG Used to sequence for strain 
confirmation 
(Harris and Hartley, 2003) 
16srv TACTGCTGCCTCCCGTA Used to sequence for strain 
confirmation 
(Harris and Hartley, 2003) 
RpoD5 GACTGATGAAGAGCTCATAGG Positive control for GBS PCR. Major 
sigma factor of GBS 
R.Whitehead, University of 
Birmingham (un published) 
RpoD6 CTCAGGAGTTGGATCTTGACC Positive control for GBS PCR. Major 
sigma factor of GBS 
R.Whitehead, University of 
Birmingham (un published) 
Pr6F CGCGGATCCTAAACCAGTAACGAAGAAAGAGTATCA Used to sequence PhppA from 
plasmid pMA2 
(Aspiras et al., 2000) 
pAT28-3 GTTGTGTGGAATTGTGAGCGG Primers for checking pAT28-GFP 
construct, plasmids pBSU98,100 and 
101 
(Gleich-Theurer et al., 2009) 
pAT28-EGFP4 CCTTGAAGAAGATGGTGCGC Primers for checking pAT28-GFP 
construct plasmids,  pBSU98,100 and 
101 
(Gleich-Theurer et al., 2009) 
PBSU100-for1 GTTGTGTGGAATTGTGAGCGG MCS pBSU100 and pBSU101 (Aymanns et al., 2011) 
PBSU100-rev1 CCTTGAAGAAGATGGTGCCG MCS pBSU100 and pBSU101 (Aymanns et al., 2011) 
                                            
3 Primers were obtained from Eurofins with the exception of RpoD5 and RpoD6 which were obtained from Altabiosciences  
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Polymerase chain reaction (PCR) 
PCR was used to confirm the presence of the plasmid in the transformed strains. 
Please see table 8 for primers used.  Primers against RpoD the major sigma factor of 
GBS and the 16s rRNA gene were used as positive controls for PCR.  The PCR 
reaction mix and cycling conditions were as follows (PCR reagents were obtained 
from Bioline, London, UK):
 
Table 9: PCR reaction mix 
 Stock concentration Concentration/reaction 
Forward primer 25pmol/μl 1μM 
Reverse primer 25pmol/μl 1μM 
NH4 Buffer 10x 1x 
MgCl2 50mM 3mM 
dNTP mix 100mM (25mM of dATP, dCTP, dGTP, 
dTTP) 
1mM 
Taq polymerase 5U/μl 0.5U 
Crude DNA extract Not quantified 2μl 
Water  To a total volume of 50μl 
 
 
Table 10: PCR cycling conditions  
Step Temperature Time  
Denaturation 95oC 2 minutes  
Denaturation 95oC 30 seconds  
Annealing 58oC 45 seconds 30 cycles 
Extension 72oC 60 seconds  
Extension 72oC 5 minutes  
Hold 15oC ∞  
 
Agerose gel electrophoresis 
Size of PCR products was confirmed on 1% agarose gel.
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2.8.6  Sequencing the promoter region of pMA2 
Sequencing was carried out by the Functional Genomics Proteomics and 
Metabolomics facility within the School of Biosciences at the University of 
Birmingham.
The sequencing reaction mix was prepared as recommended by the facility: 
Table 11: Sequencing reaction mix 
Reagent Concentration Volume/10μl reaction 
Primer Pr6fw  (1pmol/μl) 3μl 
Plasmid pMA2  (352ng/μl) 1.5μl 
Water  15.5μl 
 
The reaction was made up to 20μl by the addition of big dye terminator and labelled 
DNA run on an ABI3730 capillary sequencer. 
Sequence analysis 
Resulting sequences were downloaded as ABI files and opened using Chromas light 
software.  Chromatograms were checked for base calling and exported as text or 
FASTA files.  The sequence of the promoter region of the hppA gene that had been 
used to construct plasmid pMA2 (Aspiras et al., 2000) was identified from the 
genbank sequence L41358 using the primers Pr6F and HJ26. ClustalW2 
(http://www.ebi.ac.uk/Tools/msa/clustalw2/) was used to align the sequence obtained 
from the plasmid mini prep and the published phppA sequence. 
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2.8.7  Phenotypic analysis of GFP expressing NEM316 
Colony phenotype on solid media 
Organisms carrying the GFP plasmid were plated on THY agar with the addition of 
150μg/ml spectinomycin.  Colony fluorescence was viewed using a steromicroscope 
(section 2.7.3) 
Intracellular survival of GFP expressing organisms 
Intracellular survival of GFP expressing NEM316 in J774 macrophages was carried 
out as previously described in section 2.4. GFP expressing streptococci were allowed 
to infect macrophages settled on coverslips, these were fixed and viewed using 
fluorescent microscopy (section 2.7.3) to visualise intracellular organisms. 
Stability of GFP in killed microorganisms 
NEM316:pBSU98 was inactivated through heat, exposure to antibiotics and UV light.  
Killed organisms were used to infect J774 cells, cells were fixed and intracellular 
organisms visualised for fluorescence.  
A suspension of approximately 1.4x106 cfu/ml NEM316:pBSU98 in PBS were heat 
killed by treatment at 60oC for 30 minutes or UV killed by exposure to UV 254nm at 
0.16j/cm2 for 10 minutes.  Antibiotics were used at 100μg/ml gentamycin and 5μg/ml 
penicillin, organisms were incubated in PBS containing the antibiotics for 30 minutes 
at 37oC. Killing was confirmed by plating the PBS suspension onto THY plates and 
incubating overnight at 37oC.   
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Fitness of plasmid carrying strains and fluorescence intensity 
Growth and fluorescence kinetics of NEM316:pMA2 and NEM316:pBSU98 were 
measured.   Overnight cultures in THY broth were diluted 1/200 in 200μl of imaging 
RPMI in a 96 well plate. The plate was sealed using a breathable membrane 
(Breathe-EasyTM sealing membrane, Fisher) and incubated at 37oC in the BMG 
labtech FLUOstar omega microplate reader.  Readings were taken at OD620 for 
absorbance and excitation 485-12nm emission 520nm for green fluorescence.  The 
plate was shaken in a linear direction for 5 seconds at 200 strokes per minute before 
each reading. Fluorescence and OD end point reads were combined using script 
mode and taken every 20 minutes for 11 hours to generate a growth curve.  Growth 
curves were viewed and presented using the BMG labtech Mars data analysis 
software. 
 
2.9 STATISTICAL METHODS 
All statistical analysis was performed using SPSS software (IBM); graphs were made 
using this software or Microsoft excel.  Further details of the main statistical methods 
used are below. 
The 2 test 
The 2 test is used to investigate if the observed data are different from what would 
be expected if the characteristics were distributed randomly among the population, 
taking into account the frequencies of each observation. This gives a probability of 
the observed value happening by chance in a population with no association. 
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Two sample T test 
 A two sample T test was used to calculate the significance of differences between 
GBS tolerance to phagosomal stress conditions in vitro.  The two sample T test, tests 
the probability that the distribution of the sample means will overlap.  Equal variances 
were not assumed, this was due to the no treatment control group being normalised 
to one so not having a standard deviation value. 
ANOVA (Analysis of variance) 
ANOVA calculates the chance of a set of observations being different based on 
within group and between group variability. To identify if organisms are responding 
differently to a set of physiological conditions such as low pH ANOVA was 
performed.  ANOVA calculates the variability of the data obtained within each  
physiological condition, and can compare this with the variability of the data between 
each physiological condition. 
Mann-Whitney U 
The Mann-Whitney U test was used to establish if there was any statistical difference 
between the medium relative colony forming units (rCFU) count measuring 
intracellular survival in different strains and in different conditions. Each rCFU value 
obtained from the two sets of data to be compared were ranked together, the sum of 
the rank scores for each group calculated separately, and the test statistic calculated 
based on the probability of the two summed ranks being different. 
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Kruskal Wallis 
To identify if treatment of infected J774 cells with iron compounds changed 
intracellular survival, the Kruskal Wallis test was used. The Kruskal Wallis test 
measures if a set of data has arisen from the same distribution.  This test is the non-
parametric version of ANOVA, it uses the median values. 
Box plot 
Results for intracellular survival are presented as box and whisker plots, the box 
represents the upper and lower quartiles with the line in the centre the median value 
of all repeats, the whiskers are drawn up to the maximum and minimum values 
excluding outliers (marked with open circles) which are between 1.5 and 3 box 
lengths away from the ends of the plot and extreme values (marked with asterisk) 
which are over three box lengths away from the end of the plot. This presentation 
best represents the variable nature of the assay whilst still showing the overall 
significance of findings.
CHAPTER 3: Intracellular survival of Group B Streptococcus 
110 
 
 
 
 
 
 
CHAPTER 3:  INTRACELLULAR SURVIVAL OF 
GROUP B STREPTOCOCCUS 
 
 
 
 
 
 
Major parts of this chapter have been published (Cumley et al., 2012):   
 
Cumley, N. J., Smith, L. M., Anthony, M. & May, R. C. 2012. The CovS/CovR Acid 
Response Regulator Is Required for Intracellular Survival of Group B Streptococcus 
in Macrophages. Infection and Immunity, 80, 1650-1661
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INTRODUCTION 
In neonatal GBS disease the cells of the innate immune system provide an important 
role in host defence. Tissue resident macrophages are likely to be among the first 
cells to encounter invading GBS. It is known that many pathogenic microorganisms 
are able to survive the killing mechanisms of macrophages and that this persistence 
may contribute to disease progression and dissemination (Flannagan et al., 2009, 
Medina et al., 2003, Thwaites and Gant, 2011). It has been previously published that 
GBS can survive inside macrophages (Valenti-Weigand et al., 1996, Cornacchione et 
al., 1998), but the mechanism for the observed persistence requires further 
characterisation.   
GBS has several key gene products previously implicated in full virulence in animal 
models (Maisey et al., 2008a).  In the following work, strains deleted in genes 
hypothesised to have a role in enabling the organism to persist within the 
antimicrobial environment of phagocytic cells have been assessed for a role in 
intracellular survival and tolerance to physiological stresses in vitro.   
This chapter describes work carried out using an intracellular survival assay primarily 
in the murine macrophage- like cell line J774 and also in human monocyte derived 
macrophages (hMDM’s) to identify features of GBS which enable it to resist host cell 
killing and cope with physiological stress similar to that experienced within a 
phagosome.  
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RESULTS  
3.1 Group B Streptococcus shows extended survival in J774 
macrophages.  
It has been previously reported that group B Streptococcus can survive inside 
phagocytic cells for longer than non-pathogenic organisms such as E. coli 
(Cornacchione et al., 1998, Valenti-Weigand et al., 1996).  
 To allow further investigation of the mechanism behind this phenotype an antibiotic-
exclusion and survival assay was developed in the macrophage-like murine cell line 
J774. J774 cells are considered a useful model for macrophage activity and have 
previously been used for investigating intracellular survival of many pathogens, 
including GBS (Ralph and Nakoinz, 1975, Ralph et al., 1975, Liu et al., 2004, Valenti-
Weigand et al., 1996).  Although Lactococcus lactis, a non-pathogenic species that is 
closely related to the streptococci, was rapidly killed in J774 cells, GBS showed 
extended survival for up to 12 hours in macrophages (Figure 8). The survival 
difference is not attributable to a difference in uptake (Figure 9) and there was no 
significant difference in intracellular survival between three GBS strains, representing 
serotype III (NEM316), serotype 1a (A909) and the hypervirulent MLST type 17 clade 
(COH1).  
In conclusion, Group B Streptococcus can persist inside macrophages for prolonged 
periods. 
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Figure 8: Intracellular survival of GBS in J774 cells
The intracellular survival of three strains of Group B Streptococcus in J774 macrophages, compared 
to the non-pathogenic organisms Lactococcus lactis  subspecies cremoris (MG1363) and E. coli (dH5α) 
over a period of 24 hours (a) and (b) at six hours post infection (P.I.).  The lysate of infected macrophages 
was plated out and the number of colony forming units (CFU) counted at each time point.  rCFU is calcu-
lated as the relative/ratio difference between the initial number of intracellular bacteria (T0)  and the number 
at each time point. Intracellular survival of three different serotypes of GBS is comparable and significantly 
higher than both control organisms (P<0.05, Mann-Whitney U, n>5 for each).
a)
b)
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Figure 9: Uptake of GBS and mutant strains
All strains and mutants of GBS are internalised by J774 cells to the same extent with the excep-
tion of the strain deleted in the two component system CovS/CovR (CsrR).  Uptake into J774 mac-
rophages was enumerated by lysing infected J774 cells at the start of the intracellular survival assay 
(time point 0) and counting viable organisms. a) Strains derived from GBS NEM316 as the parent strain 
and L.lactis. Strains deleted in the CovS/CovR  TCS show  increased uptake in J774 macrophages. The 
intracellular burden of ΔcovS/R can be reduced to the same as wild type by reducing the inoculum 10 
fold (low MOI). Strains deleted in the cylE gene and sodA are internalised to the same as extent as the 
parental strain. b) Wild type strain GBS 2603 and mutants in CsrR. Strains deleted in CsrR show 
increased uptake which is reduced back to wild type levels upon repair of the strain. c) GBS wild type 
strain COH1 and COH1-13 a strain with the capsule gene disrupted. Bars represent the average number 
of colonies recovered at T0 (n=4, error bars represent standard deviation).
a)
b)
c)
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3.2 The polysaccharide capsule is not required for intracellular survival 
Generally regarded as one of the most important virulence factors of GBS, the 
polysaccharide capsule prevents complement deposition and inhibits phagocytosis. 
The intracellular survival of two strains deleted in capsule genes A909∆cspE (Jones 
et al., 2003a) and COH-13∆cspE (Rubens et al., 1993) was measured.   
In the absence of opsonin in this assay, the presence of a capsule does not 
significantly affect uptake (Figure 9).  It is noteworthy, however, that while an 
unencapsulated MLST-17 strain (COH1-13) showed no intracellular survival defect 
(Figure 10a) the loss of capsule had a larger impact on intracellular survival in a 
seroptype 1a strain (A909) (Figure 10b). 
The observed role of the capsule in strain A909 may be due to an apparent increase 
in survival of the parent strain. However, serotype 1a has been previously shown to 
have an enlarged capsule, compared to other serotypes and in contrast to our data 
has been observed by others to be phagocytosed less well (Cornacchione et al., 
1998).  It should be considered that in highly encapsulated strains such as serotype 
1a, which is the serotype of A909, the capsule may play a larger and yet to be 
identified role than in strains with less capsule.   
In line with previous findings (Cornacchione et al., 1998), the presented data suggest 
that once internalised the capsule does not have a role in aiding the organism to 
survive within cells. 
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Figure 10: Intracellular survival of capsule mutants
The polysaccharide capsule does play a major role in intracellular survival of GBS in J774 mac-
rophages.  Intracellular survival in J774 cells was measured as described previously.  (a) COH1-13, a strain 
disrupted in the capsule gene cpsE  and (b) A909 ΔcspE  were compared to the isogenic parent strains 
COH1 and A909  respectively.  In both cases survival at three, six and nine hours post infection was not 
significantly different between the mutant strain and the wild type parent strain (Mann Whitney U, n>4, 
P>0.05, outliers marked by   ).
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3.3 Resistance to oxidative stress does not contribute to intracellular 
survival.  
Host cells can produce highly antimicrobial reactive oxygen species (ROS) and 
reactive nitrogen species (RNS) in an attempt to kill intracellular organisms. In order 
to overcome oxidative stress GBS has two well-characterised mechanisms, the 
presence of a superoxide dismutase enzyme SodA (which can convert superoxide 
anions to molecular oxygen and hydrogen peroxide) and a carotenoid pigment 
associated with the cylE gene (which can scavenge free radicals).   
When oxidative stress was mimicked in vitro by incubating strains in the presence of 
hydrogen peroxide, strains deleted in cylE and sodA showed, as expected, a slight 
increase in sensitivity to high concentrations of hydrogen peroxide (Figure 16 aiii and 
iv, b iii and iv).  However, in contrast to previous studies, (Poyart et al., 2001b, Liu et 
al., 2004)  strains lacking cylE and sodA did not show any significant difference in 
intracellular survival relative to isogenic wildtype strains at three, six and nine hours 
post infection (Figure11).  
Therefore in this assay, mechanisms employed by GBS to cope with oxidative stress 
are dispensable for intracellular survival.
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Figure 11: Intracellular survival of ΔsodA and ΔcylE
GBS proteins conferring resistance to oxidative stress are not crucial for prolonged intracellular 
survival of GBS in J774 macrophages.  Intracellular survival in J774 cells was measured as described 
previously. Strains deficient in the Superoxide dismutase gene, (sodA) and the cylE gene, expression of 
which leads to production of a free radical scavenging carotenoid pigment, were compared to the isogenic 
parent strain NEM316. Neither mutant strain showed a dramatically reduced survival defect at three, six or 
nine hours post infection compared to strain NEM316  (Mann Whitney U, n>4, P>0.05, outliers marked by  
extreame values   ).
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3.4 Survival of GBS in phagocytes is dependent on the presence of the 
CovS/R regulatory system 
In order to survive in different host environments, including within cells, GBS must be 
able to detect and respond to external stimuli. The two component system (TCS) 
CovS/R is a global regulator, shown to mediate gene changes in response to pH 
(Santi et al., 2009a). Strains deleted in covS/R have been shown to be both 
hypervirulent, (Lembo et al., 2010) and also decreased in virulence (Jiang et al., 
2005, Jiang et al., 2008, Lamy et al., 2004) in whole organism models.  
In marked contrast to the other mutants tested, strain ∆covS/covR, showed 
dramatically impaired intracellular survival and was no longer distinguishable from 
the non-pathogenic control organism at six and nine hours post infection (Figure 12).  
To confirm the role of the CovS/CovR (alternatively named CsrS/CsrR4) TCS in the 
organism’s ability to resist macrophage killing, the assay was repeated using a strain, 
csrR ∆, deleted in only the regulator element, in a different strain background 
2603v/r. Strain 2603∆csrR has been repaired by the chromosomal integration of a 
genetically labelled copy of csrR to generate strain csrR ∆rep the ability of this strain 
to survive in macrophages was measured (Figure 13a). 
 ∆csrR also showed a significant decrease in intracellular survival at six hours PI 
when compared to the isogenic parent and the repaired strain, confirming the 
                                            
4 In GBS this two component system has been annotated as both CovS/CovR  (Lamy et al., 2004) and 
CsrS/CsrR (Jiang et al., 2005), the strain ∆csrR was constructed in a laboratory which uses the csr 
nomenclature and for presentation of results using this strain the nomenclature is retained. 
Throughout the rest of the thesis the TCS is referred to using the CovS/R nomenclature 
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importance of the CovS/R regulator across the species.  Since the ∆covS/R strain is 
phagocytosed more efficiently than wildtype GBS, (Figure 9) one possibility is that 
the ∆covS/R survival defect may reflect ‘overloading’ of host macrophages.  
However, reducing the number of internalised bacteria at time point 0 to the same 
level as that of the wild type organism did not change the survival kinetics (Figure 13 
and 9). 
Thus, the survival defect of  ∆covS/R mutant occurs independently of bacterial 
burden and reflects a genuine defect in intracellular survival, which may explain the 
importance of this TCS in rodent models of virulence (Jiang et al., 2005, Lamy et al., 
2004). 
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Figure 12: Intracellular survival of ΔcovS/R
The two component system CovS/CovR is required for prolonged intracellular survival in J774 
macrophages.  Intracellular survival in J774 cells was measured as described previously.  A strain 
NEM2089 deleted in the CovS/CovR TCS shows decreased survival compared to NEM316 the 
isogenic parent. Viability is reduced in the mutant strain at six hours and nine hours post infection but 
not at three hours. The same survival pattern is seen for the control organism L. lactis (Mann-Whitney 
U, N>4, p<0.05).
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Figure 13: Confirmation of ΔcovS/R phenotype using 2603ΔcsrR
The survival defect in CovS/R mutant strains is not species specific and cannot be explained by an 
increased intracellular burden of this strain.  The survival defect of ΔcovS/R was confirmed by measuring 
intracellular survival with a strain deleted in csrR (covR) in a different parental background, 2603v/r (a). 
2603v/r  csrRΔ shows decreased intracellular survival at 6 hours post infection, the defect can be repaired 
by expressing the csrR gene in trans (2603 csrRΔ rep) in the mutant strain.  Uptake by J774 cells of GBS 
with ΔcovS/R deleted is approximately 10 fold higher than the wildtype. The survival defect of the ΔcovS/R 
is not changed when the number of internalised organisms is adjusted to be comparable to the wild type 
strain (b) (Mann-Whitney U, n>4, p<0.05, outliers are marked by   extreame values  ). 
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3.5 Response of group B Streptococcus to physiological stresses 
Within the phagosome, organisms encounter reactive oxygen species (ROS), 
reactive nitrogen species (RNS) and a decreasing pH (Flannagan et al., 2009).  It 
can be hypothesised that increased tolerance to these damaging molecules could 
explain the intracellular persistence of GBS and perhaps the rapid intracellular killing 
of L. lactis and the covS/covR deleted strain. In vitro survival assays were 
undertaken with selected GBS mutants under a range of stressful conditions. 
3.5.1 Low pH 
To test the organisms ability to survive in low pH organisms were incubated in 
sodium phosphate buffers of decreasing pH. The viable count of each strain after one 
hour incubation was compared to the initial inoculum to give a relative survival ratio 
for each pH. 
There was no difference in acid tolerance between wild type GBS, ∆covS/covR  and 
L. lactis (Figure 14). Viability did not decrease until the environmental pH reached 4.4 
(Figure 14). 
GBS and L. lactis have the ability to ferment carbohydrates to produce lactic acid and 
it is therefore not unexpected in agreement with previous published reports (Yang et 
al., 2012), that they are able to remain viable in acidic conditions. However, ∆covS/R 
does not show decreased survival in low pH compared to the parental strain 
suggesting that the pH mediated response of this TCS is not crucial in the acid stress 
response of the organism.  One caveat is that, under the conditions tested, the ability 
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of the organism to replicate was not measured, and it could be that, in the absence of 
CovS/R, GBS is able to survive low pH but not replicate efficiently.   
Consequently, the CovS/R two component system does not appear to be critical for 
the organism’s survival in low pH and may instead utilise the environmental pH 
change to regulate genes required to tolerate phagosomal conditions. 
3.5.2 Nitrosative stress 
Intra-phagosomal nitrosative stress was mimicked by exposing GBS to increasing 
concentrations of sodium nitrite (NaNO2) which, at low pH, can dissociate to yield 
nitric oxide (NO.).  It has previously been demonstrated that both in culture medium 
and within J774 cells, RNS exert limited antimicrobial effects on GBS (Ulett and 
Adderson, 2005), so could this explain the increased intracellular persistence of GBS 
relative to L. lactis?  
Sensitivity to nitrosative stress, measured by survival in sodium nitrite was 
comparable across wild type GBS, GBS ∆covS/R and L. lactis to NaNO2 are 
comparable (Figure 15).  
The intra-phagosomal concentration of nitric oxide is predicted to be around 57 M 
(Brown et al., 2007), hence this agent may be responsible for limiting intra-
phagosomal growth of GBS and L. lactis but not for killing the organisms.
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Figure 14: Viability of strains of GBS in low pH
Both wild type GBS and a strain deleted in covS/R are able to tolerate acidic conditions.  
NEM316,  NEM2089  (ΔcovS/R) and L. lactis were incubated in sodium phosphate buffer solutions 
at decreasing pH for one hour before plating to give a viable count.  Relative to the input, there is 
no obvious difference in tolerance between the strains. Bars display the mean relative survival 
compared to starting CFU, error bars represent the standard deviation of at least four repeats 
(ANOVA, p>0.05, n≥4). 
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Figure 15: Sensitivity of GBS strains to sodium nitrite
The sensitivity of GBS strain NEM316, NEM2089 (Δ covS/R) and L. lactis to sodium nitrite 
(mimicking nitrosative stress) is comparable across all concentrations tested. GBS, GBS Δ covS/R 
and L. lactis were incubated for one hour in increasing concentrations of sodium nitrite in a pH4.4 buffer 
solution and relative survival scored. Bars display the mean relative CFU compared to a no treatment 
control, error bars display represent one standard deviation.  Viability of organisms is reduced with 
increasing concentrations of NaNO2.  No difference in survival was observed between strains at any 
concentration (ANOVA, p>0.05, n =5).
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GBS NEM316 ∆CovS/CovR
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3.5.3 Oxidative stress 
To test the ability of the ∆covS/R strain to respond to physiological stress, and to try 
to explain the survival differences seen between wild type GBS and L. lactis. Wild 
type GBS, ∆covS/R and L. lactis were exposed to increasing concentrations of 
hydrogen peroxide, mimicking oxidative stress.  Assays were undertaken at two 
different pH levels, representing the pH drop that occurs in the phagosome.  
 At pH7.4 (Figure 16a) wild type GBS (Figure 16ai) showed a marked increase in 
tolerance to hydrogen peroxide when compared to the non-pathogenic organism L. 
lactis (Figure 16av), which was highly sensitive to the chemical.  At pH7.4 ∆covS/R 
behaves as wildtype in its ability to handle the presence of hydrogen peroxide (Figure 
16aii).  However at pH4.4, survival of the ∆covS/R strain in H2O2 was decreased 
(Figure 16bii).  Increased sensitivity to H2O2 at low pH compared to neutral pH was 
not seen in the other strains tested.  In contrast, L. lactis showed a strikingly 
improved survival when exposed to H2O2 at pH 4.4 compared to 7.4 and this survival 
improvement was not seen in any of the other strains tested.  
Based on these data, GBS can clearly survive in moderate, but not high, 
concentrations of hydrogen peroxide. It has been suggested that in an activated 
phagosome the level of ROS can be equivalent to a  hydrogen peroxide 
concentration of 14mM (Brown et al., 2007), but may be as low as 1-4μM (Fang, 
2004).  Based on our in vitro data, it is likely that phagocytosed GBS would be killed 
if hydrogen peroxide concentrations within the phagosome reach 14mM, in contrast 
to the observed intracellular persistence. This suggests either that the phagosomal 
concentration of reactive oxygen species is not this high, or that GBS engages 
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additional survival mechanisms within macrophages that are not triggered by our in 
vitro assay.   
Together, these data indicate that the ∆covS/R mutant may have an inability to 
regulate appropriate ROS protective genes in response to low pH, which should be 
considered as a possible explanation for the poor intracellular survival of this mutant. 
Similarly, the importance of being able to respond to environmental pH could be an 
explanation for the observation that L. lactis can respond better to hydrogen peroxide 
at low pH, since L. lactis may be able to induce an acid stress response when in 
contact with weak acid. This response would not only lead to the up regulation of 
genes involved in pH homeostasis but  also genes involved in general cell protection 
and repair which may aid hydrogen peroxide resistance (Cotter and Hill, 2003).  
Within the phagosome, Lactococcus is quickly killed, potentially by reactive oxygen 
species generated at the early stages of phagosome maturation at neutral pH. It may 
therefore never experience the low pH of the mature phagosome and so may never 
be able to activate a protective response.
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Figure 16: Sensitivity of GBS strains to Hydrogen peroxide
NEM316 shows increased tolerance to Hydrogen peroxide (H2O2) compared to L. lactis.  Strains of 
GBS were exposed to increasing concentrations of H2O2 in pH7.4 buffer (a) or pH4.4 buffer (b).  Viable 
counts were taken after one hour and normalised to the control (buffer alone). Bars represent the mean 
relative CFU, error bars indicate one standard deviation.  Hydrogen peroxide shows a dose dependant 
killing affect at both pH conditions.  Paler bars indicate concentrations where mean rCFU is significantly 
different from the control.  L. lactis is very sensitive to H2O2 at pH7.4 (16av) with no viable colonies recov-
ered from H2O2 concentrations above 0.5mM.  NEM316 (16ai) shows increased resistance to H2O2 com-
pared to L. lactis  at concentrations indicated with *.  At pH 4.4 L. lactis (16bv) shows increased resistance 
to hydrogen peroxide killing and is no longer different  in its sensitivity compared to wild type GBS.  H2O2 
concentrations where a difference in survival is seen between pH7.4 and pH4.4 are indicated with ** (n<6 
for pH7.4, n<4 for pH 4.4, t-test, p<0.05).
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3.6 The CovS/R two component system is not required for intracellular 
persistence in human monocyte derived macrophages (hMDMs). 
In the murine cell line J774 the CovS/R two component system was identified as 
being important for intracellular survival.  To see if these findings could be extended 
to human macrophages, GBS was used to infect human primary monocyte derived 
macrophages (hMDMs).  Adherent monocytes isolated from pooled buffy coats were 
differentiated using Granulocyte macrophage colony stimulating factor (GM-CSF).  
GBS was incubated with hMDMs and intracellular survival measured using the same 
method as for J774 cells.   
In agreement with the survival phenotype seen in J774 cells, GBS strain NEM316 
was able to survive better in hMDM’s than L. lactis at six hours post infection (Figure 
17a). Contradictory to data obtained in J774 cells, ∆covS/R showed a similar or 
possibly improved intracellular survival capacity to the wild type strain.  To confirm 
that this was not due to increased internalisation of the mutant, infection was carried 
out using a lower MOI of 1 which lead to a comparable internalisation to the wild type 
strain (Figure 17b). Survival of ∆covS/R mutant at a lower MOI was enhanced 
compared to the wild type at a MOI of 10.  Caution must be taken when analysing 
thease data due to the low number of assay repeats especially with L. lactis and low 
MOI ∆covS/R (n=1). 
In contrast to findings in the J774 murine macrophage like cell line, the two 
component system CovS/R does not appear to play a role in the organism’s ability to 
CHAPTER 3: Intracellular survival of Group B Streptococcus 
 
131 
 
withstand intracellular killing by human macrophages.  Potential reasons for this 
discrepancy are discussed below and in Chapter Five.
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Figure 17: Survival of wild type GBS and ΔcovR/S in hMDM
CovS/R is not required for persistence in human monocyte derived macrophages (hMDMs).  Strain 
NEM316, NEM2089 (Δ covS/R) and L.lactis  were used to infect primary monocyte derived macrophages.   
Figure 17a shows intracellular survival at three, six and nine hours post infection.  Six hours post infection 
the number of viable intracellular Lactococci are greatly decreased (Yellow bars) however 50% of the 
internalised NEM316 (burgundy bars) and ΔcovS/R (Orange bars) are able to be recovered.  To confirm 
survival independent of intracellular burden a low MOI control was included (Orange square), this shows 
enhanced intracellular survival (NEM316 and ΔcovS/R n=3, ΔcovS/R low MOI n=1, L.lactis n=2). Figure 
17b shows the number of organisms internalized at the start of the assay. simular to the internalisation of 
the mutant in J774 cells, NEM2089 (Δ covS/R) shows a higher intracellular burden which can be reduced 
(low MOI). 
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DISCUSSION 
The data presented confirms the ability of Group B Streptococcus to persist for up to 
eight hours within the macrophage like cell line J774 independent of serotype, MLST 
type and clinical presentation (Cumley et al., 2012).  The two component system 
CovS/CovR has been identified as being required for intracellular survival in J774 
cells, but not the polysaccharide capsule or factors required for resistance of the 
organism to oxidative stress.  Loss of CovS/CovR abrogates intracellular survival, in 
line with previous data that has shown this mutant to be altered in virulence in a 
rodent model (Jiang et al., 2005, Jiang et al., 2008, Lamy et al., 2004, Lembo et al., 
2010).  The CovS/CovR system is known to be an important transcriptional regulator 
in pathogenic streptococci, regulating approximately 7% of the GBS genome, 
particularly during adaptation to host conditions (Lamy et al., 2004, Jiang et al., 
2008).  Adaptation may be important in responding to the physiological stress of 
being in a host phagosome, such as induction of resistance to reactive oxygen 
species, reactive nitrogen species and low pH.  In vitro, wild type GBS show similar 
tolerance levels to sodium nitrite (mimicking RNS) and low pH conditions as are seen 
in GBS∆covS/R and L. lactis, suggesting that RNS and low pH within phagosomes 
are not sufficient to explain the survival differences between these strains.  The 
CovS/R deletion mutant does, however, show reduced tolerance to hydrogen 
peroxide at pH4.4, as compared to pH7.4, whilst L. lactis shows the converse 
relationship.  The CovS/CovR mutant may have an inability to regulate appropriate 
ROS protective genes in response to low pH which could be considered as an 
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explanation for the poor intracellular survival of this mutant. However the in vitro 
hydrogen peroxide sensitivity data taken together with the predicted hydrogen 
peroxide levels in an activated phagosome and the lack of a major role for the sodA 
and cylE gene products suggests that, within the phagosome, RNS and ROS are not 
playing a major role in controlling intracellular GBS.  
Interestingly the CovS/R regulator is not required for survival within human monocyte 
derived macrophages (hMDMs).  This may reflect differences in the composition of 
the mouse and human phagosome: These include levels of available nutrients in the 
two cell types, levels of ROS or RNS, acidification, or species-specific antimicrobial 
peptides and proteases (Schneemann and Schoeden, 2007).  There are known 
differences in the inflammatory activation of mouse and human macrophages in 
response to bacterial products (Munford, 2010), one of the major differences being 
the activation of inducible nitric oxide synthase (iNOS) (Fairbairn et al., 2011). GBS 
strains deficient in aspects of the CovS/R system have been shown to be both hyper-
virulent (which is associated with an increase in expression of the β-
haemolysin/cytolysin, an inflammatory mediator,  (Lembo et al., 2010)) and reduced 
in virulence (attributed to the mutant’s inability to adapt to and survive in nutrient 
limiting conditions (Lamy et al., 2004, Jiang et al., 2005, Jiang et al., 2008)).  Thus, 
the role of this TCS is likely to be complicated in the context of intracellular survival 
and virulence.
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INTRODUCTION 
In the previous chapter it was demonstrated that GBS can survive within 
macrophages. These cells of the innate immune system constitute the first line of 
host defence against invading microorganisms.  Persistence within cells may be an 
important step in disease pathogenesis, facilitating dissemination of the organism 
and providing protection from other antimicrobial effectors (Thwaites and Gant, 
2011).  In order for an organism to survive within a macrophage, it must be able to 
either subvert or resist the antimicrobial effects of the phagosome.   
Recognition of an organism by the phagocytic cells of the innate immune system 
leads to engulfment of the organism through a process called phagocytosis (Underhill 
and Ozinsky, 2002). The nascent phagosome matures through the sequential fusion 
of early endosomes, late endosomes and finally lysosomes, to form the 
phagolysosome. Reactive oxygen species (ROS) are generated through the 
membrane assembly of subunits of NADPH oxidase and reactive nitrogen species 
(RNS) can be generated by the inducible nitric oxide sythase (iNOS).  This 
phagosomal compartment is characterised by the acquisition of lumenal proteases 
and lysosomal associated membrane proteins (LAMPs). Furthermore, this is an 
extremely hostile environment for the micro-organism, being highly acidic and 
containing reactive oxygen species (ROS), reactive nitrogen species (RNS) and 
antimicrobial proteins and peptides (Flannagan et al., 2009, Basset et al., 2003). 
This chapter focuses on the GBS-containing phagosome, and asks the following 
important questions;  
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 Does the organism modify phagosome maturation?   
 What is the role of the generation of reactive oxygen species and phagosome 
acidification in the host’s attempt to kill the organism?  
 Can the antimicrobial activity of the GBS-containing phagosome be 
enhanced?  
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RESULTS 
4.1 Group B Streptococcus resides in a phagosome that recruits late 
endosomal markers 
A mechanism by which pathogenic micro-organisms can survive phagocytic killing is 
to alter the maturation of the phagosome to create an environment that is more 
favourable for growth or survival (Flannagan et al., 2009, Huynh and Grinstein, 
2007).  
To assess whether GBS use this mechanism to survive within macrophages, the 
time-dependent acquisition of lysosomal associated membrane protein 1 (LAMP-1) 
was studied (Figure 18). This glycoprotein associates with lysosomal compartments 
and is an important marker of acidification (Kinchen and Ravichandran, 2008). The 
extent of LAMP-1 acquisition by GBS-containing phagosomes did not differ from that 
of phagosomes containing latex beads or heat killed GBS up to 180 minutes post 
infection (Figure 19). Peak LAMP acquisition is seen at 90 minutes post infection in 
live and heat killed streptococci and latex beads (Figure 19) 
Although the bulk of GBS appear remain within an intact phagosome for the duration 
of the experiment, the possibility that GBS visualised in the absence of LAMP may 
represent bacteria that have escaped from the phagosome cannot be ruled out.  
These data indicate that, in the majority of GBS containing phagsomes, the rate of 
LAMP acquisition is not being modified by an active GBS process. 
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3μm
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Figure 18: LAMP-1 recruitment
LAMP-1 is recruited to the Group B Streptococcus-containing phagosome.  J774 macrophages 
grown on coverslips were infected synchronously with live wild-type GBS strain NEM316, or latex beads.  
Coverslips were removed at time points post infection, fixed and immunostained. Streptococci were visual-
ised using an anti-streptococcal antibody and FITC conjugated secondary antibody (green). LAMP-1 
acquisition was detected using an antibody directed against LAMP-1, probed using a TRITC conjugated 
secondary antibody (red). Coverslips were visualised using a Nikon Eclipse Ti microscope with 100x DIC 
objective.  Representative images are shown from 90 minutes post infection.  Panel A shows GBS (green) 
(i) and (iv) with LAMP, (red) (ii) and (v), acquisition.  Merged image shown in (iii) and (vi). Panel B shows a 
representative image of a latex bead containing phagosome with corresponding DIC, (i) and (iv), LAMP, 
(iii) and (iv) and merged, (v) and (vi) images.
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Figure 19:  Time dependent aquisition of LAMP-1
Group B Streptococcus containing phagosomes show no delay in LAMP acquisition. The graph 
shows the average percentage of GBS or bead- containing vesicles which co-stained for LAMP.  At least 
50 phagosomes were scored in each independent repeat.  Peak acquisition can be seen at 90 minutes 
post infection (P.I.) with a slight decrease at 360 minutes P.I. in the phagosomes containing live GBS.  
There is no difference observed between live organisms (black bars), heat killed organisms (light grey) and 
3 μm latex beads (dark grey) (χ2 on raw data P> 0.05) with the exception of the live organisms and latex 
beads at 360 minutes PI (P = 0.004). Error bars represent standard error of three repeats.
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4.2 Infection of hMDM and J774 cells with GBS does not lead to an 
increase in ROS as measured by hydrogen peroxide production.  
Although, as demonstrated in the previous chapter, the viability of GBS is reduced at 
a concentration of hydrogen peroxide comparable to that within an activated 
phagosome (Brown et al., 2007), J774 cells are still able to support survival of the 
organism.  In Chapter Three, bacterial survival is also shown to be independent of 
the superoxide dismutase gene (sodA) and the cylE-encoded carotenoid pigment.  
Both of these mechanisms have previously been suggested to protect the organism 
against damaging ROS (Liu et al., 2004, Poyart et al., 2001b). The most likely 
explanation for this paradox is that GBS fails to induce a large oxidative burst in 
infected J774 cells.   
To test this, the rate of hydrogen peroxide production was measured in GBS and 
Lactococcus infected hMDM (Figure 20a) and J774 cells (Figure 20b).  The rate of 
hydrogen peroxide production was higher in hMDM (Figure 20a) than in J774 cells 
(Figure 20b).  In support of the hypothesis that GBS fails to induce a large oxidative 
burst in our assay, neither hMDM or J774 cells produced significantly more hydrogen 
peroxide than uninfected macrophages when infected with GBS or L. lactis.   
These data support previous findings that uptake of GBS through non-opsonic 
phagocytosis does not lead to a large oxidative burst (Carlin et al., 2009, Cheng et 
al., 2001)
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Figure 20: Rate of hydrogen peroxide production from infected macrophages
 
GBS does not stimulate macrophages to produce a large oxidative burst. Hydrogen peroxide produc-
tion from hMDM (a) and J774 cells (b) was measured using Amplex Ultra Red reagent.  Fluorescence was 
measured every 15 minutes post infection with wild type GBS NEM316, strains with covS/R or cylE deleted 
and L.lactis.  Uninfected cells and cells stimulated with PMA were included as controls.  Bars represent the 
average of the maximum rate of hydrogen peroxide production from three repeats. Error bars represent 
one standard deviation.  Both cell types respond positively to PMA, however J774 cells produce a low 
response (note the Y axis scale difference).   hMDM show a much larger rate of hydrogen peroxide 
production, but neither cell type responds to infection with an increased rate of hydrogen peroxide produc-
tion.
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4.3  The generation of reactive oxygen species through the NADPH 
oxidase does not contribute to killing of intracellular streptococci 
Although weak, the oxidative burst generated through the NADPH oxidase may still 
contribute to the cellular host response to GBS infection.  To further investigate the 
role of ROS in controlling survival of intracellular organisms, the NADPH oxidase was 
pharmacologically inhibited using 0.5mM apocynin, a compound that prevents proper 
formation and thus subsequent activity of the complex (Stefanska and Pawliczak, 
2008).   
When infected with GBS, the proportion of cells in the population that have 
measurable ROS is approximately 45%, not significantly different from uninfected 
cells (Figure 21). Apocynin inhibited the percentage of ROS positive cells by 10%, 
(Figure 21) but had no effect on the intracellular survival of wild type GBS (Figure 
22a) or Lactococcus (Figure 22e). In support of my findings in chapter three (Figure 
11), which show that GBS factors thought to play a role in resistance to oxidative 
stress are dispensable for intracellular survival, blocking the NADPH oxidase does 
not improve the capacity of ∆sodA or ∆cylE strains to survive (Figures  22c and 22d). 
Apocynin requires activation by H2O2 or myeloperoxidase in order to give maximal 
inhibition of the NADPH oxidase (Stefanska and Pawliczak, 2008) and thus the 
relatively low level of inhibition observed most likely reflects weak induction of the 
NADPH oxidase by intracellular GBS and therefore low levels of H2O2.    
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In summary, the presented data suggest that GBS is not activating the NADPH 
oxidase complex and that the resultant low level of ROS does not play a role in the 
host cell control of the organism. This can explain the lack of requirement in our 
assay for mechanisms that can protect GBS against oxidative stress, in contrast to 
previously published work (Liu et al., 2004, Poyart et al., 2001a).
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Figure 21: Apocynin blocks ROS production in GBS infected cells
Apocynin can be used to reduce the oxidative burst stimulated by GBS. Reactive oxygen species 
(ROS) production in J774 macrophages was measured using the dye H2DCFDA and flow cytometry.  GBS 
infection does not significantly increase the proportion of cells exhibiting ROS production. The percentage 
of cells with detectable ROS levels can be inhibited by 0.5mM apocynin, a chemical that prevents assem-
bly of the NADPH oxidase.  Bars represent percentage of cells gated by flow cytometry as positive for 
ROS, averaged over three repeats, error bars indicate one standard deviation. 
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Figure 22:  Intracellular survival of GBS in apocynin treated cells
Intracellular survival of GBS and L. lactis within J774 cells is not affected by blocking the assembly 
of NADPH oxidase.  Intracellular survival was measured in J774 cells in which the action of the NADPH 
oxidase was blocked using the drug apocynin.  In all strains tested, intracellular survival of GBS and L. 
lactis in cells treated at the point of infection with 0.5mM apocynin (dark bars) is comparable with survival 
in untreated cells (pale bars), at three, six and nine hours post infection (n>4, Mann-Whitney U p>0.0.5, 
outliers are marked by    extreame values by   ).
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4.4 CovS/R and the oxidative burst 
In chapter three the strains 2089∆covS/R  was shown to have a reduced ability to 
survive in hydrogen peroxide when combined with low pH. Could the increased 
sensitivity of ∆covS/R to oxidative killing explain the decreased intracellular survival 
of the mutant strain in murine cells?  Alternatively, it is possible that (as previously 
described in human brain microvascular endothelial cells),  ∆covS/R may stimulate 
murine cells to produce a larger, host beneficial pro-inflammatory response (Lembo 
et al., 2010, Rajagopal et al., 2006) and a correspondingly higher level of ROS.   
To investigate if infection with the ∆covS/R strain triggers a higher level of ROS 
production in murine cells than in J774 cells, the rate of hydrogen peroxide was 
measured in both cell types. However, as with wild type organisms the rate of 
hydrogen peroxide production in cells infected with ∆covS/R was not enhanced 
above the background rate of production (Figure 20).   In addition, blocking the 
NADPH oxidase using apocynin did not improve intracellular survival of the CovS/R 
mutant (Figure 22b). 
These data all suggest that the reduced intracellular survival of ∆covS/R strain in 
murine cells is not due to the mutant inciting an increased oxidative burst or 
exhibiting increased sensitivity to intracellular ROS
 
4.5 Acidification of the phagosome is important for GBS survival 
Phagosome maturation is characterised by a decrease in lumenal pH.  A decrease in 
phagosomal pH is a required for the fusion events that lead to the development of the 
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mature phagolysosome and also provides an environment for optimal activity of the 
hydrolytic enzymes in the phagosome (Flannagan et al., 2009).  Acidification of the 
phagosome can be blocked using concanamycin A, an inhibitor of the vATPase 
proton pump on the phagosomal membrane, which is largely responsible for 
acidification of the phagosome (Drose and Altendorf, 1997, Huss and Wieczorek, 
2009).  
After infecting J774 macrophages with GBS strain NEM316 or the control organism 
L. lactis, acidification of the macrophage phagosome was inhibited using 0.1M 
concanamycin A (a concentration that has no effect on J774 survival or the survival 
of GBS in Todd Hewitt broth). Concanamycin A treatment significantly reduced the 
survival of wild type GBS at six hours post infection, but not L. lactis (Figure 23).  
This suggests that GBS not only resides in a mature phagosome but also requires 
the normal phagosome acidification and subsequent maturation to survive.
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Figure 23: Intracellular survival of GBS in concanamycin A treated cells
Blocking acidification of the phagosome reduces the intracellular survival of GBS. J774 macro-
phages infected with NEM316 and L. lactis were treated with the vATPase inhibitor concanamycin A (dark 
bars). Under these conditions, the number of viable intracellular streptococci isolated at 6 hours post 
infection is significantly reduced (Mann Whitney U, P<0.001, n>5, outliers are marked by   ). 
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4.6  The requirement of phagosome acidification for intracellular survival of 
GBS is independent of the availability of iron. 
The increased pH of the phagosome following concanamycin A treatment will prevent 
the dissociation of iron from transferrin, which only will occur at a pH below 7. 
Therefore the possibility that the reduced survival of GBS under these conditions 
may be an indirect result of iron deprivation was considered.  
 Addition of FeNTA  (a non-physiological iron chelator that releases iron in a pH 
independent manner over a range of pH5-8, used in previous similar studies (Levitz 
et al., 1997, Bates and Wernicke, 1971) did not alter the intracellular survival 
phenotype of GBS either in the presence (Figure 24b) or absence (Figure 24a) of 
concanamycin A.   
 Iron availability therefore appears to have limited impact on GBS survival, which 
could reflect the relatively short time period during which the organism resides within 
the host cell.
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Figure 24:  Iron supplementation
Reduced survival of GBS in concanamycin A treated cells is independent of iron availability.   J774 
macrophages infected with strain NEM316 incubated in the presence (panel B) or absence (panel A) of 0.1 
μM concanamycin A.  The graphs show rCFU at 6 hours post infection (PI) demonstrating the effect of the 
addition of FeCl, NTA and FeNTA. The non–physiological iron chelator complex FeNTA failed to recover 
the concanamycin A associated loss of viable intracellular streptococci. There is no significant difference 
between the untreated control and the infected cells that received iron supplementation in either concan-
amcyin A treated (p=0.572) or untreated (p=0.428) cells (Kruskal Wallis test n=6). 
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4.7 IFN treatment of macrophages does not enhance streptococcal  
killing. 
IFN activation of macrophages can increase the rate of phagosome fusion with 
endosomes and lysosomes, decrease the pH of the phagosome and lead to up-
regulation of iNOS, resulting in higher levels of RNS and ROS (Torrado et al., 2010, 
Gilberthorpe et al., 2007).   
To investigate if IFN activation of macrophages increased the anti-streptococcal 
properties of J774 cells, cells were pre-treated with IFN before infection with GBS.  
At six hours post infection IFNʏ activated cells did not display any significant 
difference in their ability to remove GBS or Lactococcus than non-treated controls 
(Figure 25).  
The inability of IFN activated macrophages to remove intracellular Streptococci was 
surprising.   The concentration of IFN used in this assay, 10U/ml is felt to be a 
physiologically relevant concentration (Voelz et al., 2009), although other assays 
looking at the role of IFN activation have used higher concentrations for longer 
incubation periods (Gilberthorpe et al., 2007).  Additionally, IFN activation is thought 
to require a second signal, which can be either endogenous TNFα, produced in 
response to recognition of the pathogen through a pathogen recognition receptor 
such as toll like receptors (Mosser, 2003), or exogenous TNFα.  LPS is also known to 
be able to augment IFN activation, although it is not known if GBS can stimulate 
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macrophages to produce the necessary signals to achieve full IFN mediated 
phagosome activation.
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Figure 25: IFNγ activation
IFNy activation of J774 macrophages does not affect the intracellular survival of NEM316.   J774 
macrophages were incubated with 10U/ml IFNγ before infection with NEM316 and L.lactis. No significant 
difference is seen in the intracellular survival of organisms in activated (treated, pale bars) or not activated 
macrophages (dark bars) (Mann Whitney U, N=5, P>0.05).
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DISCUSSION  
As shown in Chapter Three, Group B Streptococcus can survive the killing 
mechanisms of phagocytic cells for a prolonged period of time.  By staining for 
lysosomal associated membrane protein (LAMP), a marker of late endosomes or 
phagolysosomes it appears that the organism is not modifying the recruitment of late 
phagosomal markers.  In vitro, the organism is sensitive to hydrogen peroxide killing 
at a physiologically relevant concentration (Brown et al., 2007, Fang, 2004), which is 
discordant with its ability to survive the phagosome oxidative burst. It is widely 
accepted that cell lines have reduced levels of reactive oxygen species when 
compared to primary cells, however, measurable levels of reactive oxygen species in 
both hMDM and J774 cells are not raised above baseline levels when infected with 
GBS. This suggests an inadequate oxidative burst in both cell types which, when 
considered together with the pharmacological inhibition of the complex in this system, 
indicates that the NADPH oxidase does not play a major role in GBS killing.   
The two component system CovS/R has a role in intracellular survival in murine cells, 
as demonstrated by poor survival of the deletion mutant. This strain shows an 
increased sensitivity to hydrogen peroxide killing at low pH (Chapter Three).  
However, the increased sensitivity of the mutant to intracellular killing cannot be 
explained by an increased sensitivity to the phagosome oxidative burst as cells 
infected with ∆covS/R fail to show high levels of ROS or an involvement of the 
NADPH oxidase. 
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In order to try to improve the anti-streptococcal activity of infected J774 cells the cells 
were incubated with IFN. Surprisingly this did not improve the outcome of infection 
and GBS survival was unchanged.  One aspect of IFN activation of phagocytic cells 
is increased phagosome and lysosome fusion which results in a decreased 
phagosomal pH (Torrado et al., 2010).  A decrease in phagosomal pH is required for 
GBS to be able to survive within the phagosome, as blocking this leads to reduced 
intracellular survival.  To this effect IFN activation may actually aid the organism’s 
intracellular lifestyle.  Unlike some intracellular pathogens, such as Legionella 
pneumophila (Byrd and Horwitz, 1991),  the dependence on low pH to aid 
phagosomal survival is not due to the lack of available iron in these conditions, since 
iron replacement does not improve the outcome.  GBS is reported to be able to 
survive in low iron conditions due to the presence of the siderophore receptor FhuD 
and other, as-yet described, mechanisms (Clancy et al., 2006).   As seen in the 
pathogenic fungus Cryptococcus  (Levitz et al., 1997) it could be that GBS is using 
the decrease in pH to sense the environment and regulate genes that are required 
for resistance to the host cell killing mechanisms.  In this context it is intriguing that 
the CovS/CovR regulator, know to respond to environmental pH (Santi et al., 2009a) 
is required for intracellular survival in murine cells.
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SUMMARY 
The data presented in Chapter Three and Chapter Four of this thesis should be 
considered together to understand the interaction of GBS with host cells.  Chapter 
Three examined the role of four genes previously characterised as having an 
involvement in the pathogenesis of the organism; csp, cylE, sodA and covS/R. Only 
covS/R was found to be required for the persistent survival phenotype of the 
organism seen in macrophages. Sensitivity of the organism in vitro to conditions 
expected to be found in the phagosome could not fully explain the capacity of the 
organism to survive macrophage killing.  Chapter Four focused on the host response 
to GBS; data presented suggested that although GBS is not modifying the 
phagosome maturation pathway the organism is not exposed to high levels of 
oxidative killing.  A major finding in this chapter is the importance of phagosomal pH 
for the organism’s survival.
 
5.1 How important is intracellular survival in phagocytes in the context of 
GBS disease? 
In this study we sought to further understand the interaction between GBS and host 
macrophages.  Although Group B Streptococcus is not thought to be an intracellular 
pathogen per se, this study confirms previous accounts (Cornacchione et al., 1998, 
Valenti-Weigand et al., 1996, Segura et al., 1998) that demonstrate it is not efficiently 
killed by phagocytic cells, the  first line of the host defence. In contrast to a close 
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relative Group A Streptococcus (GAS) (Hertzén et al., 2012) there is no evidence to 
suggest that the organism is replicating in macrophages, but this is an area that 
warrants further investigation.  In clinical GBS disease, the organism achieves a high 
level of bacteraemia, which precedes life threatening septicaemia and meningitis.  
Intracellular survival within phagocytes may contribute to disease progression by 
reducing the effectiveness of phagocyte clearance.  In addition, some pathogens, 
such as GAS, can actively exploit phagocytes to facilitate traffic between host tissues 
and it is therefore possible that a related process may underlie GBS dissemination 
(Thwaites and Gant, 2011, Medina et al., 2003). 
Due to poor cellular penetrance of most antimicrobial compounds, intracellular 
survival of an organism will protect it from the activity of antibiotics (Kaplan et al., 
2006). GBS colonises 30% of pregnant women and penicillin treatment of colonised 
pregnant women does not remove the organism (Rodriguez-Granger et al., 2012). 
This has major clinical implications as prophylactic treatment has to be given during 
labour.  The first line treatment against GBS infection is penicillin, which shows very 
poor absorbance into eukaryotic cells, hence understanding the intracellular 
persistence of this organism may enable novel therapies to combat colonisation. 
Macrophages not only have an important role in killing invading micro-organisms but 
also in mounting an immune response.  Such signalling is potentially double-edged, 
since GBS infection can lead to an inappropriate cytokine release and potentially 
fatal sepsis syndrome.  Improved knowledge of how macrophages are responding to 
GBS may therefore enable treatment options that prevent sepsis. For example 
dextromethorphan, which is commonly used as a cough suppressant but was 
recently described to have anti-inflammatory properties, (inhibition of the NADPH 
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oxidase and suppression of TNFα) prevented cytokine release and sepsis in GAS-
infected mice (Li et al., 2011). 
One of the interesting features of GBS disease is the serotype distribution; serotype 
III is more commonly associated with neonatal disease, whilst serotype Ia is often 
isolated from sites of colonisation (Weisner et al., 2004).  Compounding this is the 
emergence of the hypervirulent clade ST-17, which is strongly associated with late 
onset neonatal meningitis (Manning et al., 2009, Poyart et al., 2008). GBS shows 
considerable interspecies variability at a genetic level and host adaptation appears to 
improve strain fitness (Sorensen et al., 2010, Weisner et al., 2004, Brochet et al., 
2006).  In addition to the two serotypes tested in this study, III (NEM316) and Ia 
(A909) and the COH1 strain representing the hypervirulent ST17 clade, a diverse 
collection of GBS isolates (Herbert et al., 2005)  has been tested in the J774 survival 
assay by other members of our group (Cumley et al., 2012).  No significant 
differences in their capacity to survive within macrophages were observed between 
strains, serotypes or MLST groups.  These data suggest that epidemiological 
variation in disease progression and hypervirulence may result from differences in 
colonisation or extracellular growth, rather than differences in the interaction with 
phagocytes.  Interestingly, such a conclusion is supported by recently published data 
indicating that one explanation for the increased virulence of ST-17 clones of GBS is 
the observation that they overexpress the cell wall surface protein HgvA, leading to 
increased adherence to host epithelia (Tazi et al., 2012).
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5.2 How does GBS avoid killing by the innate immune system? 
As mentioned in the Introduction (Chapter One) organisms can employ multiple 
strategies in order to avoid killing by the host immune response: Avoidance of 
phagocytosis, modification of the host cell or a systemic response, initiating 
programmed host cell death and avoidance of phagosome killing.  The latter can 
occur by modifying phagosome maturation, escaping the phagosome or adapting to 
and resisting the antimicrobial features of the phagosome. The following section will 
discuss the ability of GBS to avoid immune killing by these mechanisms based on the 
data obtained in this study. 
Avoidance of phagocytosis and modification of host response 
The host response to an engulfed organism has been shown to be in part related to 
the receptor that mediates phagocytosis. Even though the polysaccharide capsule of 
GBS has been described to be important in this context, in our assay the prescence 
or absence of a capsule did not influence the organism’s ability to survive within cells, 
nor did it significantly prevent uptake of the organism.  The capsule has been shown 
to be important in prevention of opsonophagocytic killing (Maisey et al., 2008a), by 
reducing deposition and activation of complement components (Marques et al., 1992, 
Wessels et al., 1989). However, in our study the absence of opsonin made this 
function of the capsule immaterial. It has been shown previously that when GBS is 
taken up through the Fc receptor, in the presence of specific antibodies, a strong 
oxidative burst is generated (Senn et al., 2011, Cheng et al., 2001). Uptake through 
this receptor leads to increased numbers of lysosomal vesicles seen and the 
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organism is cleared more effectively (Valenti-Weigand et al., 1996).  It is not clear 
what receptor is being engaged to promote uptake in our assay but uptake did not 
induce a large oxidative burst.  Therefore mechanisms that the organism employs to 
protect itself against oxidative stress, such as the superoxide dismutase and 
carotenoid pigment are not required for intracellular persistence.  The Fc receptor 
signals directly to the NADPH oxidase complex, whereas phagocytosis through the 
complement receptor (the most likely uptake mechanism in opsonin independent 
GBS phagocytosis (Antal et al., 1992, Albanyan and Edwards, 2000)) does not lead 
to the production of superoxide (Underhill and Ozinsky, 2002). 
Thus, intracellular survival of GBS is linked to the receptor involved in uptake and 
subsequent signalling pathways that it engages.  This may be particularly relevant in 
neonatal disease, where antibody or opsonin levels may be low and consequently 
uptake may result in the organism residing in a weakly antimicrobial compartment. To 
confirm the role of the receptor in downstream signalling it would be interesting to 
look at phagocytosis of GBS through interaction with the complement receptor in the 
presence of complement, which provides a second signal to activate the oxidative 
burst (Russell et al., 2009). Further characterisation of the antimicrobial features of 
the GBS containing vacuole and identification of the receptor which the organism is 
taken up by would give insight into the environment which the organism is residing in.  
Host cell death 
GBS has been described to be able to cause apoptosis in macrophages through the 
action of the β-h/c (Fettucciari et al., 2006, Fettucciari et al., 2000, Ulett and 
Adderson, 2005). The cylE  gene which encodes the structural β-h/c has multiple 
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roles in GBS virulence; not only does it produce the pore forming toxin, it is also 
linked to the expression of a carotenoid pigment which can be protective against 
oxidative stress (Liu et al., 2004). In the survival assay used for this study significant 
cell death was not observed because the assay conditions were optimised to reduce 
the likelihood of apoptosis, which has been shown to be a β-h/c dose-dependent 
response (Fettucciari et al., 2000, Liu et al., 2004).  Host cell death is discussed 
further in relation to the survival of the ∆covS/R strain, below. 
 
Avoidance of phagosome killing 
Arrest or manipulation of phagosome maturation 
One method used by microorganisms to avoid being killed in the phagosome is to 
actively perturb phagosome maturation.  For instance, in both Burkholderia 
cenocepacia and Mycobacterium tuberculosis, a delay in phagosome maturation is 
associated with intracellular survival (Lamothe and Valvano, 2008, Pethe et al., 
2004). The close relative of GBS, Group A Streptococcus, has been shown to 
prevent phagosome maturation, since GAS-containing phagosomes do not recruit 
LAMP or become acidified (Hertzén et al., 2012).  In contrast, GBS does not appear 
to modify the recruitment of LAMP to the phagosome membrane, since recruitment 
occurs at the same rate in live and heat killed organisms and latex beads. This 
suggests that the organism is not modifying the phagosome maturation pathway, 
although it should be noted that recruitment of LAMP is not necessarily indicative of a 
fully functional mature phagosome. For example Salmonella enterica resides within a 
LAMP positive vacuole, which is not acidified, and has diverged from the phagosome 
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maturation pathway (Eswarappa et al., 2009, Steele-Mortimer, 2008).  Mature 
phagosomes can be distinguished by functional analysis, acidification, or the 
presence of active proteases (Russell et al., 2009). As part of the continuing work in 
our group, an acidotropic dye, lysotracker, was used by a member of the group to 
measure if GBS was residing within acidified phagosomes.  Interestingly this data 
suggested that acidification of the GBS containing compartment may be actively 
modified, as the accumulation of dye was higher in vacuoles containing heat killed 
organisms than in vacuoles containing live organisms.   
One significant barrier to further characterising the GBS containing vacuole is the 
lack of a reliable method to track live GBS within cells.  Consequently most analyses 
must be carried out on fixed samples. The development of a GFP expressing strain 
(or alternative means of fluorescently labelling live organisms) would facilitate further 
investigations into the fate of intracellular GBS.  Better markers of phagosome 
maturation include ratiometric pH imaging (Russell et al., 2009) and measurement of 
functional protease; for example, by using substrates that are fluorescent when 
degraded by an active enzyme (Russell et al., 2009).  
Phagosome escape 
A strategy employed by some organisms to avoid phagosomal killing is to escape 
from the antimicrobial phagocytic vacuole and replicate in the cytoplasm of the cell.  
Listeria monocytogenes has a well characterised mechanism to escape the 
membrane bound vacuole before it becomes acidified and can survive in the 
cytoplasm of cells. Shigella flexneri, Burkholderia pseudomallei, Rickettsia prowazekii 
and Francisella tularensis can also escape the phagosome and replicate successfully 
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in the cytosol of the cell (Ray et al., 2009).  The ability of GBS to use this strategy 
has not been tested in the work discussed above.  However, the increasing presence 
of LAMP on the GBS containing phagosome membrane until late in infection 
suggests that the vast majority of intracellular organisms reside in a membrane 
bound compartment.  Nonetheless, the availability of a GFP-expressing strain of 
GBS would allow for a much more detailed analysis via time lapse imaging.   
Adaptation or resistance to conditions inside the phagosome 
The mature phagosome of macrophages is an inhospitable environment for any 
ingested microorganisms, being highly acidic, high in reactive oxygen and nitrogen 
species and additionally containing degradative enzymes and antimicrobial peptides. 
GBS was shown in vitro to have limited resistance against ROS and RNS.  However, 
as discussed previously, the levels of ROS generated in macrophages upon 
engulfment of GBS are low and therefore fail to efficiently control the organism. 
GBS is clearly well adapted to growth in conditions of low pH, since it can ferment 
carbohydrates to lactic acid and, as a commensal, will reside in the vagina at a pH of 
3.8-4.5. However, during a systemic infection the organism must be able to respond 
to the much higher pH of blood (7.4). Previous microarray analysis has demonstrated 
that expression of 18% of the GBS genome is altered in response to a change in 
environmental pH and the majority of these changes are controlled by the covS/covR 
operon (Santi et al., 2009a).  This agrees well with our finding that normal 
acidification of the phagosome appears essential for GBS survival, since inhibiting 
acidification through the vATPase with concanamycin A reduces the survival of the 
organism.  An analogous phenomenon occurs in the fungal pathogen Cryptococcus 
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neoformans , in which a change in pH triggers transcriptional changes to promote 
intracellular survival (Levitz et al., 1997), and in Salmonella typhimurium,  where a pH 
drop is a prerequisite for expression of SPI-2 secretion system and the consequential 
expression of effectors that modify the phagosome (Sanchez, 2011, Arpaia et al., 
2011).
 
5.3 How might the CovS/R two component system be aiding the 
organism’s survival within murine cells?   
In this work the CovS/R two component system has been demonstrated to be 
required for GBS to survive within the murine macrophage cell line J774, although 
seemingly not within human macrophages.  The CovS/R (Control of virulence 
regulator) system in GBS was identified due to homology to the CsrR (capsule 
synthesis regulator) system in GAS (Glaser et al., 2002). Orthologs of the regulator 
element but not the cognate sensor have also been described in S. suis (Pan et al., 
2009) and S. mutans (Idone et al., 2003).   
On initial investigation, the GBS CovS/R TCS appears unusual in comparison to 
orthologous systems in closely related species. In GAS, S. suis and S. mutans, CovR 
acts chiefly as a repressor (Graham et al., 2002, Idone et al., 2003, Pan et al., 2009) 
but in GBS it up-regulates and down-regulates equal numbers of genes (Jiang et al., 
2008).  Additionally, deletion of CovR in S. suis  (Pan et al., 2009) or CsrR/S in GAS 
(Graham et al., 2002) leads to increased virulence in animal models, and improved 
intracellular survival of the mutant strain in phagocytic cells compared to wild type 
strains.  In support of the reduced intracellular survival of a ∆covS/R  strain, GBS 
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strains deleted in CovS/R or CovR have been shown to display decreased virulence 
in murine models (Lamy et al., 2004, Jiang et al., 2005). However, it is clear both 
from my own work and that of others (Jiang et al., 2012) that the contribution of the 
CovS/R system to GBS virulence is complicated and may be host variable.  In 
support of this, one study has found the GBS ∆covR strain to be increased in 
virulence in a murine model compared to the wild type (Lembo et al., 2010), due in 
part to its increased ability to cross the blood brain barrier (Lembo et al., 2010).   
Interestingly, a very successful strain of GAS that is currently causing outbreaks in 
the Pacific region has been shown to have mutations in the CsrR system, leading to 
an increased invasive phenotype (Tran-Winkler et al., 2011).  In GBS, a strain 
isolated from a patient with toxic shock syndrome was hyperhaemolytic and had 
mutations in the covR gene (Sendi et al., 2009a), confirming the clinical importance 
of studying this TCS. 
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The role of CovS/R in intracellular survival 
In GAS the CovS/R TCS has been shown to be up regulated 6 hours post 
phagocytosis (Hertzén et al., 2012), whereas in GBS CovS is downregulated after 30 
minutes incubation in blood but increased after 90 minutes (Mereghetti et al., 2008).  
Having identified phenotypically that the TCS is important for GBS survival in murine 
cells, it will be of great interest in the future to characterise the gene regulation that 
occurs through this system within the conditions of the phagosome. 
Unsurprisingly, given that the CovS/R system regulates approximately 7% of the 
GBS genome, strains deleted in CovS/R show pleiotropic effects in both GBS and S. 
suis. Deleted strains are phenotypically hyperhaemolytic, hyperadherent (Pan et al., 
2009, Jiang et al., 2005, Lamy et al., 2004) and show a reduced ability to replicate in 
nutrient limited media (Lamy et al., 2004).   
An attractive model based on our data is therefore an extension of that postulated by 
Santi et al (Santi et al., 2009a) in which intracellular GBS within a phagosome require 
a drop in pH to stimulate CovS autokinase activity.  This is required for 
phosphorylation of CovR, increasing its promoter binding activity and regulating 
genes that aid the organism’s survival in the phagosome.   In the absence of this 
decreasing pH signal, either through inhibition of the phagocyte vATPase or due to 
the loss of the pathogen’s ability to sense the pH change, then the organism fails to 
adapt to the intraphagosomal conditions. Figure 26 summarises a potential model by 
which CovS/R aids the organisms ability to survive within the phagosome. 
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Figure 26: Adaptation to the phagosome through CovS/R
Adaptation to phagosomal conditions through the action of the CovS/R two component system.  In 
response to a drop in pH CovS may phosphorylate CovR and increase the DNA binding capacity of this 
regulator.  Genes regulated by CovR include the immunomodulatory proteins cylE and bibA and proteins 
involved in metabolism, nutrient transport and protein synthesis. The pilus protein is upregulated in acidic 
conditions independently of CovR, while cell wall modifications may help the organism resist the antimicro-
bial phagosome in a CovR dependent manner.
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As heterotrophs, GBS and other bacteria use transporters to bring nutrients into the 
cytoplasm and this is an important adaptive response to a nutrient limiting 
environment such as the phagosome. The largest group of functional genes 
dysregulated in the ∆covS/R strain are those involved in small moleculer transport, 
including the iron siderophore receptor FhuD and genes required for polyamine 
synthesis (Santi et al., 2009a). These genes are up-regulated in low pH in a CovS/R 
dependent manner.  This suggests that in acidic conditions GBS enters a highly 
active metabolic state, and the low pH of the phagosome could be a favourable 
environment to trigger this. Without the pH regulated metabolic change, the organism 
may therefore not be able to remain viable in the nutrient limiting phagosome.  
CovR has been shown to bind directly to cylX, the regulatory element of the cylE 
operon, and repress transcription of this operon (Lamy et al., 2004). CylE is down 
regulated at low pH in the presence of CovR (Santi et al., 2009a), which suggests 
that CovR will be repressing expression of β-h/c within an acidified phagosome.  In 
our experimental conditions, ROS production was low and therefore the role of the 
cylE associated carotenoid pigment is thought to be minimal.  Consequently the 
repression of cylE by CovR in acidic conditions such as the phagosome may be more 
important due to the decreased production of the β-h/c toxin (Santi et al., 2009a).  
The β-h/c has been shown to cause cell and tissue damage and increase membrane 
permeability (Liu et al., 2004, Pritzlaff et al., 2001), as well as stimulating cells to 
increase nitric oxide production and undergo cytoskeletal rearrangements (Talati et 
al., 2008, Fettucciari et al., 2006, Fettucciari et al., 2011, Ulett and Adderson, 2005). 
The immunomodulatory role of the toxin is discussed in more detail later in 
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connection with the differences seen in survival of the mutant in murine and human 
cells. An interesting future line of work would be to look at the intracellular or even 
specifically intraphagosomal expression of cylE, either by RT-PCR or using a reporter 
assay.   
To further investigate the role of CovS/R and pH in resisting phagosomal killing it 
would be interesting to analyse the sensitivity of the ∆covS/R mutant to antimicrobial 
peptides and degradative enzymes.  Within the CovS/R regulon are genes involved 
in cell wall synthesis, and consequently ∆covS/R has an altered cell wall structure 
(Lamy et al., 2004), which is likely to strongly impact upon the organism’s ability to 
resist antimicrobial peptides (Boone and Tyrrell, 2012, Poyart et al., 2003, Quach et 
al., 2008, Hamilton et al., 2006, Allen and Neely, 2012).
 
5.4 How can  the survival difference observed with the ∆covS/R strain 
between J774 cells and hMDM be explained? 
Despite the convincing killing of ∆covS/R strain by J774 murine macrophage-like 
cells, in human monocyte derived macrophages (hMDM) the mutant shows similar if 
not improved survival to the wild type. Potentially, this could be due to differences 
between cell lines and primary cells and/or differences between mouse and human 
cells.  The increased survival of the ∆covS/R mutant in hMDM was surprising as it is 
generally held that primary cells are more antimicrobial than cell lines.  As shown in 
this study, the rate of ROS production is higher in primary human cells than the J774 
cell line.   
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One of the most striking differences between human and mouse macrophage biology 
is the role of the inducible nitric oxide synthase (iNOS) (Fairbairn et al., 2011, Mestas 
and Hughes, 2004).  In mice iNOS is upregulated during macrophage infection and is 
important for control of intracellular organisms, but this has not been observed in 
human macrophages.  This general difference is also true for GBS infection, which 
upregulates iNOS in murine macrophages (due to the combined action of the β-h/c 
and the cell wall (Ring et al., 2002) but not in human macrophages (Ulett and 
Adderson, 2005). Increased NO production in murine cells infected with GBS can 
also be achieved through TLR9 signalling. TLR9 is more abundant in murine cells 
than human cells and in GBS infection responds to the presence of ssRNA and DNA  
(Talati et al., 2008, Deshmukh et al., 2011a, Deshmukh et al., 2011b).  The increased 
NO production in this context has been shown to enhance phagosomal processing of 
intracellular organisms in a positive feedback loop (Deshmukh et al., 2011b). 
The experimental data obtained in hMDM taken with previous published reports on 
GBS and murine macrophage interactions leads to an alternative model to that 
proposed in section 5.4 and figure 25 to explain the decreased survival of ∆covS/R 
strain observed in murine macrophages (Figure 27) 
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Figure 27: Overexpression of β-haemolysin in strain ΔcovS/R
Overexpression of β-h/c may stimulate murine macrophages to incite an increased antimicrobial 
attack.  In the absence of CovR mediated repression, ΔcovS/R strains overexpress β-h/c. In murine cells 
but not in hMDM GBS infection, through recognition of β-h/c, the cell wall and signalling through TLR9, 
increases the transcription and activity of iNOS leading to elevated levels of nitric oxide.  An increase in 
NO leads to apoptosis, increased cytokine production and increased phagosomal processing. β-h/c has 
also been shown to cause membrane damage with a subsequent influx of calcium irons activating calpain 
proteins. Calpain activation can modify the host cell cytoskeleton, leading to cytoskeleton dependent cell 
signalling events and also initiation of apoptosis
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Overexpression of the β-h/c pore forming toxin combined with murine cell host 
factors may be the key to the different survival within the cell types. β-h/c, in murine 
cells but, importantly, not in hMDM, has been shown to increase the levels of nitric 
oxide (and subsequently RNS) within the GBS infected cell (Ulett and Adderson, 
2005).  Whilst In vitro data presented in this thesis revealed that wild type and 
∆covS/R  have similar sensitivities to RNS in terms of killing, others have proposed a 
more important role for these molecules in mediating host cell signalling (Ulett and 
Adderson, 2005, Bogdan et al., 2000).  Indeed it has been shown that NO increase 
enhances phagosomal processing of ingested GBS (Deshmukh et al., 2011b). To 
further understand the differences seen between murine and human cells, and the 
role of NO as a signalling molecule, it would be interesting to measure the levels of 
NO produced by cells infected with both wild type and ∆covS/R GBS and to look at 
subsequent changes in inflammatory signalling within these cells.  
Bacterial pore forming toxins can impair membrane integrity, and trigger an influx of 
calcium ions which can act as cell signalling molecules (Gekara et al., 2007). GBS 
infection has been shown, through a β-h/c-dependent mechanism, to increase the 
activity of calpains; Ca2+ dependent cytosolic proteases that drive cytoskeletal re-
modelling (Fettucciari et al., 2011). Therefore a change in host cell signalling due to 
the potential of β-h/c to cause membrane alterations should be considered when 
analysing any experimental data from a strain overexpressing β-h/c.  
A further aspect of both calpain activation and NO increase by the GBS β-h/c is the 
induction of apoptosis in infected cells (Ulett and Adderson, 2005, Fettucciari et al., 
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2006).  It is known that the induction of apoptosis in murine macrophages by GBS is 
β-h/c dose dependent (Liu et al., 2004, Fettucciari et al., 2000), so in the ∆covS/R 
strain (which is overproducing the cytolysin) there may be an increase in host cell 
death. Nonetheless, based on trypan blue counting there was no evidence for 
increased macrophage death in our assay, although it would be useful to use a more 
sensitive method for example a lactate dehydrogenase release assay to monitor 
cellular lysis or staining for cellular markers of apoptosis such as annexin 5 in order 
to confirm this in the future.  
More generally, our data highlight the significance of species-specific differences and 
thus the importance of choosing appropriate model systems. At present, most 
published data on GBS pathogenesis and host pathogen interactions is from murine 
models and thus extrapolation to the human disease should be carried out with 
caution.
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CONCLUSION  
 
This study has focused on improving our understanding of the interaction of GBS 
with phagocytic cells of the innate immune system.  Important findings are the 
reduced oxidative burst produced by GBS infection under non- opsonising conditions 
and the requirement for acidification of the phagosome to trigger intracellular survival 
of GBS. The role of the two component system CovS/R in intracellular survival is 
likely to be complex and multifactorial.  Not only does it upregulate genes that may 
aid adaptation to phagosome conditions but it also downregulates the β-h/c, which (in 
murine cells at least) has previously been shown to play an important role in 
stimulating a host cell response. 
A large amount of work still needs to be done to understand the true nature of the 
GBS-macrophage interaction.  An organism which can be visualised within cells 
would allow for experiments that would greatly enhance this understanding and 
therefore the following chapter describes the evaluation of GFP expressing 
streptococci for this purpose. 
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INTRODUCTION 
Many of the interesting questions concerning the ability of GBS to persist inside 
macrophages would benefit from being able to follow live organisms within cells.  
Due to the small size of streptococci, resolving the organism inside cells by light 
microscopy is difficult. Visualisation requires a detectable marker such as a 
fluorescent dye.  Fluorescent antibody labelling generally requires the cells to be 
fixed, therefore preventing any live imaging.  Live organisms can be covalently 
labelled with fluorescein isothiocyanate (FITC) (Carlin et al., 2009) and followed in 
real time. However this method has limitations for use with intracellular organisms, 
since the dye binds to bacterial surface proteins and this may change host pathogen 
interactions.  In addition, the FITC signal may be lost due to photobleaching (Shaner 
et al., 2005), can be quenched in acidic conditions and will be diluted out during cell 
replication. 
Green Fluorescent protein (GFP) has been successfully used to visualise intracellular 
organisms in many bacterial species (Campoy et al., 2011, Gille et al., 2006, 
Clemens et al., 2009, Voelz et al., 2010).  Originally cloned from the jellyfish 
Aequorea victoria, GFP fluoresces green at an excitation wavelength of 488nm, 
emitting green light at an optimal wavelength of 507nm and requiring no co-factors or 
specific substrates. The gene can be introduced into bacterial hosts (with expression 
driven by a bacterial promoter) either on a plasmid or introduced into the bacterial 
cell chromosome. 
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Recent publications have used GBS strains carrying a GFP expressing plasmid as a 
reporter to monitor endogenous promoter activity (Gleich-Theurer et al., 2009) and to 
quantify phagocytosis of the organism by monocytes using flow cytometry (Gille et 
al., 2009). Plasmid expressed GFP in the related organism Streptococcus gordonii 
has been used to visualise biofilm formation (Aspiras et al., 2000, Hansen et al., 
2001) 
To track the fate of phagocytosed GBS it would be desirable to visualise by 
microscopy live intracellular organisms for the duration of the survival assay.  Time 
lapse imaging could be used to follow the infection in real time, identifying if the 
organism is residing in phagosomes for the duration of the assay, if any replication of 
the organism is occurring and if the organism is able to kill or escape the host cell.  
Having a live fluorescent marker on the organism in conjunction with other 
fluorescent cellular markers would also enable determination of the subcellular 
location of the internalised GBS.   
In order to be able to use a GFP strain for these purposes the GFP expressing strain 
needs to be reliable and show a comparable intracellular survival phenotype to a wild 
type strain.  Fluorescence must be consistently expressed independently of 
replication, growth phase and environment and be able to be  detected.  The 
following work has looked at three GFP expressing plasmids for use in GBS; pMA2 
from Streptococcus gordonii, pBSU98 from a GFP expressing strain of streptococci 
and pBSU101, a vector developed for use in Group B Streptococcus.
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RESULTS 
6.1 The plasmid pMA2 displays variable GFP expression 
The Streptococcus -E.coli shuttle vector pMA2, developed for expression of GFP in 
Streptococcus gordonii, has the GFP gene under the control of the promoter for the 
hppA gene (Aspiras et al., 2000).  The hppA promoter is an active endogenous 
Streptococcus gordonii promoter driving expression of the hppA gene which encodes 
an oligopeptide binding lipoprotein.   
When this plasmid is transformed into GBS the resultant colonies appear green on 
solid media (Figure 28a) and using time lapse microscopy intracellular organisms can 
be seen and followed inside J774 macrophages for over 40minutes (Figure 28b). 
However in a population carrying the plasmid only around 10% of the organisms 
appeared to display fluorescence.  Thus the mean fluorescence level for a population 
of bacteria, as detected for instance by plate reader analysis, is too low to be useful 
(Figure 29). In addition, the heterogeneity in fluorescence expression, combined with 
the moderate uptake of the organism into macrophages, meant that the vector pMA2 
was not a viable option for detecting intracellular organisms. 
To examine this in more detail, the hppA promoter region on this plasmid was 
sequenced using the primer Pr6F and aligned with the promoter region that had been 
amplified from the S.gordonii chromosome during initial plasmid construction (Aspiras 
et al., 2000). This sequence revealed mutations throughout the promoter sequence 
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(Figure 30b) which may potentially be one cause of the heterogeneous efficiency of 
GFP transcription. 
Therefore, in conclusion plasmid pMA2 GFP expression is weak and heterogeneous 
and, although carrying this plasmid does not affect the growth of the organism, 
fluorescence levels are too poor to be useful for visualising intracellular organisms. 
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Figure 28: Colonies of NEM316:pMA2 express GFP
Colonies of NEM316 carrying pMA2 express GFP. a) Individual colonies of NEM316:pMA2 (i) grown on 
solid media and viewed with an epi-fluorescence stereo microscope can be seen as green when using the 
blue filter (ii). b) J774 cells infected with NEM:pMA2 were visualised using a time lapse imaging capture 
system.  NEM316:pMA2 (arrowed) can be seen by detection of GFP expression. The organism is seen 
residing inside the J774 cell as it moves around the field of view. Selected stills are presented from a 
series of images taken every two minutes. 
i ii
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Figure 29: Plasmid pMA2 does not impose a fitness cost
Plasmid pMA2 does not infer a fitness cost to NEM316:pMA2, however GFP expression is weak.  
Figure 29a shows growth of WT NEM316 and NEM316:pMA2 measured by OD600 readings every 20 
minutes for 11 hours.  Figure 29b Shows fluorescence (excitation 485-12, emission 520) every 20 minutes 
for 11 hours, no fluorescence can be detected above the level of the baseline. The images presented are 
representative curves of three repeats.
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Pr6FHJ26
HJ25
CLUSTAL 2.1 multiple sequence alignment
--------------------------GGAAGCTGA----AAATGGATTAA-GAAAAAGAA
AAACCAGTAACGAAGAAAGAGTATCAAGAAGCTGAGAAGAAATGGATTAAAGAAAAAGAA
********    *********** *********
GAATCTAACAAAAAAG-CTCAAGAAGAACTTGAGAAGCATATAAAATAATCCGTAATTCC
GAATCTAACAAAAAAGGCTCAAGAAGAACTTGAGAAGCATATAAAATAATCCGTAATTCC
**************** *******************************************
CCCCTATCT-CAAT---GAGAGATAGGGGGTG--TTTTAGTAA--TTAAGTGAGAAG-AA
CCC-TATCTTCAATTGAGAAGAATAGGGGGTTGTTTTTAGTAAATTTAAGTGAGAAGGAA
*** ***** ****   **   *********   *********  ************ **
GGATAGTT-GTTTTTT----AAGAAAGGAAAGAGGATAATAAGACCCG--TTATTTTTGA
GGATAGTTTGTTTTTTTAAGAGGAAGGAGAAGAGGATAATAAGACCCCGTTTATTGTTGA
******** *******    * *** *  ******************   ***** ****
AATCGCCAATATTTCACATGTTGAATACCCTATAGGAGC-TATGTATTTGTTGGCTATGT
AATCGCCAATATTTCACATGTTGAATACCCTATAGGAGCCTATGTATTTGTTGGCTATGT
*************************************** ********************
GAGTCAATATCACAAAATATTCTGACAATTCTGGTTTACATTTAAATTATTATGTGATAT
GAGTCAATATCACAAAATATTCTGACAATTCTGGTTTACATTTAAATTATTATGTGATAT
************************************************************
AATCTTAGACAAAACTAAATTTGAAATTGAAATGGAGCTCGGAGGCATATCAAATGGGTA
AATCTTAGACAAAACTAGATTTGAAATTGAAATGGAGA----------------------
***************** *******************                       
AAGGAGAAGAACTTTTCACTGGAGTTGTCCCAATTCTTGTTGAATTAGATGGTGATGTTA 431
------------------------------------------------------------
Pr6F
HJ26
GFP
PhppA (L41358)
pMA2 (Pr6F)
PhppA (L41358)
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PhppA (L41358)
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Figure 30: Sequence of the hppA promoter region
The sequence of the hppA promoter region on plasmid pMA2 is different from the published 
sequence. The promoter sequence of pMA2 was sequenced from the primer Pr6F, which reads through 
PhppA and into the sequence of the GFP gene (Figure 30a). The sequence was aligned using clustalW 
(Figure 30b) against the published sequence for the region that had been amplified using primers HJ25 
(not shown, due to it being upstream of PrF) and HJ26 during plasmid construction. Consensus sequence 
is marked as stars. The promoter sequence from the pMA2 plasmid used to express GFP in GBS shows 
multiple nucleotide changes from the published sequence.
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6.2  Strains BSU98 and BSU99 have an intracellular survival defect, 
which may be due to a fitness cost associated with the GFP expressing 
plasmid. 
Strains BSU98 and BSU99 were developed to measure intracellular survival in 
human monocytes using flow cytometry (Gille et al., 2009). Strain BSU98 has been 
constructed from the parental strain 090R carrying a pAT28 plasmid with EGFP 
expressed under the control of the cfb (CAMP factor) promoter. Strain BSU99 is 
carrying a control plasmid, which is unable to express GFP (Gille et al., 2009). The 
parental strain, 090R, is a poorly encapsulated variant of the serotype Ia strain 090 
(Wessels et al., 1989). This strain was generated by serial passage in anti-serotype 
Ia antisera by Rebecca Lancefield in the 1920’s (Craig Rubens, personal 
communication) and is therefore not a well characterised strain.   
When tested for intracellular survival under our assay conditions strains BSU98 and 
BSU99 show decreased intracellular survival in macrophages compared to strain 
NEM316 (Figure 31). They do however show strong GFP expression which can be 
clearly visualised within macrophages (Figure 32).   
The poor intracellular survival of strains BSU98 and BSU99 (which may be due to the 
strain background not being representative of wildtype GBS strains) led us to 
conclude that these strains would not be useful for monitoring intracellular dynamics 
of streptococcal infection. This poor intracellular survival is in line with the published 
sensitivity of these strains to killing over 180 minutes by cord blood monocytes and 
peripheral blood monocytes (Gille et al., 2009).
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Figure 31: Intracellular survival of strains BSU98 and BSU99
The capacity for intracellular survival in J774 macrophages is reduced in strains BSU98 and 
BSU99. Strains BSU98 and BSU99 were used to infect J774 macrophages. At three, six and nine hours 
post infection the number of viable intracellular organisms were enumerated by CFU count. Wild type 
NEM316 and L. lactis were included as controls. Survival of BSU98 and BSU99 is markedly reduced 
compared to NEM316
Figure 32:  Intracellular expression of GFP by strain BSU98
GFP expressing strain BSU98 can be clearly visualised inside macrophages using fluorescence 
microscopy.  J774 macrophages were infected with BSU98. GFP expression was visualised using 
microscopy.  Figure 32 panel (i) shows a false coloured image of GFP expressing BSU98 within a J774 
macrophage. A phase image of the same cell can be seen in (ii); chains of streptococci are marked with an 
arrow. 
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6.3  Evaluation of NEM316:pBSU98 
Since GFP expression was high from strain BSU98, the vector (pBSU98) was 
removed from BSU98 and transformed into the NEM316 strain to construct the 
tagged strain NEM316:pBSU98. NEM316:pBSU98 showed high levels of GFP 
expression both on solid medium (Figure 33) and in RPMI (Figure 34). Growth of 
NEM316:pBSU98 was however significantly retarded compared to wild type NEM316 
(Figure 34). The decrease in fitness of these strains could be due to toxicity 
associated with the GFP protein or the cost to the host associated with high level 
protein expression. 
Thus, plasmid pBSU98 confers high levels of GFP fluorescence in the host strain, but 
this is detrimental to the growth rate of the organism, limiting its usefulness for 
studies of intracellular survival. 
 
6.4  Fluorescence emitted by the GFP protein is stable and appears to 
vary with growth phase. 
In addition to the strain-specific growth issues described above, we noted a number 
of other limitations with this experimental approach.  Firstly, it is well documented that 
the GFP protein is generally very stable (Cubitt et al., 1995) .  
In line with this, we observed that fluorescence can be detected from intracellular 
organisms that are non culturable having been killed prior to infection (Figure 35). 
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Persistence of fluorescence in killed organisms may make this method of visualising 
intracellular organism inappropriate as dead organisms will potentially still be visible.  
Secondly, colonies of NEM316:pBSU98 showed a high level GFP expression, which 
appeared to be growth phase or density dependent, since colonies on the outside of 
a semi confluent lawn of organism had higher detectable levels of fluorescence than 
those inside  (Figure 33). In addition, although levels of GFP fluorescence increased 
with cell density during exponential growth (Figure 34), a slight delay of 
approximately one hour was observed before detectable fluorescence started to 
increase. Fluorescence intensity continued to increase after NEM316:pBSU98 had 
reached stationary phase.  
Accordingly, the dynamics of GFP protein expression and degradation and how the 
promoter driving expression is regulated must be considered in constructing a 
reporter for use in monitoring intracellular organisms.
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Figure 33: GFP expression on solid media
Strain NEM316 carrying plasmid pBSU98 shows good GFP expression on solid media, which is 
growth phase or density dependant.  Streaks of a lawn of strain NEM316:pBSU98 grown on THYSpec 
plates were visualised using an epi fluorescence stereo microscope. The two images presented are from 
the same plate with the same starting inoculum streaked in a dilution series, such that image (ii) is ten 
times more concentrated than image (i). Colony density can be seen in the light image in panel a) with the 
corresponding GFP image below in panel b).  Good GFP expression can be seen in this strain. Colonies 
that are on the edge of the lawn exhibit higher levels of detectable GFP compared to those in the higher 
density region at the centre of the lawn. 
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Figure 34:  Growth rate of strain NEM316:pBSU98
Levels of GFP fluorescence increase with increasing optical density in NEM316:pBSU98 however 
this strain shows a decreased growth rate. NEM316:pBSU98 was cultured in RPMI medium. OD600  (a) 
and (b) fluorescence (excitation 485-12 emission 520) measurements were taken every 20 minutes for 11 
hours. Compared to NEM316, NEM316:pBSU98 shows a decreased growth rate and takes longer to reach 
maximum OD. GFP fluorescence levels seen in b) increase in accordance with optical density increase. 
The approximate phase of exponential growth for NEM316:pBSU98 is indicated with arrows on both the 
OD and fluorescence measurements. Maximum OD is reached at six hours in NEM316:pBSU98. The level 
of fluorescence detected continues to increase past this point reaching maximum at nine hours.
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Figure 35:  Stability of GFP
The GFP protein is stable in killed microorganisms.  GFP expressing streptococci were killed by heat, 
antibiotics or UV. After infection into J774 macrophages GFP expression was visualised using microscopy. 
GFP expression can be seen in non-culturable organisms. 
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6.5  Plasmids encoding the GFP gene confer a fitness cost to the host 
cell 
Having identified the detrimental effect of the presence of the plasmid pBSU98 to the 
host cell both on intracellular survival and during growth in defined media, NEM316 
was transformed with a pair of plasmids, pBSU101 (NEM316:pBSU101) carrying the 
EGFP gene under the control of the cfb promoter and pBSU100 (NEM316:pBSU100) 
the same construct but without the promoter. The presence of the control plasmid 
pBSU100 allowed us to separate the cost of carrying the plasmid and the cost of 
expressing the GFP protein.  
The intracellular survival of three individual transformants of the two strains can be 
seen in Figure 35. The survival assay was performed both with and without 
spectinomycin (to select for the plasmid). There is no difference in survival in the 
presence or absence of spectinomycin for either of the strains (excluding 100 clone B 
which may have lost the plasmid). Multiple clones were selected to try to select the 
most stable and healthiest clone for use in visualising intracellular organisms. 
Strains harbouring both plasmids showed a decreased ability to cope with 
macrophage killing (Figure 35). Strains that are carrying the plasmids show visible 
phenotype changes; colonies look small, dry and hyperpigmented compared to the 
wild type.  Recovery of the strains from frozen stocks is inconsistent and the resultant 
colonies are slow and show variable growth. This has made assays with these 
strains difficult to perform.  
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In conclusion, although the pBSU98 and pBSU101 plasmids confer high level GFP 
fluorescence the host cells do not show wild type phenotypes, thus preventing proper 
analysis of the strains in order to determine their viability in being used for live 
imaging.
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Figure 36: Intracellular survival of strains carrying plasmids pBSU100 and pBSU101
Strains of NEM316 carrying the plasmid pBSU100 or pBSU101 have decreased intracellular survival at six hours post infection. Three 
individual colonies from a transformation were selected and used to infect J774 macrophages. The assay was carried out in the presence and 
absence of spectinomycin. rCFU is presented at six hours post infection. No difference can be seen between the viable count in the presence or 
absence of spectinomycin with the exception of 100B which may have lost the plasmid. Intracellular survival is decreased in all clones carrying 
either plasmid compared to the wild type. This was statistically significant in strains 100A and 100C but not when tested in the others, this may 
reflect the low number of repeats. Repeating the assay was challenging due to the poor and inconsistent growth of strains.  Statistical significance 
(Mann-Whitney U p<0.05) in survival compared to wild type is marked by a star n=3. 
*
* *
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DISCUSSION 
To facilitate intracellular visualisation of group B Streptococcus it would be desirable 
to be able to express Green Fluorescent protein (GFP) in the organism.  We have 
tested three plasmids, pMA2 previously used in Streptococcus gordonii  (Aspiras et 
al., 2000) and  pBSU98 and pBSU101 used in Streptococcus agalactiae (Gille et al., 
2009, Aymanns et al., 2011).  Plasmid pMA2 did not affect growth of the bacterial cell 
but, as seen in Streptococcus gordonii, had weak and heterologous GFP expression 
(Aspiras et al., 2000).  Plasmids pBSU98 and pBSU101 expressed strong 
fluorescence but to the detriment of growth of the host bacterium.  pBSU98 and 
pBSU100/101 are related plasmids carrying the gene for Enhanced Green 
Fluorescent Protein (EGFP) which shows increased solubility and fluorescence 
intensity compared to wild type GFP and is now in widespread use, hence it will be 
referred to as GFP in the remainder of the text.   
 
Optimal folding of GFP is seen in the presence of oxygen and at a pH of 7 (Cubitt et 
al., 1995, Hansen et al., 2001).  The microaerophilic conditions and reducing 
environment of the streptococcal cytoplasm have previously been suggested as the 
cause of heterogenous GFP fluorescence detection in Streptococcus gordonii 
carrying plasmid pMA2 (Aspiras et al., 2000).  However high level GFP fluorescence 
can be detected in GBS carrying pBSU98 and 101, suggesting that correct 
fluorophore formation is able to occur within the Group B streptococcal cytoplasm.  
The poor GFP fluorescence detected in NEM316:pMA2 could be due to poor gene 
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expression. Transcription through the hppA promoter may be sub-optimal due to 
species specific gene regulation. In addition the observed changes in the hppA 
promoter sequence could lead to inefficient recognition and binding of transcription 
factors and RNA polymerase.   
The requirement of carefully controlled conditions for optimal GFP folding may 
explain the increase in GFP fluorescence seen at the edge of the colony of 
NEM316:pBSU98. The edge effect may be due to limited availability of oxygen in the 
dense region of growth on the plate. However, (Hansen et al., 2001) report folding of 
the protein in conditions of near anaerobiosis and instead suggest that the 
phenomenon of increased GFP expression seen at the edge of a colony could be 
reflective of the acidification of the medium by the growing organism (Hansen et al., 
2001).  In areas of dense growth, metabolic end products may lower the 
environmental pH, whereas in less dense regions the media and colony pH may stay 
nearer the optimal pH for fluorophore maturation.  The same group observe that 
during the prolonged stationary phase of S.gordonii fluorescence is not able to be 
detected, hence it is possible that colonies in the centre of the streak are older and 
thus in a prolonged stationary phase.  Finally, it has also been suggested that the 
thick cell wall of streptococci prevents detection of fluorescence (Aspiras et al., 2000, 
Hansen et al., 2001).  
 
GFP has a long half-life within the cytoplasm, of up to 24 hours (Qazi et al., 2001, 
Cubitt et al., 1995).  Similarly, we have observed continued GFP fluorescence in 
organisms that have been subjected to killing and are not able to be cultured.  
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Fluorescence in dead organisms will reduce the potential of this protein as a reporter 
for intracellular organisms, since fluorescence may still be seen in non-viable 
organisms providing they are intact and the protein is not subjected to denaturing 
conditions.  In line with this, the decrease in mean GFP fluorescence as detected by 
flow cytometry by (Gille et al., 2006) is not as rapid as the decrease in the number of 
viable intracellular organisms (Gille et al., 2009).  During growth of NEM316:pBSU98 
fluorescence could be detected increasing with cell density. However, there is a 
prolonged lag phase before the detectable fluorescence increases, this may be due 
to delay in gene expression through the promoter but could also be attributed to the 
time required to generate a mature fluorophore. (Qazi et al., 2001) observed that 
GFP fluorescence took longer to be detected than luciferase generated 
bioluminescence when both genes were under the control of the same promoter.   
 
Interestingly fluorescence can be seen continuing to increase after the OD600  has 
plateaued, indicating that the population has reached stationary phase and there is 
no more cell division. This continued increase in fluorescence could be due to the cfb 
promoter still being active in stationary phase. However this again supports the 
notion that GFP is not a good real time reporter of promoter activity due to the time 
required for post translational modification of the fluorophore (Qazi et al., 2001). The 
fluorescence detected does reach a maximum level, it is not possible to tell if this is 
due to a decrease in promoter activity at late stationary phase, a decrease in the 
protein folding due to environmental conditions, or the amount of GFP protein able to 
be tolerated by each cell. 
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Plasmids pBSU98 and pBSU101 express GFP under the control of the cfb promoter. 
The cfb promoter is a strong promoter (Gleich-Theurer et al., 2009) which makes it 
ideal for high level expression of GFP. The cfb gene encodes the CAMP factor, 
(Podbielski et al., 1994),  a pore forming toxin which is not directly implicated in the 
pathogenesis of GBS (Hensler et al., 2008, Lang and Palmer, 2003). The cfb gene is 
regulated, since expression is decreased at pH7.0 (Santi et al., 2009a) and up 
regulated in a CsrR (CovR) deletion mutant suggesting regulation can occur through 
this two component system (Jiang et al., 2005).  Regulation of the cfb promoter may 
give inconsistent gene expression and subsequent fluorescent levels during 
intracellular monitoring, making it non-ideal for our purposes. 
 
Initially the poor survival of NEM316:pBSU98 was thought to be due to the high level 
of GFP protein being produced by the organism, with the potential for misfolding in 
the less than optimal conditions in the GBS cytoplasm.  Misfolded proteins may form 
into weakly fluorescent inclusion bodies. When GBS was transformed with pBSU100 
containing a promoter-less copy of the GFP gene, the fitness cost was still observed.  
The backbone for these constructs is the multi-copy number plasmid pAT28.  Multi 
copy number plasmids may divert host cell resources into plasmid replication and 
maintenance.  pAT28 (Trieu-Cuot et al., 1990) encodes a spectinomycin 
adenyltransferase which may act as an energy drain on the host cell and in addition 
by-products generated by this enzyme may affect the health of the cell.  The 
observed hyperpigmented phenotype of NEM:pBSU100 and NEM:pBSU101 
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suggests that the CylE gene is upregulated.  This gene is also up regulated in strains 
deficient in CovS/CovR  two component system which as shown in chapter three 
exhibit a decreased capacity to survive within murine cells.   
 
In summary, the three plasmids evaluated are not currently suitable for live 
intracellular imaging, due either to low fluorescence levels or their tendency to induce 
atypical phenotypes (primarily poor growth) in host cells.  
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FUTURE WORK: Development of a fluorescent strain of GBS 
To date there are only a few publications using GFP in streptococci (Aymanns et al., 
2011, Gille et al., 2009, Gille et al., 2006, Gleich-Theurer et al., 2009, Hertzén et al., 
2012, Qazi et al., 2001, Qazi et al., 2004). Discussion with colleagues working on 
Gram positive organisms around the world has highlighted that GFP expression is a 
challenge that is not limited to GBS.  In the future, inserting the GFP gene into the 
GBS chromosome would be one strategy to remove the possible cost of maintaining 
a plasmid with antibiotic selection.  Expression may be reduced in this situation, due 
to only having one copy of the gene, in spite of this under a strong promoter such as 
the cfb promoter protein expression may still remain high enough to be detected. 
However, this chromosomal insertion of the GFP gene into the GBS chromosome 
has been tried by researchers with little success (Brandon Kim, personal 
communication).   
Secondly, the GFP protein has been cloned and codon optimized for use in a 
mammalian host.  Modification of the GFP sequence to reflect the low CG content 
genome, the codon preference and tRNA prevalence of GBS may improve 
expression of the gene.  In support of this, the expression of Yellow fluorescent 
protein and Cyan fluorescent protein has been improved in Bacillus by modifying the 
gene sequence to include codons favoured by this organism (Sastalla et al., 2009). 
The same study demonstrated an improvement in GFP intensity with an optimised 
sequence variant, however the GFPmut1 described in this study has a low GC 
content (39%) and as such did not require substantial modification for optimal 
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expression in Bacillus. Similarly the EGFP gene used in plasmid pBSU101 has a 
GFP content of 40% this is not much higher than the GC content of the GBS genome 
which is 35%. Condon optimisation and reduction of CG content in the EGFP gene in 
pBSU101 may reduce the fitness cost of carrying this plasmid to GBS and improve 
GFP expression.    
To address the issue of prolonged GFP stability following host cell death, changing 
the C terminal end of the protein may reduce the half-life of the protein as it would 
facilitate recognition by host cell proteases.  Tools including optimal promoter and 
terminator sequences have been optimised by (Ruiz-Cruz et al., 2010) and such 
systems could be helpful in developing the optimal GFP expressing plasmid for GBS. 
Ideally a promoter for GFP expression would be constitutively expressed and not 
regulated, promoters for housekeeping genes (Voelz et al., 2010) or a synthetic 
promoter such as the synthetic constitutive lactococcal promoter CP25  could be 
considered (Lun and Willson, 2004). 
An approach that was tried during this study to improve fluorescent detection of GBS 
was to replace the GFP gene in the pMA2 vector with mCherry. This was not 
completed due to time constraints and technical difficulties.  mCherry is a fluorescent 
protein which fluoresces red upon excitation at 587nm, emission 610nm.  The protein 
has been cloned originally from a coral, Discosoma sp. (Shaner et al., 2005). These 
characteristics may give mCherry an advantage over GFP in terms of folding and 
maturation in the cytoplasm, although there are no published reports of the use of 
mCherry in streptococci.  
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In conclusion the three plasmids evaluated in this work are not currently suitable for 
live intracellular imaging but future work to develop a vector optimised for fluorescent 
protein expression in Gram positive organisms would aid the investigation of host 
pathogen interactions. 
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